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SUMMARY
Plasm inogen activator inh ib ito r (PAI) activity, tissu e  
p lasm inogen  activator (tPA) antigen  and  von W illebrand factor (VWF) 
an tigen  are  endothelial p roducts w ith  roles in fibrinolysis an d  p latele t 
function  respectively. Fibrin  D-dim er an tigen  (D-dimer) is a  m ark e r of 
cross-linked  fibrin form ation and  lysis.
P lasm a levels of these  four haem ostatic  variables (as well a s  the  
acu te  p h a se  reac tan ts , fibrinogen and  red cell aggregation) were 
stud ied  w ith  regard  to variability, associations w ith ischaem ic h e a rt 
d isease  (IHD) an d  its  risk  factors, and  associations w ith  d iabetes 
m ellitus (including m icroalbum inuria  an d  response  to in su lin  an d  
exercise). Laboratory, biological and  to tal variability  w ere defined and  
appeared  sa tisfactory  for clinical stud ies.
In a  population  sam ple (North Glasgow MONICA study) 
d istrib u tio n s and  independen t associations were defined. PAI w as 
rela ted  to tim e of day, se rum  triglyceride, alcohol in take, d iabe tes and  
in terleuk in -6 . tPA w as related to PAI, age, m ale sex, tim e of day, 
cigarette sm oking, triglyceride and  alcohol use . VWF w as rela ted  to 
age, sm oking an d  diabetes. D -dim er w as rela ted  to age, VWF, 
fibrinogen and  red cell aggregation.
In a  case control study, survivors of p rem atu re  m yocardial 
infarction  h a d  h igher levels of PAI, VWF, D-dim er, fibrinogen and  red 
cell aggregation (which were independen t of s ta n d a rd  risk  factors);
an d  of tPA (which w as n o t independent). In a  prospective popu lation  
s tu d y  (Caerphilly H eart Study), D -dim er and  VWF w ere independen t 
p red ictors of IHD events, while PAI an d  tPA w ere not. In a  prospective 
s tu d y  of p a tien ts  w ith  peripheral a rte ria l d isease  (Edinburgh 
C laudication  Study), D -dim er w as an  independen t p red ic to r of IHD 
events an d  progression  of arteria l disease; while fibrinogen w as a n  
independen t p red ic to r of m ortality.
N on-insu lin -dependen t diabetic p a tien ts  w ith  m icroalbum inuria  
(a p red ictor of IHD) h a d  h igher levels of tPA an d  VWF th a n  diabetic or 
non-d iabetic  controls w ithou t m icroalbum inuria . C om pared to n o n ­
diabetic controls, in su lin -dependen t d iabetic p a tien ts  h ad  lower 
increm en ts in  tPA in  response  to in su lin  induced  hypoglycaem ia or 
exercise, suggesting  an  endothelial defect.
The re su lts  of these  s tud ies  are  consisten t w ith  po ten tia l roles of 
d is tu rb ed  fibrinolysis, endothelial and  p late le t function , and  fibrin 
tu rnover in  the  pathogenesis of ischaem ic h e a r t d isease  and  of 
diabetic v ascu la r com plications.
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CHAPTER 1
REVIEW OF HAEMOSTASIS. FIBRINOLYSIS AND VON 
WILLEBRAND FACTOR IN CARDIOVASCULAR DISEASE AND 
DIABETES MELLITUS
INTRODUCTION
C ard iovascu lar disease, especially ischaem ic h e a r t  d isease  
(IHD), is th e  m ost im portan t cause  of d ea th  in  W estern  countries. 
Ischaem ic h e a r t  d isease  is due to the  progressive developm ent of 
a therosclero tic  p laques in  the  coronary a rte ries du ring  a d u lt life, and  
to th e  form ation of acu te  p latelet-fibrin  th rom bi u p o n  ru p tu re d  
p laques (Davies 1994). These acu te  th rom bi m ay  cau se  su d d en  
coronary  death , m yocardial infarction, or u n s ta b le  an g in a  (chest pa in  
w ith o u t evidence of infarction). Incorporation  of th rom b i in to  th e  
ru p tu re d  p laque m ay cause  an  increase  in  chronic sten o sis  an d  stab le  
an g in a  (Davies 1994) (Figure 1.1).
T he recen t epidem ic of IHD in  W estern  coun tries s ta r te d  in  th e  
1950's. Prospective s tu d ies  su ch  a s  th e  F ram ingham  stu d y  
estab lished  th a t  certa in  "risk factors" pred icted  IHD an d  o th er 
card iovascu lar d iseases su c h  a s  stroke an d  peripheral a rte ria l d isease  
(Kannel e t al 1961). T hese risk  factors include fam ily h isto ry  of 
card iovascu lar d isease, m ale sex, increasing  age, cigarette-sm oking, 
h igh  blood p ressu re , abnorm al blood lipids (high to ta l an d  low density  
lipoprotein  (LDL) cholesterol); h igh  triglyceride and  very low density
1
Multi  c h a n n e l e d  
l u m e n
Total c h r o n ic  
o c c l u s i o n
I n c r e a s e d
o b s t r u c t io n
H e a le d  f i s s u r e  
n o  n c r e a s e  in 
o b s t r u c t io n
F ig u re  1.1 D iagram atic rep resen ta tion  of th ro m b u s form ation (black) 
u pon  a  ru p tu red  atherosclerotic plaque (stippled). The th rom bus m ay 
totally  occlude the  artery  causing  m yocardial infarction; increase  
obstruc tion  causing  angina (unstable or stable); or heal w ith no 
increase  in obstruction. T hrom bus is e ither lysed by the fibrinolytic 
system , or replaced bv new connective tissu e  (grey). From Davies 
( 1994 ).
(VLDL) cholesterol; low high  density  lipoprotein  (HDL) cholesterol; 
obesity; im paired glucose to lerance an d  d iabetes m ellitus. More 
recently , h igh blood p ressu re , abnorm al blood lipids, obesity, glucose 
in to lerance  and  high p lasm a  in su lin  levels have been  grouped and  
recognised a s  th e  "insulin  res istance  syndrom e" (Reaven 1988). 
Prevention of card iovascu lar d isease  h a s  concen tra ted  on  lifestyle 
advice (reduce sm oking and  d ietary  sa lt an d  sa tu ra te d  fat; increase  
exercise and  d ietary  u n sa tu ra te d  fat; avoid obesity), an d  d rug  
tre a tm e n t of hypertension , dyslipidaem ia an d  diabetes.
In te rest in  the  con tribu tion  of th rom bosis to card iovascu lar 
d isease  is relatively recen t (Davies an d  T hom as 1984; Davies 1994). 
A ngiographic s tu d ies  (De Wood et al 1980) a s  well a s  p o s t m ortem  
stu d ie s  (Davies 1994) have show n th a t  coronary  th rom bosis is p re sen t 
in  m o st p a tien ts  w ith  acu te  m yocardial infarction  or u n s ta b le  angina. 
T he ISIS-2 Trial (1988) show ed th a t  b o th  asp irin  an d  throm bolysis 
w ith  strep tok inase  reduced  m ortality  in  acu te  m yocardial infarction, 
suggesting  th a t  b o th  p latele ts and  fibrin a re  im p o rtan t com ponen ts of 
th e  acu te  th ro m b u s (Figure 1.1). A spirin  h a s  also b een  show n to 
reduce  the  risk  of m yocardial infarction  an d  stroke  in  p e rso n s w ith  
chron ic  arte ria l d isease  (Antiplatelet T riallists C ollaboration 1994).
In 1980, M eade an d  colleagues in  th e  N orthw ick P ark  H eart 
S tu d y  show ed th a t  fibrinogen (the p recu rso r of fibrin) an d  clotting 
fac to rs VII and  VIII were pred ictors of fatal IHD (Meade e t al 1980), 
a n d  la te r of non-fata l IHD (Meade e t al 1986). T hese coagulation  
factors were a s  strongly  predictive a s  se ru m  cholesterol. T hese 
findings have been  confirm ed by  o ther g roups (E rnst an d  R esch  1993; 
H einrich et al 1994; Lowe et al 1995), an d  suggest th a t  tria ls  of
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fibrinogen lowering d rugs (e.g. bezafibrate) an d  oral an ticoagu lan ts 
w hich  lower factor VII (e.g.warfarin) shou ld  be perform ed. S u ch  
stu d ies  a re  in  progress (Meade 1995).
P latelets an d  clotting factors are  called "haem ostatic  variables" 
b ecau se  they  con tribu te  to the  form ation of th e  haem osta tic  p lug  
w hich  preven ts excessive bleeding after in ju ry  to blood vessels. Low 
levels of p latelets, of von W illebrand factor (VWF) w hich  is required  for 
p la te le t adhesion  an d  aggregation, or of clotting factors su c h  a s  factor 
VIII (anti-haem ophiliac factor) re su lt in  b leeding d isorders.
H aem ostatic p lugs require  rem oval by  th e  fibrinolytic system , 
w hich  lyses fibrin deposits. Im paired fibrinolysis m ay prom ote 
th rom bosis (Astrup and  Perm in 1947). U ntil recently, only global te s ts  
of th e  fibrinolytic system  (such as clot lysis tim es or fibrin  p late  lysis 
area) w ere available for s tu d y  of th is  system  (Lowe an d  Prentice 1980). 
In the  1980's the  identification of tissu e  p lasm inogen activator (tPA) 
an d  of its  m ajor inhibitor, p lasm inogen activator inh ib ito r type 1 fPAI- 
11 allowed the  developm ent of specific a ssay s of th ese  m ajor 
com ponents of th e  fibrinolytic system  (Kluft 1988). Activity a ssay s 
w ere facilitated by  chrom ogenic su b s tra te s  (Lijnen e t al 1980).
The developm ent of enzym e-linked im m unoso rben t assay s 
(ELISA's) in  the  1980's allowed th e  specific a ssay s of n o t only PAI-1 
an d  tPA, b u t  also of fibrin degradation  p ro d u c ts  resu ltin g  from  fibrin 
form ation and  lysis in  vivo su c h  a s  fibrin D -dim er (Gaffney an d  
B rash er 1973; E lm s et al 1983). In the  la te  1980's, ELISA's becam e 
available for accu ra te  a ssay  of von W illebrand factor (VWF) w hich like 
tPA and  PAI-1 is released  from endothelial cells an d  m ay be a  m ark er
3
of endothelial d is tu rb an ce  (Pearson 1994). E ndothelial d is tu rb an ce  
m ay be a n  im portan t trigger of b o th  a therogenesis (Ross 1993) an d  
throm bogenesis (Pearson 1994).
The aim s o f th e  stu d ies reported in  th is  th e s is  w ere to  
rela te  th e se  recen tly  available assays o f PAI a c tiv ity , tPA antigen , 
fibrin D-dim er antigen , and von  W illebrand factor an tigen  to  
isch a em ic  heart d isease  and to  d iab etes m ellitu s. T his chapter  
review s h aem ostasis , th e  fibrinolytic  sy stem , degradation o f  
fibrinogen and fibrin to  degradation products, von  W illebrand  
factor, and know ledge o f th e  rela tion sh ip  o f  th e se  variables to  
cardiovascular d isease  and diabetes m ellitu s w hen  th e se  stu d ies  
were started .
HAEMOSTASIS
Blood h a s  a  variety  of essen tia l functions includ ing  the  
m ain tenance  of pH, tran sp o rt of oxygen and  carbon  dioxide, th e  
delivery of n u tr ie n ts  to cells, and  th e  rem oval of w aste  p ro d u c ts  from  
them . The circu lation  of the  blood therefore is essen tia l to life, an d  
th is  circu lation  occurs a round  a  specialised type of closed system  in  
w hich  th e  volum e is k ep t fairly constan t. Like any  p lum bing  system , 
there  is th e  possibility  of leaks, an d  th ese  m u s t be repaired  to 
m ain ta in  the  in tegrity  of the  system . The em ergency m echan ism  for 
stopping  blood loss is the  form ation of a  haem osta tic  p lug  - 
haem ostasis .
After injury to th e  endothelial lining of a  blood vessel, 
subendo thelia l collagen fibres becom e exposed, an d  th is  in itia tes the
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T issue fact.
Factor VII -------------^  F acto r IX
Factor X F acto r VIII V W F
A ntithrom bin Prothrom bin
Protein S 
Protein C
Thrombin
Fibrinogen Fibrin X-linked fibrin
F ibrinopeptides 1 | F acto r XIlla
Figure 1 .2  Schem e of the  coagulation pathw ay  (modified from 
E liasson  1995). T issue fact = tissue  factor; VWF = von W illebrand 
factor. Heavy lines indicate inhibition.
p la te le t com ponent of haem ostasis . A dhesion of p la te le ts is followed 
by  m orphological changes (shape change, degranulation) an d  the  
re lease  of p latele t p roducts. T hese include th rom boxane A2  and  
se ro ton in  (which cause  vasoconstriction, reducing  blood flow, and  
w hich  prom ote p latele t activation), grow th factors (which s tim u la te  
tis su e  repair), p latele t factor 4 (a h ep arin  b ind ing  pro te in  w hich 
p reven ts  hep arin -an tith ro m b in  com plexes from inh ib iting  clotting 
factors, an d  is also chem otactic), factor V (a p ro tein  cofactor in  the  
clo tting  process), von W illebrand factor, an d  a  su b u n it  of factor XIII 
(the tran sg lu tam id ase  required  to cross link  fibrin). The m ost 
im p o rtan t glycoprotein w hich facilitates p late le t adhesion  is von 
W illebrand factor, w hich is also the  carrier p ro tein  for factor VIII 
(Bloom e t al 1994).
Following p latele t adhesion , in ter-p la te le t aggregation occurs to 
form  th e  in itia l p latele t plug. Von W illebrand factor an d  fibrinogen link  
p la te le t m em brane recep tors (Gp lb; Gp Ilb/IIIa) specific for p latele t 
aggregation, w hich is stim ula ted  by  exposure to collagen, th rom bin , 
adenosine  d iphosphate  (ADP), th rom boxane an d  catecholam ines. The 
p la te le t p lug  is subsequen tly  stab ilised  by  fibrin, form ed th ro u g h  th e  
coagulation  pathw ays (extrinsic an d  in trinsic) (Bloom e t al-
1994)(Figure 1.2)(EK«sso* W s } .
W hen th e  endothelium  is in jured , tissu e  factor (factor III), a  
m em brane  b o u n d  protein , is exposed. C oagulation factor VII th en  
b in d s  to tis su e  factor in  the  p resence of Ca^+ ions. The resu lting  
tis su e  factor-V II-Ca^+ complex is a  catalytically  active species 
(activated VII or VIIa), and  h a s  a  h igh  affinity for factor X. T his 
com plex activates factor X, w hich is a ttach ed  to th e  endothelial or
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p la te le t su rfaces. Xa  is the  endopeptidase w hich  activates 
p ro th rom b in  (factor II) to throm bin . F acto r Va  is a n  essen tia l co-factor 
for th is  activation. F actor V (which is p resen t in  p la te le ts a s  well as 
p lasm a), b in d s  to the  tissu e  factor VII-Ca^+-Xa com plex an d  is 
activated  by  th rom bin  or Xa  to give th e  activated form  of th e  pro tein  
w hich  is able to  a c t a s  a  co-factor for th e  activation  of p ro throm bin . 
T hrom bin  converts soluble fibrinogen in to  an  insoluble fibrin netw ork  
a t  th e  site  of in jury , w hich stab ilises the  in itial p la te le t plug. T hrom bin  
also activa tes p la te le ts an d  factors V and  VIII; and  activates factor XIII 
w hich  cross-links fibrin. (Figure 1.2). T his tis su e  factor (extrinsic) 
pa thw ay  of blood coagulation is cu rren tly  th o u g h t to be th e  m ain  
p a thw ay  for in itia tion  of th rom bin  and  fibrin form ation (Nemerson
1992).
T he co n tac t activation system  w hich  in itia tes th e  in trin sic  
p a thw ay  of blood coagulation involves th e  action  of factor XII 
(H agem an factor), prekallikrein  and  high  m olecular w eight kininogen 
(HMWK). The activated  form of factor XII w hich  is generated  (factor 
XIIa) th e n  activates factor XI. The precise m echan ism  for th e  in itiation  
of co n tac t activation  h a s  n o t yet been  estab lished . F acto r XIa  in  tu rn  
activa tes factor IX, w hich  can  also be activated  by  th e  factor VIIa - 
tis su e  factor com plex (Figure 1.2). F acto r X is th e n  activated  by  th e  
enzym e com plex of IXa , th rom bin  modified factor VIII, negatively 
charged phospholip id  a n d  C a^+. F actor VIII w hich  a c ts  a s  a  cofactor 
in  th is  activation  m u s t first be cleaved by  th rom bin  or by  factor Xa , to 
form  factor VIIIa . In th e  p resence of C a^+ ions, negatively charged 
phospholip id  and  modified factor VIII, th e  ra te  of factor X activation is 
greatly  enhanced . The in trinsic  system  of coagulation is cu rren tly  
th o u g h t to m ain ta in  th rom bin  and  fibrin form ation (Figure 1.2).
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T hrom bin  can  be directly inactivated  by  a  n u m b er of 
coagulation  in h ib ito rs , the  m ost im p o rtan t of w hich is an tith ro m b in  
(an tith rom bin  III). The activity of th is  p ro te in  is m arkedly  enhanced  by 
h ep arin . H eparin -an tith rom bin  also inh ib its  free factor Xa  (but n o t Xa  
w hen  it is b o u n d  to Va ) and  also IXa  (Figure 1.2). O ther th rom bin  
inh ib ito rs include heparin  cofactor II, 0C2  m acroglobulin  an d  
0 C2  an titrypsin .
Protein  C, w hich is activated w hen  th rom b in  b inds to 
th rom bom odulin  on the  endothelial cell surface, is a  v itam in  K 
d ep en d en t serine  pro tease  w hich deactivates factor Va  an d  factor 
VIIIa , th u s  preventing fu rth er th rom bin  generation . T his effect of 
p ro te in  C is dependen t on its cofactor, p ro te in  S, an o th e r v itam in  K 
d ep en d en t p ro tein  w hich b inds pro tein  C to the  p late le t su rface 
(Figure 1.2). J u s t  as coagulation deficiencies (haem ophilias) are 
assoc ia ted  w ith  bleeding, congenital deficiencies in  an tith rom bin , 
p ro te in  C an d  pro tein  S are associated  w ith  increased  risk  of venous 
th rom bosis (throm bophilias). Recently, activated p ro te in  C resistance , 
d ue  to a  m u ta tio n  in the  gene for factor V, resu lting  in  res is tan ce  to 
inactiva tion  by  activated pro tein  C, h a s  also been  associated  w ith 
increased  risk  of venous th rom bosis (Bertina e t al 1995, D ahlback  
1995).
FIBRINOLYSIS
T here is a  ba lance  betw een the  form ation of a  p latelet-fibrin  clot 
(haem ostasis), and  its d isso lu tion  - fibrinolysis. W hile coagulation is 
e ssen tia l to p reven t blood loss from in ju red  vessels, the  p rocess m u s t 
be  carefully controlled and  be reversible. B oth h aem osta tic  and
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fibrinolytic system s are in ternally  ba lanced  betw een active an d  
inh ib ito ry  elem ents.
In Figure 1.3 the  principal e lem ents of the  fibrinolytic system  
are  show n. E ssentially , p lasm in  a ttack s  th e  insoluble fibrin 
enzym atically  to p roduce soluble fibrin degradation  p ro d u c ts  (FDP); it 
can  also digest soluble fibrinogen and  fibrin. P lasm in  is form ed from  
its  inactive p recursor, p lasm inogen , w hen  activated  by  one of its  
activators, of w hich two exist in h u m an s . T hese a re  tissu e  
p lasm inogen  activator ftPA) and  u rok inase  for u ro k in ase  type 
p lasm inogen  activator) (uPA). These proteolytic enzym es can  be 
inh ib ited  by  specific inhib itors, the  p lasm inogen activator inh ib ito rs 
PAI-1 an d  PAI-2 (Sprengers and  Kluft 1987). P lasm in is inh ib ited  by 
an tip lasm in s, principally  by ot2  an tip lasm in , b u t  also by  (X2  
m acroglobulin  (Figure 1.3).
Serine p ro teases of the  fibrinolytic system
The enzym es of the  fibrinolytic system  are  all serine  p ro teases 
(Table 1.1). T hese are so called because  they  have a t th e ir active site 
a n  u n u su a lly  reactive serine residue. X -ray ciysta llographic  s tu d ies  
show  th a t  the  -CH2 OH group of serine  w hich is u su a lly  quite 
un reactive  u n d e r physiological conditions is m ade strongly  
nucleophilic  by  the  in terac tion  w ith  a n  a sp a rta te  residue  an d  a  
h istid ine  residue. A lthough no t close to each  o ther in  th e  p rim ary  
sequence  of the  protein, m olecular folding enab les th ese  res id u es to 
se t u p  a  charge relay netw ork. S tud ies have indicated  th a t  th e  ra te  of 
cata lysis is enhanced  by a  factor of the  order 10^ by  th is  charge relay
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tPA uPA
PlasminP lasm inogen
Fibrin degradation 
products (FDP)FibrinFibrinogen
F igure 1 .3  Schem e of the  fibrinolytic system  (modified from  E liasson
1995). tPA = tissue-type plasm inogen activator; uPA = urok inase-type  
p lasm inogen  activator; PAI = plasm inogen activator inh ib ito rs. Heavy 
lines ind icate  inhibition
netw ork (Stiyer 1988). The enzym es of th e  fibrinolytic system , 
p lasm in , and  the  p lasm inogen activators tPA an d  uPA all belong to 
th is  family of serine p ro teases, as  do th rom bin , e lastase , tiy p s in  an d  
chym otrypsin. The high degree of hom ology in these  p ro te ins denotes 
a  com m on ancestor, and  m u ta tio n s of the  an cestra l gene are  th o u g h t 
to have given rise to the  p resen t day  p ro te ins (Patthy 1985). A nother 
com m on feature  of these  p ro teins is th a t  th e  active enzym e h a s  two 
chains held  together by  d isu lphide bonds, while th e  inactive zymogen 
exists a s  single chain  m olecules. All serine  pro teases have th e  active 
site of the  enzym e located on the B (light) chain  w hich  com es from  the  
C -term inal p a r t  of the  zymogen. The A (heavy) cha in  w hich 
corresponds to th e  N -term inal of the  inactive pro te in  con ta ins 
s tru c tu ra l dom ains w hich are involved in th e  b ind ing  p roperties of the  
enzyme. Different exons are responsib le for the  coding of these  
dom ains. Table 1.1 sum m arises the  general fea tu res of the  th ree  
principal fibrinolytic enzym es.
Plasm inogen
This 92kD a single chain  glycoprotein h a s  a  relatively high  
concen tra tion  in  the  circulation (0.2 m g /m l, 2 M) an d  h a s  a  h a lf  life of 
ab o u t 2 days. T his inactive species is specifically cleaved a t  th e  Arg 
560 - Val 561 bond  by  tPA and  uPA to form  a  two ch a in  m olecule 
bou n d  by  d isu lph ide bridges.
W hile the  active site is located on th e  B chain , th e  A cha in  h a s  
five hom ologous regions, know n as kringles, w hich are  involved in  
b inding  to lysine and  its analogues, includ ing  tranexam ic  acid. Kringle 
1, n e a re s t the  N -term inal end of the  m olecule, h a s  th e  h ighest affinity
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site  (K^ 5 M) for lysine while kringles 2-5 exhibit lower affinity b ind ing  
(K^ 5mM). The high affinity of p lasm inogen for lysine is u sed  in  the  
purification  of the  pro tein  by affinity chrom atography . T his ability  to 
b ind  to  lysine is responsib le  for the  in te rac tion  of b o th  p lasm inogen 
a n d  p lasm in  w ith fibrin, and  th u s  is im m ensely  im p o rtan t in  the  
regu la tion  of fibrinolysis. These lysine-binding regions are  also 
involved in  the  b ind ing  of the  inh ib ito r oc2 an tip lasm in  to p lasm in . 
Proteolysis of p lasm inogen, w ith the  rem oval of a  sm all N -term inal 
peptide, converts the  native G lu-plasm inogen to Lys-plasm inogen. 
A ddition of inh ib ito rs su ch  a s  apro tin in  p revents th is  proteolysis 
du rin g  the  purification of the  protein. Activation by tPA is different in 
th ese  two form s of plasm inogen, and  it h a s  been  show n th a t  it is Lys- 
p lasm inogen  th a t  is m ore like fibrin b o u n d  p lasm inogen  in  its 
p roperties (Hoylaerts et al 1982). Som e heterogeneity  in  p lasm inogen  
h a s  been  found an d  is a ttrib u ted  to differences in  carbohydrate  
com position (Collen and  DeMaeyer 1975).
Lysine b ind ing  sites are  also involved in  th e  b ind ing  of 
p lasm inogen  to h istid ine rich  glycoprotein. T his reduces the  
p lasm inogen  available for activation by ab o u t 50% (1 M) (Booth 1991).
T issue  plasm inogen activator (tPA)
T his activator of p lasm inogen w as originally purified from 
various tis su e s  including  u terine  tissue . It is p re sen t in  th e  p la sm a  a t 
low concen tra tions of ab o u t 5-10 n g /m l (Ranby e t al 1982b, 1986) 
a n d  only ab o u t 15% of th is  is active. The re s t is com plexed to its  m ain  
inh ib ito r PAI-1, and  to a  lesser degree to a 2 an tip lasm in  (Figure 1.3). A 
m arked  and  rap id  increase  in  p lasm a  tPA levels is seen  w ith  various
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stim uli, su c h  as  exercise, venous occlusion and  catecholam ines 
(Prowse and  M acGregor 1988). tPA is a  glycoprotein of ab o u t 65 kDa, 
and  in  c o n tra s t to m ost o ther serine p ro teases is active in  th e  single 
chain  form  (Ranby et al 1982a). The two chain  form  occurs after 
cleavage of the  Arg 275 - lie 276 bond, and  its  active site is 
hom ologous to o ther serine p ro teases w ith the  charge relay  netw ork 
involving His 322, Asp 371 and  Ser 478. The A chain  of tPA is th e  p a rt 
of th e  m olecule involved w ith su b s tra te  b ind ing  an d  a  n u m b er of 
different dom ains on th is  chain  show  high  hom ology w ith  o ther 
sim ilar p ro teins. The finger region is hom ologous to th a t  in 
fibronectin , the  grow th factor dom ain is hom ologous to epiderm al 
grow th factor, an d  two kringles are  hom ologous to p lasm inogen. The 
two dom ains m ost involved w ith  su b s tra te  b ind ing  are  th e  finger 
region an d  the  second kringle (van Zonneveld e t al 1986). In the  
absence  of fibrin, the  affinity of tPA for p lasm inogen is relatively low, 
w ith  a  Km  of 65 M. In the  presence of fibrin, however, th is  affinity is 
increased  w ith  a  Km  of 0 .15 M (Hoylaerts e t al 1982). tPA h a s  bo th  
fibrin affinity and  fibrin specificity, m aking  it a  key m olecule in  the  
regu la tion  of fibrinolysis. These p roperties have also led to its 
developm ent a s  a  th erap eu tic  agen t for lysis of th rom bi (e.g. coronary  
a rte ry  th rom bi in  acu te  m yocardial infarction).
U rokinase (urokinase type plasm inogen activator. uPA)
T his p ro tein  is so nam ed because  it w as originally purified from 
u rine. It cleaves the  sam e specific bond on  p lasm inogen  a s  tPA, b u t  
un like  tPA can  a c t efficiently on its  su b s tra te  in  the  absence  of fibrin. 
uPA w as th o u g h t for m any  years to have no role in  haem ostasis, b u t  
m ore recently  it h a s  becom e evident th a t it occurs in  th e  circu lation  a t
11
levels of ab o u t 2  n g /m l, predom inantly  in  the  single cha in  form. 
S tud ies are  con tinu ing  on the  role of uPA in  haem ostasis and  
th rom bosis, b u t  a s  yet th is  is n o t well defined (B achm an 1994), an d  
will n o t be considered further.
Inhib itors of Fibrinolysis
Inhibitors in  the  fibrinolytic system  are m em bers of th e  SERPIN 
(SERine Protease INhibitors) family and  like the  serine  p ro teases  are 
closely related. The action of these  inh ib ito rs is the  m ost im portan t 
m echan ism  for regulation  and  control of fibrinolysis. The enzym e 
inh ib ito r form s a  stab le  stoichiom etric 1 : 1  com plex w ith  the  enzyme, 
thereby  rendering  it inactive. Covalent b onds are  form ed an d  a  
fragm ent is re leased  from the C -term inal end  of th e  inhib itor. This 
com es ab o u t as th e  enzyme recognises a  region on th e  inh ib ito r w hich  
is sim ilar to the  enzym e's n a tu ra l su b s tra te . The Arg-X bond  w hich  is 
u su a lly  recognised a t the  site w hen the  p lasm inogen activators cleave 
th e ir  su b s tra te  is also p resen t a t the  reactive cen tre  of the  inh ib ito r 
m olecule, conferring specificity of the  inh ib ito r for its  enzyme.
The glycoprotein a oan tip lasm in  is th e  m ajor inh ib ito r of 
p lasm in , and  is p resen t in  the  p lasm a  a t  a  relatively high  
concen tra tion  (1 M). The ra te  c o n stan t for th e  form ation  of the  
p lasm in -an tip lasm in  complex is very high, 2x lO ^ /M  s (Table 1.2). The 
h igh  p lasm a concen tra tion  of th is  inhibitor, coupled w ith  th e  rap id  
reaction  w ith  th e  enzyme m akes it a n  im p o rtan t regu la to r of the  
fibrinolytic system .
12
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Plasm inogen A ctivator Inhibitors
The existence of specific inh ib ito rs of p lasm inogen  activator w as 
d ispu ted  for m any  years. M ost assays for p lasm inogen activators 
depend  on the  generation  of p lasm in , w hich is detected  by  its  action  
on fibrin. This m ade it difficult however, to differentiate betw een 
inh ib ition  of p lasm in  and  inh ib ition  of p lasm inogen activators. The 
occurrence of a  specific inh ib ito r of the  la tte r  in  p lasm a  w as confirm ed 
u sin g  chrom ogenic assays by C hm ielew ska et al (1983), by  K ruithof e t 
al (1983) an d  la te r by  o ther w orkers. S tud ies using  
im m unohistochem ical techn iques th en  d em onstra ted  the  p resence  of 
the  m ajor p lasm inogen activator inh ib ito r (PAI), w hich is now  know n 
a s  PAI-1, in  m any  tis su e s  and  in  endothelial cells. PAI-1, th e  sequence 
of w hich  h a s  been  deduced from  its  c-DNA s tru c tu re , is a  glycoprotein 
of 48kD a, and  is a  po ten t inh ib ito r of b o th  tPA an d  uPA w ith  a  h igh  
ra te  c o n stan t (10^/M  s) sim ilar to th a t  for p lasm in -an tip lasm in  (Table 
1.2). Unlike a 2 antip lasm in , however p lasm a  levels of th e  inh ib ito r are  
low a t ab o u t 20 n g /m l (Booth e t al 1988, Declerck e t al 1988, K ruithof 
e t al 1988). A lm ost 90% of PAI-1 in  the  blood is con tained  in  p latelets, 
b u t  th ese  are n o t the  source of p lasm a PAI-1. E ndo thelium  an d  the  
liver have been  im plicated a s  sou rces of PAI-1 (Sprengers an d  Kluft 
1987).
Activity in  the  two pools of PAI-1 differs widely. W hile only 3 to 
5% of p latele t PAI-1 h a s  been  show n to be active (Booth e t al 1990), 
a lm ost all p lasm a  PAI-1 is active. Activation of the  la ten t p la te le t PAI-1 
can  occur u n d e r  den a tu rin g  conditions , b u t  it is n o t know n w hether 
th is  activation can  occur u n d e r any  physiological conditions.
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A second inh ib ito r of plasm inogen activator h a s  been  described  
(PAI-2) w hich is rela ted  to PAI-1 b u t quite  d is tinc t from  it (Kruithof et 
al 1986). It is th o u g h t to be m ainly p lacen ta l in  origin a s  it is found in  
m ate rn a l p lasm a  during  pregnancy; however there  is also evidence for 
its  presence in  m onocytes (Golder and  S tep h en s 1983), so it m ay have 
a  m ore general role in n on -p regnan t individuals. The specificity of PAI- 
1 and  PAI-2 is sim ilar, b u t  the  affinity of PAI-2 for tPA an d  uPA is 
m u ch  lower th a n  th a t  of PAI-1 (Table 1.2).
R egulation of Fibrinolysis (Figure 1.4)
The ta rg e t m olecule for the  fibrinolytic system  is fibrin, w hich 
therefore p lays a n  im portan t role in th e  regulation  of th e  system . 
Lysine-binding sites on the  kringles of p lasm inogen b ind  to fibrin, a s  
does its m ajor activator tPA (Figure 1.4). The zym ogen an d  the  
activator are  th e n  in  close proximity, an d  local p roduction  of p lasm in  
a t  the  site of fibrin form ation is achieved. T his activation occurs m u ch  
m ore readily in  th e  presence of fibrin th a n  in  its absence. The widely 
differing K ^ a lu e s  for these  two situ a tio n s  (65 M in  the  absence  of 
fibrin, 0 .15 M in  its  presence) m ean  th a t  p lasm inogen  is n o t norm ally  
activated  in th e  c irculation  u n less  fibrin  form ation h a s  occurred  
(Hoylaerts e t al 1982). Fibrinolysis is fu rth e r  regu la ted  by  th e  effect of 
o^an tip lasm in , th e  m ain  p lasm a inhibitor. W hen p lasm in  is formed, 
th e  avid b ind ing  of o^an tip lasm in  (to form  a 2 an tip lasm in -p lasm in  
compexes) m ean s th a t  the  half-life of the  enzym e is very sho rt, ab o u t 
100 m s (Wiman and  Collen 1978). The p lasm in  form ed on the  fibrin 
surface however is less suscep tib le  to th is  b ind ing  since its  active site 
is already b o u n d  to its su b s tra te . Its lysine b ind ing  sites  are  also
14
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Figure 1 .4  Regulation of fibrinolysis (modified from  E liasson 1995). 
For descrip tion  see text.
bou n d  to fibrin (Figure 1.4). These regu latory  m echan ism s m ean  th a t  
p lasm in  generation  is lim ited to sites of fibrin form ation an d  does n o t 
u su a lly  occur in  the  circulation.
B oth p lasm inogen and  ot2 an tip lasm in  are p re sen t in  relatively 
high  concen tra tion  (Table 1.3) and  have h a lf  lives in  th e  o rder of days, 
so these  are  the  m ore stab le  p a rt of the  system . In co n trast, tPA, uPA 
an d  PAI-1 a re  p resen t in  m uch  lower concen tra tion  and  have very 
sh o rt h a lf lives due to rapid  clearance (Table 1.3). S yn thesis and  
release  of th ese  p ro teins m u s t be con tinuous an d  fine control m u s t 
exist to m ain ta in  the  balance  betw een them . A lthough p la sm a  levels of 
tPA and  its  inh ib ito r are  low (Table 1.3), it is likely th a t  th e re  is 
significant com plex form ation, due to the  h igh  affinity of th e  m olecules 
for each o ther, and  m ost of the  tPA in  p lasm a ap p ea rs  to be 
com plexed to PAI-1 (Thorsen and  Philips 1984) (Figures 1.4 an d  1.5). 
T here m ay be a  h igher proportion of free tPA in vivo th a n  in  in vitro 
sam ples since there  is rap id  clearance from the  blood of b o th  enzym e 
an d  inhibitor.
V arious stim uli, su ch  as exercise, venous occlusion and  
ad m in istra tio n  of vasopressin  or its analogue DDAVP re su lt in  release 
of tPA from  th e  endothelium . These responses have been  u sed  as  a  
te s t  for fibrinolytic po ten tial in individuals by  m easu ring  p lasm a  tPA 
levels before an d  after the  stim u lus. Only a  sm all increase  in  tPA is 
requ ired  to com pletely overwhelm the  low levels of PAI-1 norm ally  
p re sen t (Prowse and  M acGregor 1988). It h a s  also been  show n th a t  
som e people term ed "non-responders" who were th o u g h t to have failed 
to release tPA after su c h  stim uli h ad  high levels of PAI-1 activity 
(Nilsson e t al 1985). This would re su lt in  the  inh ib ition  of any  released  
tPA. PAI-1 behaves as an  acu te  ph ase  re a c ta n t (Juhan-V ague e t al
15
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Figure 1 .5  Binding of tissu e  plasm inogen activa to r (tPA) 
to p lasm inogen  activator inh ib ito r type 1  (PAI-1 ). The arrow s indicate
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1985, Kluft e t al 1985) and  h as  been  found to be ra ised  in  a  n u m b er 
of pathological conditions (Juhan-V ague et al 1984, 1988).
L aboratory investigations of the  fibrinolytic system .
The m easu rem en t of fibrinolytic system  com ponents in  recen t 
years h a s  becom e m ore reliable due to various technological 
developm ents. M any of the  original a ssay s were global m easu rem en ts  
and  th ese  are  still used . These include clot lysis tim es (whole blood 
and  plasm a), and  lysis of preform ed fibrin by  the  p lasm a  euglobulin  
fraction (Lowe and  Prentice 1980; Booth 1991). T hese a ssay s are  
usefu l a s  a  background  for deciding w he ther m ore specific a ssay s m ay 
be appropria te . Clots p repared  using  d ilu ted  whole blood are  observed 
to determ ine the  dilute whole blood clot lvsis tim e, b u t  th is  is very 
slow, therefore im precise and  im practical. The p rep a ra tio n  of the  
euglobulin  fraction of the  p lasm a by acidification p rec ip ita tes o u t 
a lm ost all th e  tPA and  p lasm inogen p resen t. This also includes the  
PAI-1 th a t  is com plexed to tPA, b u t n o t all th e  free PAI-1 rem ains in 
th e  su p e rn a te n t as  is the  case w ith  o ther inh ib ito rs. The clot form ed 
w ith  the  euglobulin  fraction will lyse in a  few h o u rs  in  a  norm al 
individual, and  a  shorten ing  of th is  euglobulin  clot lvsis tim e im plies 
increased  fibrinolysis.
The addition  of the  euglobulin fraction to a  p la te  of preform ed 
fibrin m ade w ith  a  s ta n d a rd  concen tra tion  of fibrin, an d  m easu rem en t 
of the  fibrin p late lvsis a rea  is a  m ore reliable estim ate  of to ta l 
fibrinolysis.
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More specific a ssays available for the  com ponen ts of the  
fibrinolytic system  are now available, som e of w hich are  functional 
a ssa y s  an d  som e im m unological. The developm ent of chrom ogenic 
su b s tra te s  som e 15 years ago (Lijnen e t al 1980) h a s  m ade functional 
m ea su re m e n t of m any of the  fibrinolytic enzym es an d  inh ib ito rs m ore 
prec ise  an d  reliable. These su b s tra te s  are  sh o rt pep tides of 3 or 4 
am ino  acids w hich m im ic the  cleavage site of the  enzym e. At th e  C- 
te rm in a l end of the  peptide, there  is a  m olecule of p -n itroanaline .
W hen th is  is sp lit from the peptide by th e  action  of the  enzym e, a
yellow colour develops w hich can  be m easu red  spectrophotom etrically . 
T hese su b s tra te s  are  com m ercially available and  are  specific for the  
various p ro teases u n d e r investigation.
Plasm inogen can  be assayed by m easu ring  th e  p lasm in
produced  after its activation using  a  p lasm in  specific chrom ogenic 
su b s tra te . Similarly, a g an tip lasm in  can  be determ ined  w ith  th is  
su b s tra te  by  adding  an  excess of p lasm in  an d  m easu rin g  th e  res idua l 
enzym e after a 2 an tip lasm in-p lasm in  com plexes have been  form ed. 
tPA activity  canno t be directly m easu red  chrom ogenically a s  no 
s u b s tra te  h a s  yet been  developed, b u t a ssay s can  u se  th e  
chrom ogenic su b s tra te  for p lasm in  to determ ine tPA activity.
P lasm inogen added to a  te s t p lasm a  is cleaved by  th e  endogenous tPA, 
a n d  th e  resu lting  p lasm in  can  be m easu red  chrom ogenically. 
F rag m en ts  of fibrin are u sed  as a  s tim u la to r in  th is  m ethod. Since PAI 
is p re se n t in  abou t a  five-fold excess com pared to tPA in  th e  p lasm a, 
after w ithdraw al of blood any  free tPA will rap id ly  form  com plexes w ith  
PAI. To avoid th is  in vitro artefact, the  sam ple m u s t be collected in to  
a n  an tico ag u lan t w hich is e ither acidified (Chm ielew eska an d  W im an 
1986) or w hich con ta ins a  specific reagen t w hich will b lock the  active
17
site  of tPA. B ecause of th is  sam pling requ irem ent, sto red  c itrated  
p la sm as  are  u n su itab le  for tPA activity m easu rem en t, and  su ch  
m ea su re m e n ts  in  large epidemiological s tu d ies  are m ade m ore difficult 
by  th e  necessity  for an  additional sam ple.
PAI-1 activity m easu rem en t also m akes u se  of th is  ability of 
p lasm in  to sp lit its artificial su b s tra te . An excess of tPA added  to a  
te s t  p la sm a  re su lts  in complex form ation. The excess tPA in  the  
p resence  of fibrin fragm ents th en  activates p lasm inogen added  to the  
system . The p lasm in  generated  in th is  w ay can  be m easu red  w hen  it 
a c ts  on  th e  chrom ogenic su b s tra te ; th is  concen tra tion  of p lasm in  is 
p roportiona l to  the  rem aining  tPA and  th u s  to the  PAI activity in  th e  
te s t  p la sm a  (Chm ieleweska and W im an 1986).
T hese functional assays have im proved the  reliability  of m any  of 
th e se  enzym e assays, b u t  they  are n o t alw ays com pletely specific. 
Im m unological a ssay s are highly specific and  recen t developm ents 
m ake  su c h  assay s quick and  easy  to perform . Rocket 
im m unoelectrophoresis h a s  been  u sed  for a  n u m b er of p ro te ins w hich  
have  relatively high concen tra tions in th e  p lasm a. T his involves the  
add ition  of an tise ru m  to an  agarose gel. The te s t p la sm a  is th e n  
applied  to th e  gel, and  during  e lectrophoresis th e  an tigen  m oves 
th ro u g h  th e  gel un til m axim al b inding  to the  an tibody  occurs. After 
ap p ro p ria te  stain ing , the  concentra tion  in  the  te s t p la sm a  can  th e n  be 
e stim ated  from  the  height of the  peak.
T his techn ique  h a s  largely been  su perseded  by  th e  u se  of 
Enzym e Linked Im m unoSorbent A ssays (ELISA), w hich  are  m u ch  
m ore sensitive and  can  be used  for p ro te ins w ith  very low
18
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concen tra tions in the  p lasm a  (e.g. tPA, VWF, FDP). They allow a  m ore 
rap id  estim ation  of the  pro tein  levels and  a  m uch  larger th ro u g h p u t of 
sam ples. T his is useful, for exam ple, in  epidem iological s tu d ies  w here 
sam ple  n u m b ers  are  high. The principle of the  m ethod  is illu stra ted  in  
figure 1.6. Typically, a  m onoclonal an tibody  to th e  pro te in  u n d e r 
investigation is coated to a  solid su p p o rt. This can  be a  p lastic  tube, 
or m ore com m only a  m icrotitre plate. The addition  of s ta n d a rd s  and  
te s t  p lasm as to each  well allows b ind ing  of the  p ro tein  to th e  antibody  
du ring  a  su itab le  incubation  period. The p late  is th e n  w ashed  and  a  
second an tibody  to the  protein  is added. B inding occurs du ring  a  
second incuba tion  period. This so-called second, or tag  an tibody  is 
linked to a n  enzyme, often h o rse rad ish  peroxidase. After fu rth er 
w ashing , th e  addition  of su b s tra te  to th e  well re su lts  in  a  coloured 
p ro d u c t after the  cleavage of the  su b s tra te  by  the  enzyme. The 
abso rbences in  each  well can  be read  u s in g  a  m icrotitre p la te  read er 
w hich  can  be program m ed to co n stru c t th e  s ta n d a rd  curve and  read  
th e  unknow n  values from the  curve.
DEGRADATION OF FIBRINOGEN AND FIBRIN
Fibrin  form ation
Fibrinogen (Doolittle 1981) is a  large elongated m olecule (length 
460A) w ith  a  m olecular w eight of 340  kDa. It co nsists  of six  
polypeptide ch a in s  and  there  are th ree  k inds of these: Aa, BJ5, an d  y. 
T hese ch a in s  have m any  d isu lphide bonds. E lectron  m icroscopy 
show s th a t  th e  fibrinogen m olecule is m ade u p  of 3 nodu les connected 
by  2 rods. Biochem ical s tud ies ind icate  th a t  the  cen tra l nodule 
com prises th e  am ino term inal ends of all six  polypeptide chains.
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T hrom bin  cleaves arginine-glycine bonds on each  of th e  Aa 
c h a in s  to give a  16 residue  peptide, fibrinopeptide A (FpA), an d  fibrin I 
or desAA fibrin. The new  am ino term inal end of the  a  cha in  form ed by 
th is  cleavage is the  site w here the  newly form ed fibrin I can  b ind  to a  
p re-ex isting  site  on the  fibrinogen. At low concen tra tions of fibrin, the  
com plexing to fibrinogen allows the  fibrin to be k ep t in  so lu tion . This 
is know n as soluble fibrin (Brass e t al 1976, Graeff e t al 1979). At a  
ce rta in  critical concentration , the  fibrin I m olecule spon taneously  
asso c ia tes  in  a  staggered a rray  to form  long fibrin I polym ers (Figure 
1.7). T his is due  to the  change in the  surface charge p a tte rn  w hen a  
n u m b e r of negatively charged res idues are  released  by  th e  action  of 
th ro m b in . The initial clot formed by  th e  sp o n tan eo u s aggregation of 
fibrin  m onom ers is quite fragile, and  is su b seq u en tly  stab ilised  by  the  
fo rm ation  of cross links betw een the  side chains of different m olecules 
in  th e  fibre. Peptide bonds are form ed betw een specific g lu tam ine and  
lysine side chain s in a  tran sam id a tio n  reaction  involving F acto r XHIa 
(Doolittle 1981).
F ibrinopeptide B, a  14 residue  peptide is released  from  the  BJ3 
ch a in  s im u ltaneously  w ith  FpA, b u t  a t a  m uch  slow er rate . The 
fibrinogen m olecule from w hich bo th  FpA and  FpB have been  cleaved 
is know n a s  fibrin II or desAABB (Figure 1.7), This will also aggregate 
a n d  becom e cross linked (Herm ans and  M cDonagh 1982).
Increased  coagulation activity is ind icated  by increased  p lasm a  
levels of soluble fibrin. If the  fibrinolytic system  does n o t adequately  
com pensa te  for th is, a  throm botic  event m ay resu lt.
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Figure 1 .7  Form ation of fibrin and  deg radation  of fibrin  by  p lasm in  
(from N ieuw enhuizen 1991). For descrip tion  see text, p = polymer.
M olecular form s of fibrinogen
The enzym e p lasm in  w hich occurs w hen  fibrinolysis is activated 
is n o t specific for fibrin. It will also a tta c k  fibrinogen u n d e r  certa in  
conditions. Three m ain  form s of fibrinogen occur in the  c irculation  
(Holm e t al 1985; N ieuw enhuizen 1991). T hese are:
(1) The high m olecular w eight form (HMW) in  w hich  b o th  a lp h a  
cha in s are in tact,
(2) The low m olecular w eight form (LMW) in w hich one of th e  a lp h a  
cha in s h a s  been  cleaved, and
(3) th e  low est m olecular w eight form (LMW') w hich h a s  b o th  a lp h a
chain s shortened  a t the  carboxy term inal end.
The relative am o u n ts  of these  form s in  norm al p la sm a  are  70%, 
26%, and  4% respectively. It is possible th a t  even sm all increases  in 
proteolytic activity m ay resu lt in a  change in the  ratio  of LMW' to 
HMW fibrinogen. W ith fu rth er digestion of LMW', a  p ro d u c t called 
fragm ent X is form ed w hich is a  form of fibrinogen w ith  only ab o u t 
35%  of th e  a lpha  chain s rem aining. This is still clo ttable fibrinogen, 
b u t will clot only slowly. Since the  am ino term inal end  of the  a lp h a  
chain s is still a t lea st partly  in tac t the  FpA fragm ent is still p re sen t on 
th e  m olecule (N ieuwenhuizen 1991).
Form ation of fibrinogen degradation  p roducts
F ragm ent X is cleaved by p lasm in  sym m etrically  in to  fragm ents 
Y and  D (see Figure 1.7). F ragm ent Y is the  cen tra l nodule  connected
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to one of the  ou ter nodules, and  fragm ent D consists  of the  o ther 
ou ter nodule. Finally the  rem aining  bond  betw een fragm ent D an d  the  
cen tral nodule in  Y is cleaved. The cen tra l nodule is designated  
fragm ent E and  still con ta ins som e FpA.
C onform ational changes take  place in  fragm ents X, Y an d  E, 
exposing regions of the  b e ta  chain  w hich  are  norm ally  bu ried  in  the  
fibrinogen m olecule.
Form ation of fibrin degradation p roducts
B oth F ibrin  I and  Fibrin  II (cross-linked and  non-crosslinked) 
are  digested by p\aswuv\ via a  series of in term ediate  p roducts , 
com parable to those  form ed in  the  lysis of fibrinogen. P lasm in  seem s 
to follow the  in terdom ainal cleavage p a tte rn  in  fibrin a s  in  fibrinogen. 
The degradation  of non-cross linked fibrin I (des AA fibrin) will 
sequentially  yield fragm ents Xj, Yj, D and  Ep and  non -cro ss linked 
fibrin II (des AABB fibrin), Xjj, Yjj, D an d  E jj, w here th e  su b sc rip t I 
denotes th e  absence of FpA and the  su b sc rip t II denotes th e  absence 
of bo th  FpA and  FpB (Figure 1.7).
C ross linked fibrins I and  II are  com posed of long polym ers of 
fibrin I an d  II w hose a  and  y  chains are  cross linked by  isopeptide 
bonds. T hese su b u n its  are suscep tib le  to a ttac k  by  p lasm in  an d  th is  
occurs in  random  order. Soluble fragm ents of the  original polym er 
w ith  varying m olecular w eights are  the  resu lt. T hese fragm ents are  
know n as X-oligomers (Graeff and  H after 1982, Gaffney an d  Perry 
1985, Gaffney e t al 1986). F u rth e r degradation  of these  X-oligomers 
yields fragm ents Ej (or Ejj) and  fragm ent D -dim er (Doolittle 1981,
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G raeff an d  H after 1982). This D -dim er fragm ent is form ed from  two 
fragm ents covalently cross linked by peptide bonds on th e  gam m a 
chain  of each  fragm ent (Figure 1.7).
Table 1.4 describes som e of th e  m olecular ch arac te ris tic s  of 
fibrinogen an d  som e of its  breakdow n products .
M easu rem en t of fibrin(ogen) degradation  p roducts
It h a s  been  realised th a t  the  in vivo activity of the  fibrinolytic 
system  can  be assessed  from p lasm a levels of fibrin degradation  
p ro du cts , and  th a t  these  m easu rem en ts give inform ation ab o u t the  
tu rn o v er of fibrin in an  individual. Previous a ssay s were b ased  on 
se ru m  sam ples w hich were a  no torious source of artefac ts , since they  
depend  on th e  effective rem oval of fibrinogen in v itro . T his rem oval 
w as som etim es incom plete. In addition, a  se ru m  sam ple is u n su itab le  
for the  m easu rem en t of any  param eters of coagulation, p rec lud ing  any  
m easu rem en ts  of fibrinolytic and  coagulation p a ram ete rs  in  th e  sam e 
sam ple. The fibrinolytic system  is n o t absolu te ly  specific for fibrin, 
an d  u n d e r  som e conditions m ay a ttack  fibrinogen. This h a s  only been  
show n conclusively by  the  advent of a  p lasm a  a ssa y  specific for 
fib rinoaen  degradation  p roducts (Nieuw enhuizen 1991).
Reliable ELISA techn iques now exist for th e  quan tita tive  
m easu rem en t of a  nu m b er of fibrin(ogen) degradation  p ro d u c ts  in  
p la sm a  includ ing  D-dim er, X-oligomers and  soluble fibrin 
(N ieuw enhuizen 1991). Latex agg lu tination  a ssay s are  also used , 
w here the  m onoclonal antibody to a  specific fragm ent is b o u n d  onto 
la tex  particles. T h fjb inds to only one type of epitope and  agglu tination
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Table 1.4
Molecular characteristics of fibrinogen and some of its 
derivatives (from Nieuwenhuizen 1991) _________
Fibrinogen or Fibrin(ogen) 
derivative
Molecular features
Intact fibrinogen FpA present; carboxyl terminal 
end(s) of Aa-chain(s) intact
Soluble fibrin FpA absent; new amino 
terminal ends on a-chains (and 
possibly p-chains) are neo­
epitopes. Also neo-epitopes in 
Aa-[148-160]. No cross-links 
present
Cross-linked fibrin Same as soluble fibrin plus the 
presence of cross-links
Fibrinogen degradation 
products (FgDP)
FpA present; no cross-links; 
neo-epitopes amongst others in 
Bp-[58-114]
X-oligomers FpA absent; high molecular 
weight; cross-links present
Fibrin degradation products 
(FbDP)
FpA absent; neo-epitopes in Bp- 
[58-114]; cross-links present 
in cross-linked FbDP
D-dimer No FpA; cross-linked y-chains
can  only occur if there  are m ultiple epitopes on the  fragm ent u n d e r 
test. V irtually all fibrin(ogen) derivatives have a t lea s t two since they  
are sym m etrical or polymeric. This m akes them  su itab le  for su c h  
agglutination tests , w hich have the  prac tical advantage of a  rap id  
resu lt, b u t  these  a ssays are only sem i-quantita tive  an d  in te r-opera to r 
variability m ay occur w hen reading  the  test.
High levels of fibrin degradation  p roducts , includ ing  D-dim er, 
have been  found in  certain  clinical situa tions, su c h  as  d issem inated  
in trav ascu lar coagulation (Wilde et al 1989), and  p u lm o n a iy  em bolism  
and  deep venous th rom bosis (Kroneman et al 1990). D -dim er is also 
elevated in acu te  coronary syndrom es and  du ring  throm bolytic 
th erap y  of acu te  m yocardial infarction (Seifreid and  Tansw ell 1987; 
DeClerck et al 1987), and  raised  levels have been  reported  in  som e 
p a tien ts  w ith pre-eclam psia  (Trofatter et al 1989).
VON WILLEBRAND FACTOR
This factor is deficient in the  p lasm a  of p a tien ts  w ith  the  
bleeding disorder, von W illebrand's d isease. Von W illebrand factor 
(VWF) w as first purified in  the  m id-seventies an d  found to be a  
m ultim eric protein. It is p resen t in endothelial cells, m egakaryocytes, 
p latele ts and  p lasm a. The basic  su b u n it h a s  a  m olecular w eight of 22 
kD a and  dim ers are  held together by  d isu lph ide bridges a t  the  
carboxyterm inal end. In ter dim er d isu lph ide bridges form  m ultim ers. 
VWF is com plexed in the  p lasm a to Factor VIII by non-covalen t 
b inding  to the  light chain  of th is clotting factor. The m ultim eric  n a tu re
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of th is  p ro tein  h a s  been  dem onstra ted  by  SDS-PAGE (Meyer and  
G irm a 1993).
This p ro tein  is syn thesised  in the  endothelial cells and  m ost of it 
is secreted  constitu tively  into the  p lasm a, a lthough  ab o u t 5% is sto red  
by th e  cells in  Weibel Palade bodies (W agner et al 1982). VWF h a s  
been  d em onstra ted  im m unohistologically in  subendo thelia l tissu es .
The p rim ary  im portance of VWF in h aem o stas is  is b ecau se  of its 
in te rac tions w ith platelets, endothelial cells and  subendo thelia l 
s tru c tu re s . It m ediates p latelet adhesion  to subendo thelium  w hen  a  
p late le t p lug  begins to form, b inding  to the  GPIb m em brane  receptor. 
VWF also m ed iates p latele t aggregation, as does fibrinogen w hich also 
bridges betw een p latelets. In addition, VWF induces expression  of the  
fibrinogen recep to r on the  p latelet surface. These p latele t-p late le t 
in te rac tions a re  essen tia l for the  form ation of a  haem osta tic  plug, and  
VWF therefore plays a  key role in  p rim ary  haem ostas is . In the  
coagulation cascade, FVIII is an  essen tia l cofactor for th e  generation  of 
th rom bin . VWF acts  as a  carrier pro tein  for FVIII, p ro tec ts  it from 
proteolysis, an d  also delivers it to the  po in t of v ascu la r in ju ry  (Meyer 
a n d  G irm a 1993).
The secretion  of VWF is stim ula ted  by  th rom bin  (Loesberg e t al 
1983) and  also by fibrin (Ribs et al 1987). The p lasm a  concen tra tion  is 
a b o u t lO m g/m l b u t  there  is a  wide range in  norm al individuals. There 
is also a  tendency  for p lasm a levels to increase  w ith  age.
E xperim ental an im al s tud ies suggest th a t  VWF m ay con tribu te  
to a therogenesis and  arteria l th rom bosis (Badim on et al 1993). Few
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epidemiological or case control s tud ies  have looked a t th e  association  
of VWF w ith card iovascu lar d isease in  m an . Since a  reliable ELISA 
techn ique  h ad  recently  becom e easily available, it seem ed usefu l to 
look a t  VWF levels in parallel w ith  th e  fibrinolytic variables, PAI an d  
tPA. In particu lar, if p lasm a  tPA an tigen  levels partly  reflect 
endothelial d istu rbance , it would be usefu l to com pare the  
assoc ia tions of the  two endothelial release  p roducts, VWF an d  tPA. 
B oth a re  released from endothelial cells by ad renaline  an d  vasopressin  
(Prowse and  M acgregor 1988) and  failure to release tPA h a s  been  
reported  in  som e cases of von W illebrand 's d isease  (Ludlam e t al 
1980).
POTENTIAL ROLE OF IMPAIRED FIBRINOLYSIS AND OF 
ENDOTHELIAL DISTURBANCE IN CARDIOVASCULAR DISEASE AND 
DIABETES MELLITUS
The m ajor card iovascu lar d iseases (ischaem ic h e a r t  d isease, 
ischaem ic stroke and  peripheral a rte ria l disease) are  due  to the  
progressive developm ent of atherosclero tic  p laques an d  su b seq u e n t 
th ro m b u s  form ation (Davies 1994). Progressive incorpora tion  of fibrin 
in to  th e  vessel wall m ay play a  p a r t  in  the  developm ent of 
atherosclerosis: the  R okitansky-D uguid hypo thesis (R okitansky 1852; 
D uguid 1946; Schw artz et al 1988; T hom pson an d  S m ith  1989). 
F ibrin  is a  consisten t com ponent of a therosclero tic  p laques (Sm ith 
1986; Bini et al 1989; Thom pson an d  Sm ith  1989), an d  it m ay 
con tribu te  to p laque growth by stim u la tion  of sm ooth  m uscle cell 
proliferation (Naito et al 1992) and  by b ind ing  and  accum ulating  w ith
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low density  (LDL) lipoprotein; especially lipoprotein (a) (Lp(a)) (Sm ith et 
al 1976, 1990).
It is therefore possible th a t  underactive  fibrinolysis could lead to 
decreased  rem oval of arteria l fibrin deposits and  th u s  to prom otion of 
a therosclerosis (Astrup and  Perm in 1947). E xperim ental tes ting  of th is  
hypo thesis h a s  been  difficult un til recently  because  only global assay s 
of fibrinolytic activity were available. However, the  purification  of tPA 
in th e  1980's and  the  developm ent of specific a ssays for tPA and  for 
its m ajor inh ib ito r PAI-1, have allowed m ore specific tes tin g  of the  
hypo thesis th a t increased  levels of PAI activity (usually  due  to PAI-1) 
m ay prom ote atherosclerosis and  th rom bosis.
R ecent experim ental s tud ies have show n th a t  increased  PAI-1 
levels have prothrom botic  effects (K risnam urti e t al 1987; V aughan  et 
al 1992), Q uenching of PAI-1 activity w ith  a  specific an tibody  
stim u la tes  endogenous throm bolysis (Levi et al 1992). T ransgenic 
m ice w ith  over-expression of the  h u m a n  PAI-1 gene developed 
peripheral venous th rom bosis (Erickson et al 1990).
In m an, congenital defficiency of PAI-1 cau ses  a  bleeding 
d isorder (Fay et al 1992). A dm inistration of certa in  anabolic  stero ids 
su c h  as stanozolol in  m an  lowers p lasm a  PAI-1 levels an d  increases 
tPA activity and  system ic p lasm in  activity a s  m easu red  by  p lasm a  
levels of the  BJ3 1 5 - 4 2  fragm ent (Lowe and  Sm all 1988). However, to 
da te  clinical tria ls  of anabolic stero ids in prevention  of th rom bosis 
have been  inconclusive, and  adverse effects m ake them  u n su itab le  for 
long-term  prevention of throm bosis (Lowe and  Sm all 1988). O n the
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o th er h an d , recom binan t tPA is a  highly effective throm bolytic agen t 
in acu te  m yocardial infarction (Sobel 1988).
Locally, a therosclero tic  lesions con ta in  h igher concen tra tions of 
PAI-1 an d  its m essenger RNA th a n  do norm al a rte ria l w alls 
(Schneiderm an et al 1992). Furtherm ore , the  high concen tra tion  of 
p la te le ts  in  arte ria l th rom bi con ta ins a  large pool of la te n t PAI-1; 
release  and  activation of th is  pool m ay locally inh ib it throm bolysis 
(Booth 1991).
As well a s  im paired fibrinolytic activity, there  is increasing  
evidence for endothelial d is tu rb an ce  in  card iovascu lar d isease. 
E ndothelia l d is tu rb an ce  m ay be one com m on m echan ism  th rough  
w hich  several card iovascu lar risk  factors (e.g. sm oking, infections) 
m ay prom ote a therogenesis. It m ay be followed by a rte ria l wall cell 
proliferation in response  to endothelial injury: proliferating
m acrophages and  sm ooth m uscle cells accum ulate  cholesterol, 
resu ltin g  in typical a therosclerotic  lesions (Ross 1993).
E ndothelial cells have several pro throm botic  an d  a n ti­
th rom botic  m echan ism s, the  balance  of w hich m ay change du ring  
b o th  h aem o stas is  and  th rom bosis (Pearson 1994).
Release of bo th  PAI-1 and  tPA from  endothelial cells m ay  reflect 
endothelial d istu rbance , and  a ltera tions in the  ba lance  of PAI and  tPA 
activities m ay prom ote throm bogenesis. Release of VWF from 
endothelial cells m ay also prom ote throm bogenesis, by  increasing  
p la te le t adhesion  and  aggregation; and  by localising factor VIII a t  the  
sites of vessel in ju ry  (Badimon et al 1993).
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The increased  risk  of card iovascu lar d isease  in  p a tien ts  w ith  
d iabe tes m ellitus m ay in  p a rt be due to im paired fibrinolysis an d  
endothelial d is tu rb an ce  (O sterm an and  van  de Loo 1986; G ran t and  
M edcalf 1990).
The lite ra tu re  on the  association  of fibrinolytic variab les an d  
VWF w ith  card iovascu lar disease, w hich  w as available w hen  the  
s tu d ies  reported  in  th is  thesis  were s ta rted , is now  reviewed. C ase- 
control s tu d ies  of prevalen t d isease are  considered first; followed by  
prospective stu d ies  of inciden t card iovascu lar d isease  in  non-d iabetics 
an d  diabetics.
CASE CONTROL STUDIES OF FIBRINOLYSIS AND VWF IN 
CARDIOVASCULAR DISEASE AND DIABETES MELLITUS
Deep vein th rom bosis
A lm ost all of the  early case control s tu d ies  have show n p a tien ts  
w ith  deep vein th rom bosis to have depressed  fibrinolytic activity 
(Juhan-V ague et al 1988; Lowe and  Sm all 1988). Lower levels of tPA 
activity observed after venous occlusion in som e p a tien ts  are  now  
know n to be the  re su lt n o t u sua lly  of defective tPA release, b u t  of high 
PAI activity (Nilsson et al 1985). T his cau ses  the  inactivation  of tPA 
giving lower activity, b u t  w hen m easu red  by an  an tigenic m ethod 
w hich m easu re s  bo th  free and  bound  tPA th ese  levels w ere found to 
be no rm al or increased  (Bergsdorf e t al 1983; N ilsson 1989).
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Ischaem ic h e a rt d isease
The rela tionsh ip  betw een ischaem ic h e a r t d isease  and  
fibrinolysis is sum m arised  in Table 1.5. M ost s tu d ies  have observed 
ra ised  levels of tPA an tigen  and  PAI activity, an d  decreased  levels of 
tPA activity. In p a tien ts  who h ad  res tenosis  after p e rcu tan eo u s 
tran s lu m in a l coronary angioplasty, there  were h igher levels of tPA 
an tigen  and  lower tPA release after venous occlusion w hen  com pared 
to a n  age m atched  group w ithou t restenosis  (K irschstein e t al 1989). 
PAI activity w as h igher in the  restenosis  group in th is  s tu d y  b u t the  
difference w as n o t sta tistically  significant. In a  s tu d y  com paring 
p a tien ts  w hose a rteries occluded w ith  those  who h a d  p a te n t arte ries 
a fter throm bolytic th erap y  w ith recom binan t tPA, p re tre a tm e n t levels 
of PAI activity and  tPA antigen  were significantly h igher in  the  group 
w ho occluded (B arbash et al 1989). W hen com pared  to healthy  
contro ls, the  p a tien ts  w hose arteries rem ained  p a te n t h a d  significantly 
h igher levels of tPA an tigen  b u t no t PAI activity.
T here are  fewer s tud ies  w hich have looked a t VWF in  p a tien ts  
w ith  ischaem ic h e a rt d isease (Table 1.5). H igher levels of VWF were 
found in  p a tien ts  w ith ang ina  pectoris who h ad  m yocardial in farc ts 
th a n  in  su c h  p a tien ts  who h ad  no h isto ry  of m yocardial infarction  
(Schm itz-H uebner e t al 1988). One s tu d y  show ed a  h igher p lasm a  
VWF level in  w om en who survived a  m yocardial in farc t w hen  
com pared  to controls (H am sten et al 1985), b u t  the  m ale g roups h ad  
sim ilar levels of VWF. O ther reported  assoc iations of VWF w ith 
card iovascu lar d isease are an  association  w ith  clinical severity of 
an g in a  pectoris (Moisseev 1988), an d  ischaem ic cerebrovascu lar
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Table 1.5 Case control studies on VWF, tPA, PAI and 
ischaemic heart disease
Author n VWF tPA PAI tPAac
Hamsten et al 1985 71 T
women
T t 4-
Nilsson & Johnson 1987 124' = r 4-
Verheugt et al 1987 
(AMI)
18 t i
Juhan Vague etal 1989 
(AMI)
67 T
Barbash etal 1989 (AMI) 125 T =
Paramo et al 1985 118 T t
Aznaret al 1988 92 T T
Francis et al 1988 99 T I
Schmitz-Heubner et al 
1988
aas* T
Olofsson et al 1989 213 T T
Mehta et al 1987 75 = =
Vanderkerckhove et al 
1988
71 = =
Oseroff et al 1989 65 = =
tPA = tPA antigen, PAI = PAI-1 activity, tPAac = tPA activity, 
AMI = studies on patients with acute myocardial infarction. 
Notice that only the most recent studies have been listed here.
d isease  (W ahlberg et al 1980, M ettinger 1982). T hese case  control 
s tu d ies  indicate th a t  high levels of VWF m ay  be a  m ark e r of ongoing 
a therosclero tic  changes and  risk  of th rom botic  events, possibly  due  to 
its release  from d istu rbed  arteria l endothelium .
D iabetes m ellitus
Fibrinolytic activity is im paired in  p a tien ts  w ith  d iabetes 
m ellitus (Fuller et al 1979; O sterm an  and  van  de Loo 1985; G ran t and  
M edcalf 1990) w hich m ay be relevant to th e ir increased  risk  of arteria l 
d isease. Improved diabetic control w ith in su lin  show s im proved 
fibrinolytic activity in bo th  in su lin  dependen t d iabetes m ellitus (IDDM) 
(Greaves e t al 1983) and  non- in su lin  dependen t d iabetes m ellitus 
(NIDDM) (Small e t al 1987). Both high PAI activity and  high tPA 
an tigen  are  associated  w ith p lasm a insu lin , obesity, triglyceride and  
an d  blood p ressu re ; the  in su lin  resistance  syndrom e (Juhan-V ague et 
al 1988).
Several s tu d ies  have consistently  show n th a t  p la sm a  VWF levels 
are elevated in in su lin -dependen t d iabetes m ellitus (IDDM) and  n o n ­
in su lin  dependen t d iabetes m ellitus (NIDDM) (O sterm ann an d  van  de 
Loo 1985). This m ay reflect bo th  m icrovascular and  m acrovascu lar 
endothelial d istu rbance  in  th is  disease.
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PROSPECTIVE STUDIES ON FIBRINOLYSIS AND VWF IN ISCHAEMIC
HEART DISEASE AND DIABETES MELLITUS
Some recen t prospective stud ies looking a t  assoc iations of 
fibrinolysis and  card iovascu lar events are sum m arised  in  tab le  1.6. In 
a  large prospective s tu d y  in healthy  m en carried  o u t a t Northwick 
P ark  H ospital, 109 ou t of 1511 m en developed ischaemic h e a r t  d isease 
du ring  the  7-year follow up  (Meade et al 1986). In th is  study , global 
fibrinolytic activity w as m easured  by the  d ilu te  whole blood clot lysis 
tim e, b ecau se  assays of PAI and  tPA were n o t yet available. 
Fibrinolytic activity w as significantly lower in  those  w ho w ent on to 
develop IHD w hen  com pared to those who did not. O n th e  o th er h an d , 
euglobulin  clot lysis tim e w as n o t predictive of IHD or stroke  in  the  
Goteborg S tu d y  (W ilhelmsen et al 1984).
PAI activity w as an  independen t r isk  factor for predicting  
reinfarction  and  card iac death  am ong survivors of p rem atu re  
m yocardial infarction  (under 45 years) (H am sten e t al 1987). However, 
n e ith e r PAI activity no r tPA an tigen  were predictive of rec u rren t 
m yocardial infarction  in  older m en (Jansson  et al 1991b). In ang ina  
pectoris, tPA antigen , b u t  no t PAI activity w as predictive of m yocardial 
infarction  (Jan sso n  et al 1991b, 1993).
As a lready  described, VWF is also a  m ark e r of endothelial 
d is tu rb an ce  and  m ight therefore be expected to m irro r a ltered  levels of 
fibrinolytic p ro te ins of endothelial origin (tPA, PAI-1). Very few 
prospective s tu d ies  have assessed  the  re la tionsh ip  of VWF to 
ischaemic h e a r t  d isease. The Northwick P ark  H eart S tu d y  show ed th a t
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h igher incidence of IHD w as associated  w ith increased  factor VIII 
levels, an d  factor VIII is know n to correlate well w ith  VWF 
concen tra tions, b u t  th is  association  w as n o t sta tistica lly  significant 
(Meade et al 1986). H aines et al (1983) show ed th a t  h igher VWF levels 
occurred  in  p a tien ts  w ith  acu te  m yocardial in farction  w ho died w ith in  
one year. Patien ts were sam pled soon after adm ission  an d  th e  re su lts  
m ay  therefore be affected by acu te  p h ase  reactions. B reddin  e t al 
(1986) reported  th a t  VWF levels p red ic t card iovascu lar events in  a  
group  of d iabetic pa tien ts .
AIMS OF STUDIES REPORTED IN THIS THESIS
The above lite ra tu re  review suggested  th a t  abnorm alities in  
specific com ponents of the  fibrinolytic system  (PAI, tPA, fibrin D- 
dimer), a s  well as in  VWF (which like PAI-1 and  tPA is a  m ark e r of 
endothelia l d istu rbance), m ay be assoc iated  w ith  card iovascu lar 
d isease  especially ischaem ic h e a rt disease; and  w ith  d iabetes m ellitus 
in  w hich  the  risk  of card iovascu lar d isease  including  ischaem ic h e a r t 
d isease  is increased .
The recen t availability of chrom ogenic assay s for PAI activity, a s  
well a s  specific ELISA's for tPA, D -dim er and  VWF an tigens, m ade it 
possible  to perform  fu rth e r clinical and  epidemiological s tu d ies  of 
th ese  variab les in card iovascu lar d isease  and  d iabetes m ellitus. As 
well as th e ir  biolgical associations, th e ir po ten tial u tility  a s  pred ictors 
of ischaem ic h e a r t d isease  events w as also add ressed .
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It w as decided to a ssay  p lasm a PAI activity (which is largely PAI- 
1  activity in  n o n -p regnan t persons) ra th e r  th a n  antigen , on the  
p rem ise th a t  it is PAI activity w hich is th e  m ain  po ten tia l d e te rm in an t 
of fibrinolytic activity in  vivo (evidence for th is  is sum m arised  above). 
F u rtherm ore , p lasm a PAI-1 an tigen  is partly  inactive com plexes w ith 
tPA (Figure 1.5); and  can  be a rtefac tually  fu rth e r elevated by  release of 
inactive PAI-1 from blood p latele ts du ring  ven ep u n c tu re  (Booth 1991), 
w hich  m ay  be a  problem  especially in  epidemiological s tu d ies  u n d e r 
"field conditions".
It w as also decided to a ssay  p lasm a  tPA an tigen  ra th e r  th a n  tPA 
activity, on the  b asis  th a t  sam pling conditions and  an ticoagu lan t to 
p reven t com plexing of active tPA w ith  PAI-1 during  sam ple  hand ling  
(which w ould re su lt in  false low levels of tPA activity) were n o t well 
s ta n d a rd ise d  a t the  tim e these  s tud ies  w ere in itiated . Betw een them , 
PAI activity and  tPA an tigen  rep resen t th e  to ta l a m o u n t of circu lating  
PAI-1, tP A an d  PAI-1-tPA com plexes (Figure 1.5).
The aim s of th is  s tu d y  were as follows:-
(a) to a sse ss  the  laboratory  variability, biological (longitudinal 
in tra-indiv idual) variability, and  to ta l (laboratory and  biological) 
variability  in  PAI activity, tPA antigen, fibrin  D -dim er an tigen  an d  VWF 
an tigen  (C hapter 2);
(b) to a sse ss  the  in ter-indiv idual variability  of PAI activity, tPA 
antigen , fibrin D -dim er an tigen  and  VWF an tigen  in  a  large random  
sam ple  of the  general population  - the  Second Glasgow WHO-MONICA 
Survey; w ith in  th is  sam ple to determ ine th e  re la tionsh ips of th ese
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variab les to tim e of sam ple, dem ographic and  life style variables, 
card iovascu lar r isk  factors and  p revalen t card iovascu lar disease; an d  
w ith in  th is  sam ple to estab lish  the  m ajor independen t d e te rm in an ts  of 
th ese  variables in  the  population  by m ultivariate  analysis (C hapter 3);
(c) to a sse ss  w he ther som e of these  assoc iations of PAI activity 
m ay arise  because  of its "acute p h ase  protein" reactions (Juhan-V ague 
et al 1985; Kluft e t al 1985) (possibly m ediated  th ro u g h  th e  cytokine 
in te rleu k in -6 ,IL-6 ) (C hapter 3);
(d) to determ ine the  association  of PAI activity, tPA antigen, 
fibrin  D -dim er antigen, VWF antigen, fibrinogen an d  red cell 
aggregation w ith  prevalent ischaem ic h e a r t d isease  (IHD) in  a  
popu lation  controlled case-control s tu d y  of p rem atu re  m yocardial 
infarction  (C hapter 4);
(e) to a sse ss  the  predictive value of PAI activity, tPA antigen, 
fibrin  D -dim er an tigen  and  VWF an tigen  for inciden t IHD, in  the  
prospective Caerphilly H eart S tudy  (C hapter 5);
(f) to a sse ss  the  predictive value of fibrin D -dim er antigen , VWF 
an tigen  an d  fibrinogen for inciden t IHD, in  th e  prospective E d inburgh  
C laudication  S tudy  (C hapter 6 );
(g) to com pare PAI activity, tPA antigen , VWF an tigen  and  
fibrinogen in  m atched  p a tien ts  w ith  no n -in su lin -d ep en d en t d iabetes 
m ellitus (NIDDM) w ith  and  w ithou t m icroalbum inuria  (a r isk  factor for 
IHD), an d  in  m atched  non-diabetic  controls; and  to correlate  levels of
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th ese  variables w ith  two m easu res  of free rad ical form ation w hich is 
one po ten tial cause  of endothelial d is tu rb an ce  (C hapter 7);
(h) to com pare the  responses of PAI activity, tPA antigen , fibrin 
D-dim er, VWF an tigen  and  fibrinogen to acu te  in su lin -induced  
hypoglycaem ia in  p a tien ts  w ith in su lin -dependen t d iabetes m ellitus 
(IDDM) and  m atched  non-diabetic  controls (C hapter 8 ). T his s tre ss  
w as u sed  bo th  to a sse ss  dynam ic endothelial response  a s  a  te s t of 
endothelial function, and  also to a sse ss  the  possible con tribu tion  of 
hypoglycaem ic episodes to elevation of th ese  variab les in  IDDM;
(i) to com pare the  response  of PAI activity, tPA antigen , VWF 
an tigen  and  fibrinogen to acu te  subm axim al exercise in  p a tien ts  w ith  
IDDM and  m atched  non-diabetic  controls (C hapter 9). This s tre ss  te s t 
w as again u sed  as a  te s t of dynam ic endothelial function.
The m ethods u sed  in  these  s tud ies  are  described in  C hap te r 2.
CHAPTER 2
SUBJECTS AND METHODS
SUBJECTS
The sub jec ts  who partic ipa ted  in  each  s tu d y  are  described  in  
th e  re levan t chap ters  of th is  thesis.
LABORATORY METHODS
Sam ple hand ling  and  storage
C areful blood collection, sam ple hand ling  an d  sto rage are  
essen tia l for the  accu ra te  m easu rem en t of th e  variab les repo rted  in 
th ese  s tud ies . The reliability of these  re su lts  u ltim ately  reflects the  
care tak e n  w ith  these  procedures. W ithdraw al of blood re su lts  in 
im m ediate changes in  the  com ponents of h aem o stas is  (Thomson, 
1992), activating  som e factors (such a s  tis su e  factor an d  p la te le t 
release  factors), while o ther labile factors su c h  a s  tPA an d  F acto r VIII 
m ay quickly deteriorate. To reduce the  possibility  of the  p re-analy tica l 
p h ase  affecting the  resu lts , adherence to recom m ended protocols 
m u s t be stric tly  observed. This is particu larly  tru e  w hen  sam ples are  
being  h an d led  ou tside the  laboratory, e.g. in  popu lation  stud ies . 
Sam pling  p rocedures in su c h  stud ies are d iscussed  in  the  re levan t 
c h ap te rs  of th is  thesis .
In all s tu d ies  w here blood sam ples were b ro u g h t to the  labora to ry  for 
handling , th e  protocol for blood collection and  storage designed by  the
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E uropean  Concerted Action on T hrom bosis (ECAT) w as followed 
(Thomson, 1992).
M inimal s ta s is  w as applied to the  u p p er a rm  prior to ven ep u n c tu re  
an d  blood w as added to tu b es  contain ing  0 .109  mM trisod ium  c itrate  
w ith  a  final ratio  of 9 volum es of blood to 1 volum e of citrate . T hese 
tu b es  w ere pre-cooled on m elting ice so th a t  th e  blood sam ple  w as 
cooled rapidly, th u s  preserving those com ponents th a t  de terio ra te  a t 
h igher tem p era tu res . The tu b es  were th e n  p u t on m elting ice, and  
w ere centrifuged w ith in  one h o u r a t 2 0 0 0 g for 2 0  m in u tes  in  a  
refrigerated centrifuge a t +4°C to give p late le t poor p lasm a. After the  
careful rem oval from the  cells w ith  a  d isposable P asteu r p ipette  the  
m iddle layer of the  p lasm a  w as aliquoted and  sn ap  frozen a t  -70°C  
u n til assay .
P lasm inogen Activator Inhibitor (PAD Activity
P lasm a p lasm inogen activator inh ib ito r activity levels were 
determ ined by  a  com m ercially available chrom ogenic su b s tra te  a ssay  
(Coatest PAI; Chrom ogenix, Epsom , U.K.). The a ssay  involves the  
addition of a  fixed am o u n t of single-chain  tissu e  p lasm inogen 
activator (tPA) in excess to und ilu ted  p lasm a, w here m ost of it rapidly  
form s a n  inactive com plex w ith the  fas t inh ib ito r PAI-1. (Single-chain 
tPA is u sed  in  the  a ssay  because  PAI-2, an o th e r inh ib ito r of tPA found 
in  p lasm a, inh ib its th is  single-chain  form very poorly). The res idua l 
tPA th en  activates p lasm inogen to p lasm in  in  the  p resence  of a  
stim ula to r. The am o u n t of p lasm in  form ed is directly p roportional to 
the  PAI activity in  the  p lasm a  sam ple (which u n d e r  m ost 
c ircum stances is m ostly  PAI-1). P lasm in levels are th en  determ ined  by
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m easu rin g  the  am idolytic activity of p lasm in  on a  chrom ogenic 
su b s tra te  (S-2403), w hich releases p-n itroaniline, levels of w hich  are 
determ ined  using  a n  au tom atic  m icroplate reader (MR700 from 
D ynatech, W est Sussex , UK), a t 405nm . The abso rbance  of th e  sam ple 
is th en  com pared  w ith  the  s ta n d a rd  curve generated  for each  te s t ru n , 
an d  a  value for the  level of PAI activity obtained. This is expressed  in 
a rb itra ry  u n its  (AU), one AU being defined as  the  a m o u n t w hich 
inh ib its one IU of tPA /m l u n d e r the  te s t conditions (Chm eilew ska et 
al 1986, G ram  et al 1993). A sam ple s ta n d a rd  curve is show n in 
Figure 2.1.
At th e  tim e th is  w ork w as u n dertaken , only two PAI activity k its  
were available comm ercially. These were th e  k it from Chrom ogenix 
(then know n as Kabi) and  a  k it from Biopool AB, Umea, Sw eden.The 
k its were com pared and  found to correlate well. It w as decided on 
term s of cost to u se  the  Chrom ogenix k it (Chm ielewska et al. 1986). 
T his k it h a s  a  reported  sensitivity  of 5 a rb itra ry  u n its /m l, an d  is n o t 
affected by  norm al levels of a lpha-2 -an tip lasm in . D uring the  course  of 
th e  MONICA 2 s tu d y  (reported in C hap ter 3), w hich  w as the  firs t s tu d y  
in  w hich PAI activity w as m easured , there  w ere changes m ade to the  
k it and  a  new  su b s tra te  w as in troduced . T his resu lted  in  h igher 
values for PAI activity: the  norm al pooled p lasm a  w hich w as ru n  w ith  
each  a ssa y  for quality  control w as consisten tly  h igher w ith  th e  new  
kits . (This control p lasm a  w as produced by  pooling no rm al p la sm a  
from  20 h ea lth y  vo lun ters, 10 m en and  10 w om en, aged betw een 25 
an d  45 years. This w as th en  aliquoted and  rapid ly  frozen a t -70°C). It 
w as therefore decided to express the  re su lts  a s  a  percen tage of the  
norm al pool ra th e r  th a n  as a rb itra ry  u n its /m l. The value ob tained  for 
the  pool on each  p late  w as used  to calculate the  PAI activity va lues for
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th e  sam ples on th a t  plate. This m ethod of recording th e  re su lts  w as 
th e n  u sed  in  all su b seq u en t stud ies. Successive p lasm a  pools were 
calib ra ted  against each  other.
A ssay of the  norm al pool in  each  se t of a ssay s  also gave 
inform ation  ab o u t th e  coefficient of varia tion  (CV) of th e  assay . The 
in te r  a ssa y  CV perform ed on a  norm al pool on 10 occasions w as found 
to be 8.1%. The in tra  a ssay  CV calcu lated  on 5 single a ssay s  of a  
norm al pool w as 7.9%. The m ean  PAI activity level w as p lo tted  ou t 
dally on a  Levey-Jennings plot (Levey and  Je n n in g s  1950). An exam ple 
is show n in  Figure 2.2.
At th e  tim e th is  w ork w as u n d ertak en , no s ta n d a rd  reference 
m ethod  or s ta n d a rd  for PAI w as available, a lthough  one p lasm a  
s ta n d a rd  is cu rren tly  u n d e r s tu d y  (Gaffney 1993). D uring th e  s tu d ies  
reported  in  th is  thesis , the  D epartm ent of M edicine w as asked  to 
partic ipa te  in  an  in te rnational com parison  of PAI estim ation . T his w as 
a  s tu d y  se t u p  to a sse ss  the  analy tical perform ance of different 
com m ercial k its  u sin g  eight "blind" sp lit sam ples se n t to 1 1  different 
h aem o stas is  laboratories (Gram et al 1993). This s tu d y  show ed wide 
in ter-laborato ry  and  in te r-k it variability, w hich m ight be reduced  by  
expressing  the  re su lts  a s  a  percentage of norm al p lasm a  pool.
T issue Plasm inogen Activator (tPA) Antigen
P lasm a levels of tPA were m easu red  w ith  a  com m ercially 
available enzym e linked im m unosorben t a ssa y  (ELISA) from  Biopool 
AB, Um ea, Sw eden (Tintelize #101120). The a ssay  quantifies h u m a n  
single chain  and  two chain  tPA antigen . No cross reaction  w ith
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u ro k in ase  is observed. M aximal sensitiv ity  of the  a ssay  is reported  by 
th e  m an u fac tu re r a s  1.5 n g /m l.
In th is  a ssay  som e interference m ay  occur from p lasm a  levels of 
o th er an tibodies su c h  as an ti-goat an tibod ies and  rheum ato id  factor. 
To exclude false positives, each  sam ple is applied to two wells, one 
con ta in ing  norm al goat IgG, an d  the  o ther con ta in ing  goat a n ti-h u m a n  
tPA IgG. The difference in  a ssay  response  betw een th ese  two wells is 
h ighly  tPA specific. After initial b ind ing  to th e  pre-coated  well, th e  
second  antibody w hich is conjugated to h o rse rad ish  peroxidase is 
added  to the  wells. This will b ind  to free an tigenic de te rm in an ts  on the  
tPA m olecules p resen t. U nbound conjugate is w ashed  aw ay after a  
fu rth e r  incubation  period, and  the  rem ain ing  peroxidase is th en  
m easu red  by the  addition  of its su b s tra te  orthophenylenediam ine 
dihydrochloride. The colour developm ent is proportional to the  
a m o u n t of tPA bound  to the  well. The abso rbancies were read  a t  492 
n m  on an  MR 700 p late  reader (Dynatech, W est Sussex,UK). B ecause 
of th e  b lan k  read ing  for each  te s t and  s ta n d a rd , the  curve h a d  to be 
p lo tted  m anually  an d  the  re su lts  from each  te s t  read  from  th e  curve.
In ter a ssay  CV w as determ ined a s  before u sin g  a  norm al pool 
m easu red  on 10 occasions and  found to be 9.8%. In tra  a ssa y  CV 
calcu lated  on 5 single assay s w as 9.0%. W hen 6  p a tien ts ' p lasm as 
w ith  a  wide range of tPA levels were u sed  to calculate  th e  CVs they  
w ere found to be very sim ilar.
A Levey Je n n in g s  plot of the  m ean  tPA an tigen  level of a  norm al 
pool is show n in Fig 2.3.
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An In terna tional S tan d ard  for tPA h a s  recen tly  been  developed 
by  Dr. P Gaffney, NIBSC, S ou th  Mimms, UK (Gaffney e t al 1993), and  
in  1995, th e  laboratory  in  the  D epartm en t of M edicine w as asked  to 
partic ipa te  in  its evaluation in  an  in te rnational collaborative study . 
The value assigned  to the  s tan d a rd  by th is  laboratory  (24.7 ng /m l) 
w as very sim ilar to the  co n sen su s m ean. T his s ta n d a rd  h a s  now  been  
su b m itted  to the  W orld H ealth  O rganisation (WHO).
Von W illebrand Factor (VWF) Antigen
P lasm a von W illebrand factor (VWF) an tigen  levels were 
m easu red  u sin g  an  in -house  enzyme linked im m unoso rben t a ssay  
(ELISA), em ploying rab b it an ti-h u m an  polyclonal an tibod ies obtained  
from  DAKO pic, High W ycombe, UK (Short et al 1982).
The s ta n d a rd  curve w as constructed  u sing  a  norm al pooled 
p lasm a  from  20 vo lun teers as previously described, an d  th e  5 th  
B ritish  S tan d ard  (obtained from National In stitu te  for Biological 
S ta n d a rd s  an d  Control, S ou th  M imms, UK) w as u se d  for pool 
calibration . T his m ean t th a t  the  resu lts  could be reported  as 
in te rn a tio n a l u n its /d ec ilitre  (iu/dl), in stead  of a s  a  percen tage of the  
pool.
The cap tu re  an tibody  is coated onto the  wells of a  96  well 
m icro titre  p late  (Dynatech, W est Sussex, UK). D iluted p lasm a  sam ples 
and  s ta n d a rd s  are th en  added and  incubated  for 30 m inu tes. After 
w ash ing  w ith  buffer, the  antibody, w hich is conjugated to  h o rse rad ish  
peroxidase, is added. After th is  h a s  in cuba ted  for a  fu rth e r 30 
m inu tes, an o th e r w ash ing  procedure tak es place. The peroxidase 
su b s tra te , orthophenylenediam ine w hich h a s  been  activated  by
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add ition  of hydrogen peroxide is added an d  after a  rap id  colour 
developm ent, the  reaction  is stopped by  the  addition  of 1.5M 
su lp h u ric  acid. The absorbance  in the  wells is th en  read  u s in g  the  
m icroplate  reader (MR700 from D ynatech, W est Sussex , UK) a t  492 
n m  and  the  re su lts  of the  te s t sam ples a re  read  ag a in st th e  s ta n d a rd  
curve plotted for the  assay . A sam ple curve is show n in  F igure 2.4.
U sing the  5 th  B ritish  S tan d ard  in  10 assays, th e  CV for the  
in te r-a ssay  variability  w as 7.7%. The in tra -a ssa y  variability  w as 6.0%, 
being th e  CV of 5 aliquots of the  s ta n d a rd  in  a  single assay . As 
p a rtic ip an ts  in the  UK National E xternal Q uality  A ssesm en t Schem e 
(NEQAS) for Blood Coagulation, we regularly  received sam ples during  
th e  s tu d ies  for a ssay  of von W illebrand factor an tigen  levels. R eports 
on th e  re su lts  of these  surveys during  th e  period of th e  s tu d ies  gave 
u s  a  sa tisfac to ry  grading.
Since the  norm al pool w as u sed  to co n s tru c t the  s ta n d a rd  curve 
in  th is  assay , it could n o t be used  as a  quality  control p lasm a. The 5 th  
B ritish  S tan d a rd  w as therefore assayed  on each  p late  an d  th e  re su lts  
p lo tted  o u t on a  Levey Jen n in g s  plot (not shown).
F ibrin  D -dim er an tigen
The m easu rem en t of p lasm a fibrin D-dim er, w hich is p resen t in  
several cross-linked fibrin degradation  p roducts , w as carried  o u t 
u sing  th e  'D im ertest' enzym e linked im m unoso rben t a ssa y  (ELISA) k it 
from  Agen Biom edical Limited ( Parsippany, New Jersey , U.S.A.). The 
cleavage of bo th  fibrinogen and  fibrin by  the  fibrinolytic enzym e 
p lasm in  yields fibrin(ogen) degradation  p ro d u cts  (FDPs). However,
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Figure 2 .4  Sam ple curve for VWF antigen.
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only those products from the degradation of cross-linked fibrin 
contain D-dimer. Elevated levels of cross-linked FDPs detected by th is 
method indicate increased form ation and lysis of cross linked fibrin, 
and imply an  increase in the  turnover of cross-linked fibrin.
The principle of the tes t involves the use  of the  m onoclonal 
antibody DD-3B6, w hich recognises D-dim er and  FDPs containing it. 
The DD-3B6 is bound  to m icrotitre p lates to w hich either p lasm a or 
standard dilu tions of D-dim er are added. After an  incubation  period to 
allow binding of the D-dim er to the cap tu re  antibody, the  plate is 
washed w ith buffer and  a second m onoclonal antibody (DD-4D2) is 
added. This is conjugated to ho rserad ish  peroxidase and  b inds to the 
cross-linked FDPs th a t have been imm obilised by the DD-3B6 
antibody bound  to the  wells. After fu rther w ashing, a su b s tra te , 3- 
ethyl benzthiazoline sulphonic acid (ABTS) is added, w hich is 
hydrolysed by the  ho rserad ish  peroxidase resu lting  in  a  coloured 
product w hich is proportional to the am ount of D-dim er p resen t in the 
well. The absorbance is then  read spectrophotom etrically  on an  
MR700 plate reader (Dynatech, W est Sussex, UK) a t 405nm , and  
compared w ith the  s tan d ard  curve.
Quality control of th is assay  proved ra th e r difficult. There is no 
international s tan d a rd  for D-dim er as yet (Gaffney 1993), and  since 
the kit is designed to look a t pathologically high levels of D-dimer, the 
use of a  norm al pool is no t entirely suitable. Nevertheless, quality 
control as assessed  by a Levey Jen n in g s plot w as satisfactory  during  
these studies. The CVs for th is assay  were higher th a n  for o ther 
assays, w ith an  in ter assay  variation of 15.8% calculated by 
measuring the  D-dim er level of the pool in 10 different assays. The
44
in tra  assay  CV calculated  from 5 aliquots of pool ru n  on th e  sam e 
a sssa y  w as 14.2%.
Fibrin  plate lvsis area.
The fibrin p late  lysis a rea  of the  p lasm a euglobulin  fraction  w as 
perform ed by the  m ethod of Kluft e t al (1976L This m ethod  involves 
the  precip itation  of the  euglobulin fraction of the  p lasm a  by d ilu tion 
and  acidification. This fraction con ta ins m ost of the  p lasm a  fibrinogen 
and  plasm inogen, and  also con ta ins p lasm inogen activators. The 
precip ita ted  euglobulin  fraction w as resu sp en d ed  in  buffer, and  
applied to a  petri d ish  in  w hich a  s ta n d a rd  so lu tion  of 
fibrinogen/buffer h ad  been  clotted w ith  th rom bin . The te s t  euglobulin  
precip ita te  w as tested  in  parallel w ith a  s ta n d a rd  control p lasm a  
w hich h ad  been  precip ita ted  in  the  sam e way. One control an d  the  
te s t p lasm a  in  trip licate  were applied to the  plate, w hich  w as th en  
incuba ted  a t 37^C for 18 hours. Two perpend icu lar d iam eters were 
m easu red  to calculate  the  a rea  of lysis. T his a rea  of lysis gives a  
m easu re  of global fibrinolysis since lysis is affected by  p lasm inogen 
activator activity, as well as the  activity of p lasm in  and  o ther 
p ro teases.
F ibrinogen
C lottable fibrinogen w as m easu red  by  the  d ilu te  th rom bin  
clotting tim e m ethod of C lauss (1957). This w as done on a  Coag-A- 
Mate X2 au tom ated  coagulom eter (Organon Teknika, Cam bridge, UK) 
using  reagen ts and  s ta n d a rd s  from the  m an u fac tu rer. The 
In terna tional Fibrinogen S tan d ard  (Gaffney and  Wong 1992) w as also
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u se d  to check  the  m an u fac tu re rs  s tan d ard ; th is  w as satisfactory . An 
in -h o u se  p lasm a  pool from 2 0  h ea lthy  donors w as u sed  a s  th e  
in te rn a l quality  control; th is  w as a liquotted  and  stored  a t  -70°C  and  
u se d  in  each  assay . U sing fibrinogen levels of the  norm al pool over 10 
a ssay s  th e  CV for in te r a ssay  variability  w as found to be 5.1%. The 
in tra  a ssa y  variability  w as 3.2%, calcu lated  from fibrinogen levels 
m easu red  on the  pooled p lasm a ru n  5 tim es in the  sam e assay . 
E x ternal quality  control w as provided as before by partic ipa tion  in  the  
UK NEQAS schem e. Again, laboratory  re su lts  were sa tisfac to ry  du ring  
th e  s tu d ies  reported  in  th is  thesis .
Red Cell Aggregation
M easu rem en t of red  cell aggregation w as perform ed in  whole 
blood an ticoagu lated  w ith  d ipo tassium  EDTA (1.5 m g/m l). A 
pho tom etric  techn ique using  an  au tom ated  MAI aggregom eter 
(M yrenne GMBH, Roetgen, Germany) w as employed (Schm id- 
S honbein  et al 1982; Stoltz et al 1984).
25pl of well m ixed whole blood is p laced on th e  aggregom eter 
cone w hich  con tacts a  g lass slide on closing the  m achine. The sam ple 
is sub jected  to a  1 0  second period of high sh e a r  (around 6 0 0 s 1) to 
d is ru p t any  red cell aggregates. The change in  light tran sm iss io n  over 
a  5 second period of s ta s is  is th en  m easu red . The g rea ter the  red  cell 
aggregation, the  g rea ter the  tran sm iss io n  of light th ro u g h  th e  sam ple, 
and  the  h igher the  num erica l value ob tained  in  a rb itra ry  u n its  from 
the  aggregom eter.
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T hese m easu rem en ts  were carried  ou t a t am bien t tem p era tu re  
(20-25°C) and  a t  native haem atocrit. S tandard ising  for haem atocrit 
ap p ea rs  to have no effect on red cell aggregation in  m ost clinical 
s itu a tio n s  (M acRury and  Lowe 1990). The m ean  of duplicate  read ings 
w as ta k e n  and  th e  procedure  w as repeated  if there  w as a  difference of 
m ore th a n  0.3 u n its  betw een the  readings, u n til co n sis ten t re su lts  
w ere achieved.
H aem atocrit
H aem atocrit w as m easu red  by  the  Hawksley m icrohaem atocrit 
m ethod  (Hawksley and  Sons, Lancing, Sussex , UK) in  accordance  w ith  
In te rn a tio n a l Com m ittee for S tandard isa tion  in  Haem atology (ICSH) 
recom m endations (1986).
W hole blood anticoagulated  w ith d ipo tassium  EDTA w as well 
m ixed, an d  duplicate  sam ples of th is  were d raw n u p  in to  g lass 
capillary  tu b e s  of 1 m m  in d iam eter w hich w ere th en  sealed a t  one 
end. The tu b es  were th en  placed in  th e  Hawksley m icrohaem atocrit 
centrifuge and  sp u n  a t 13,000g for 5 m inu tes. The h am ato c rit w as 
th e n  read  as a  percentage of the  sam ple w hich  w as packed  cells, 
w ith o u t correction  for p lasm a trapping . An average read ing  of th e  two 
sam ples w as taken .
O ther A ssays
In certa in  stud ies, IL-6 , adrenaline, noradrenaline , cortisol and  
free rad ica ls  w ere assayed  in o ther laboratories. D etails of these  
m easu rem en ts  are  given in  the  appropria te  chap ters .
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STUDY OF TOTAL VARIABILITY IN PAL TPA. VWF. D-DIMER AND
FIBRINOGEN.
Having estab lished  the  variability  in  laboratory  m easu rem en t, I 
th e n  proceeded to s tu d y  to ta l variability  of PAI activity, tPA antigen , 
VWF antigen , D -dim er and  fibrinogen. Total variability  is th e  su m  of 
biological variability  and  laboratory  m easu rem en t variability  (usually  
in ter-assay) an d  is estim ated  by repeated  m easu rem en ts  in  a  group of 
ind iv iduals over a  period of tim e (usually  several weeks) (E rnst et al 
1985). W hile d iu rnal variation  in p lasm a  levels of PAI and  tPA is well 
estab lished  (Andreotti et al 1988; Angleton e t al 1989), th e re  is little 
p ub lished  inform ation on longitudinal biological varia tion  in  PAI, tPA, 
VWF, D -dim er or fibrinogen. T hom pson et al (1987) s tud ied  su c h  
v aria tion  over a  3 year period in several haem osta tic  variables, 
includ ing  VWF and  fibrinogen. They concluded th a t  biological 
variability  w ith in  individuals w as m u ch  g rea ter th a n  laboratory  
m ea su re m e n t variability. This is n o t su rp ris in g  as fibrinogen is a  
" reac tan t " protein , an d  because  p la sm a  VWF levels also rise  in  
resp o n se  to endothelial stim ula tion  (e.g. horm onal) or in ju ry  (see 
C h ap te r 1). De B art e t al (1992) com pared variability  in  fibrinogen and  
PAI activity, an d  found th a t  bo th  labora to ry  and  (especially) biological 
variability  of PAI w as h igher th a n  for fibrinogen (see Table 2.1).
For th e  s tu d y  of to ta l variability, 30 m ale p a tien ts  aged 60-80  
y ears  w ith  s tab le  peripheral a rteria l d isease  (in term itten t claudication) 
w ere recru ited  from the Peripheral V ascu lar Clinic, E d inbu rgh  Royal 
Infirm ary, or from  the  E d inburgh  A rteiy S tudy  (Sm ith et al 1993). O ur 
previous s tu d ie s  in  th is  labo ra to iy  have show n th a t  su c h  p a tien ts
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Table 2.1
Results of laboratory (inter-assay), total and biological 
variabilities (mean CV, %) in haemostatic and 
fibrinolytic variables. _______________________
Current Study Other Studies
Fibrinogen 
(Clauss) 
-inter assay
-total (n=30)
-biological
(range 2.12-6.72g/l) 
5.1%
10.4%
5.68%
3-5% (de Bart 1992) 
5.8% (Rosenson 1994)
11 ±5% (d Bart1992) 
17.8% (Rosenson 1994)
PAI activity 
•inter assay 
-total (n=30) 
-biological
(range 30-196%) 
8.1%
14.6%
6.5%
10-15% (de Bart 1992) 
55±34% (de Bart 1992)
tPA antigen 
-inter assay 
-total (n=30) 
-biological
(range 4.4-29.4ng/ml) 
9.8%
14.0%
4.7%
14.5% (Nguyen etal 1995) 
18.2% (Nguyen et al 1995)
vWF antigen 
-inter assay 
-total (n=30) 
-biological
(range 65-276iu/dl) 
7.7%
8.6%
I Mo
12.7% (Nguyen etal 1995) 
21.6% (Nguyen etal 1995)
D-dimer antigen 
-inter assay 
-total (n=30) 
-biological
(range 27-489ng/ml) 
15.8%
16.3%
0.59%
have significantly h igher m ean  levels an d  a  w ider range of these  
variab les th a n  controls (Reid 1991; Sm ith  e t al 1993). Therefore the ir 
p la sm a  levels of PAI, tPA, VWF, D -dim er and  fibrinogen cover a  
b ro ad e r range th a n  in  healthy  controls, allowing a sse ssm e n t of 
variab ility  a t  b o th  norm al and  m oderately  elevated levels in  in  older 
p e rso n s. T his is appropria te  w hen considering  th e  assoc ia tions of 
th e se  variab les w ith risk  factors for card iovascu lar d isease, w ith 
card iovascu lar d isease, and  w ith d iabetes m ellitus, w hich  were 
investigated  in  the  s tu d ies  reported  in th is  thesis .
The m ain  pu rpose  of th is  s tu d y  w as to a sse ss  variability  in  
cytokine levels in  peripheral a rteria l d isease  and  th e ir re la tionsh ip s to 
haem o sta tic  variables; however it also gave m e a n  opportun ity  to 
a s se s s  variability  in PAI, tPA, VWF, D -dim er and  fibrinogen. Subjects 
gave inform ed consen t to the  study, w hich  w as approved by  the  
ho sp ita l E th ica l Com m ittee. V enous blood sam ples w ere tak e n  a t 
w eekly in tervals for 4 weeks, a t approxim ately  the  sam e tim e of day  to 
m in im ise d iu rn a l variation. Sam ples were tak en  by  n u rs in g  staff 
tra in ed  by  m yself in  sam ple handling, processing, an d  sto rage w hich 
w as perform ed as described above. PAI, tPA, VWF, D -dim er and  
fibrinogen w ere assayed  as  described above w ith in  4 w eeks of 
collection. T otal varia tion  in  each  variable  w as a sse ssed  for each  
su b jec t by  calcu lation  of the  coefficient of varia tion  over the  4 
sam ples. Biological variation  w as calcu lated  according to the  
fo rm ula  of E rn s t  e t al (1985);
Total - m ethological variability  
Biological variability  = _______________________________
1 - m ethodological variability
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Table 2.1 show s the  re su lts  for each  variable, p resen ted  as  the  
range  of individual m ean  m easu rem en ts  across th e  30  sub jects; the  
in te r-a ssa y  laboratory  m easu rem en t variability  (m ean CV; a s  reported  
above); the  to ta l variability  (m ean CV); and  the  biological variability  a s  
calcu lated  above. The re su lts  are com pared to those  of de B art e t al 
(1992) for fibrinogen and  PAI activity; R osenson e t al (1994) for 
fibrinogen; Kluft (1994) for tPA antigen; and  Nguyen e t al (1995) for 
tPA an tigen  an d  D -dim er an tigen  (which were reported  after 
perform ance of th e  p resen t study).
For fibrinogen (m easured by th e  C lauss assay), th e  in te r-assay  
CV (5.1%) w as sim ilar to th a t  of de B art et al (1992) (3-5%) and  
R osenson  e t al (1994) (5.8%). The to tal variability  (10.4%) w as sim ilar 
to th a t  of de B art et al (1992) (11±5%) and ra th e r  lower th a n  th a t  of 
R osenson  et al (1994) (17.8%).
For PAI activity , the  in te r-assay  CV (8.1%) w as ra th e r  lower 
th a n  th a t  of de B art e t al (1992) (10-15%), possibly  b ecau se  the  
com m ercial k it u sed  in  the  p resen t s tu d y  carries less r isk  of 
m easu rem en t e rro r th a n  th e  m ethod of Verheijen e t al (1984) u sed  in  
the  s tu d y  of de B art e t al (1992). This difference w as a p p a re n t w hen 
o u r labora to ry  changed from the  m ethod of V erheijen e t al (1984) to 
the  com m ercial C hrom ogenix/K abi a ssay  in 1988. The to ta l variability  
(14.6%) w as m u ch  lower th a n  th a t  reported  by  de B art e t al (1992) 
(55±34%). Possible reasons for th is  wide biological variability  reported  
by de B art e t al (1992) include the  perform ance of th e ir s tu d y  over a  6  
m o n th  period (which m ight therefore include a  seasonal varia tion  in 
PAI levels); and  the  inclusion  of young w om en (which therefore
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in c ludes m en s tru a l variation). The la tte r group  w ould n o t u su a lly  be 
a sse ssed  for th e ir card iovascu lar risk, w hich is very low.
For tPA an tigen , th e  in te r-assay  CV (9.8%) w as ra th e r  lower 
th a n  th a t  of Nguyen et al (1995) (14.5%); while the  to ta l variability  
(14.0%) w as sim ilar to th a t  of Kluft (1994) (14%) and  Nguyen et al 
(1995) (18.2%).
For VWF an tig en , the  in te r-assay  CV w as 7.7%  and  th e  to ta l 
variability  w as 8 .6 %, indicating  th a t  long itud inal varia tion  w as low. 
T hese re su lts  are  sim ilar to those of Nguyen et al (1995) (12.7% and  
2 1 .6 % respectively).
For D -dim er an tigen , the  in te r-assay  CV w as 15.8% 
an d  the  to ta l variability  w as 16.3%.
In conclusion, the  re su lts  of th is  s tu d y  are sim ilar to those  of 
th e  few recen tly  reported  s tud ies  of laboratory  an d  biological 
variability  in  PAI, tPA, VWF, D -dim er an d  fibrinogen. Laboratory 
m easu rem en t (inter-assay) variability  is low est for fibrinogen (5%); 
h igher for VWF, PAI and  tPA (8-10%); and  h ig h est for D -dim er (16%). 
Total variability  (laboratory m easu rem en t variability  p lu s  in tra ­
individual biological variability  over 4 weeks) is low est for fibrinogen 
and  VWF (9-10%); and  h ighest for PAI, tPA and  D -dim er (14-16%). 
T hese variabilities shou ld  be considered w hen  designing s tu d ies  of the  
assoc iations of these  variables w ith  card iovascu lar risk  factors, 
card iovascu lar d isease, and  diabetes m ellitus. They m u s t also be 
considered in  calculating  the  n u m b er of sam ples requ ired  to ob tain  an
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a cc u ra te  estim ate  of a  person 's  "average" p lasm a  levels. T his is 
im p o rtan t if these  variables are  to be m easu red  in  th e  fu tu re  a s  
"card iovascu lar r isk  factors" in  individual persons. For exam ple, 
R osenson  e t al (1994) calcu lated  th a t  th e  average of 4  p lasm a  
fibrinogen m easu rm en ts  over 6  w eeks is requ ired  to reduce 
m isclassification  erro r to less th a n  1 0 %.
STUDY DESIGN AND STATISTICAL ANALYSIS
The labora to ry  and  biological va ria tions in  PAI, tPA, VWF, D- 
d im er an d  fibrinogen w hich were a p p aren t in  the  lite ra tu re , an d  from 
m y own s tu d y  reported  in  the  previous section  of th is  chap ter, suggest 
th a t  large s tu d ies  are  required  to be sufficiently powerful to investigate 
th e ir  re la tionsh ip s to card iovascu lar risk  factors, and  card iovascu lar 
d isease. Epidemiological s tud ies  u sing  h u n d re d s  of su b jec ts  were 
therefore chosen  for th is  purpose! C hap te rs  3, 5 an d  6 ). In th e  case- 
control s tu d y  of p rem atu re  m yocardial infarction  (C hapter 4), it w as 
calcu lated  th a t  1 0 0  survivors of infarction shou ld  be s tu d ied  to have a  
90%  power to detect biologically significant differences in  fibrinogen 
(Meade et al 1986) or PAI activity (H am sten e t al 1988).
In th e  s tu d ies  of d iabetic m icroalbum inuria , in su lin  induced  
hypoglycaem ia, and  exercise (C hapters 7-9), sm aller n u m b ers  were 
accepted, b a sed  on m atch ing  sub jec ts  for age an d  sex, an d  on th e  
lim ited n u m b er of vo lun teer sub jects available for th e  s tre sse s  of 
in su lin  and  exercise.
D istribu tions of PAI, tPA, VWF, D -dim er and  (in som e studies) 
fibrinogen ten d ed  to be positively skewed, a s  found by  o th er a u th o rs
52
(e.g. E liasson  1995). The re su lts  are  therefore u su a lly  p resen ted  as 
m ed ians an d  in te rquartile  ranges (IQR), or ranges or SEM for sm aller 
stud ies . S ta tistica l analyses were those recom m ended by  th e  relevant 
sta tis tic ian  in  each  s tu d y  after inspection  of the  da ta , an d  are  
described  in  each  of the  following chap ters .
53
CHAPTER 3
DISTRIBUTIONS AND ASSOCIATIONS WITH CARDIOVASCULAR 
RISK FACTORS OF PLASMINOGEN ACTIVATOR INHIBITOR 
ACTIVITY. TISSUE PLASMINOGEN ACTIVATOR ANTIGEN. VON 
WILLEBRAND FACTOR ANTIGEN. AND FIBRIN D-DIMER ANTIGEN 
IN A RANDOM POPULATION SAMPLE - NORTH GLASGOW MONICA 
STUDY
INTRODUCTION
In C hap ter 1, it w as noted th a t  p lasm a  levels of p lasm inogen 
activator inh ib ito r (PAI) activity, tissu e  p lasm inogen activator (tPA) 
antigen , von W illebrand Factor (VWF) antigen , and  fibrin D -dim er 
an tigen  were recently  in troduced  a ssay s of fibrinolysis, endothelial 
d istu rbance , and  fibrin tu rnover w hich  show ed po ten tia l in  s tu d ies  of 
card iovascu lar d isease  and  d iabetes. In C hap te r 2, th e  labo ra to ry  and  
biological variability  of these  assays w as evaluated, and  found to be 
sufficiently acceptable for su ch  stud ies. In C hap ter 1, it w as noted  
th a t  th e re  were few reported  s tu d ies  of th e  d is trib u tions of these  
variables in  random  sam ples of the  population , and  th e ir assoc iations 
in  su c h  sam ples w ith  dem ographic factors and  card iovascu lar r isk  
factors (e.g. age, sex, horm onal s ta tu s , sm oking, alcohol u se , diet, 
social class, d iabetes, h isto ry  of card iovascu lar d isease, obesity, blood 
p ressu re , cholesterol and  triglyceride). It is im p o rtan t to perform  su ch  
stud ies , to allow in te rp re ta tion  of th e  re la tionsh ip s of th ese  p lasm a  
factors to card iovascu lar d isease or d iabetes.
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The opportun ity  to perform  su c h  a  s tu d y  occurred  in  1989, 
w hen  a  random  sam ple of m en and  w om en aged 25-64  years w as 
perform ed in  N orth Glasgow: the  Second W.H.O. MONICA Survey of 
card iovascu lar r isk  factors. In 1985, th e  W orld H ealth  O rganisation  
(W.H.O.) se t u p  the  m ultinational MONICA stu d y  (MONItoring  of 
tren d s  and  d e te rm inan ts of C A rdiovascular disease) to s tu d y  in  a  
s tan d ard ised  w ay th e  incidence of card iovascu lar events (m yocardial 
infarction  and  stroke) over a  10 year period (W.H.O. MONICA Project 
1988; T unstall-Pedoe et al 1994). The s tu d y  involved 38 popu lations 
in  21 different countries; North Glasgow w as selected a s  th e  s tu d y  
popu lation  in  the  U nited Kingdom b ecau se  it h a s  one of th e  w orld 's 
h ig h est risk s of ischaem ic h e a r t d isease  in  bo th  m en  an d  w om en 
(Tunstall-Pedoe e t al 1994). At the  s ta rt, m iddle and  end of th e  10 year 
s tu d y  period, a  rep resen ta tive  popu lation  sam ple of m en  an d  w om en 
aged 25-64 years w as perform ed by each  s tu d y  centre, in  o rder to 
a sse ss  the  prevalence of know n card iovascu lar r isk  factors su c h  as 
sm oking, hypertension , and  hyperlipidaem ia. T rends in r isk  factors 
will be com pared a t  the  end of the  s tu d y  period to changes in 
incidence of card iovascu lar events, in  order to clarify to w h a t degree 
changes in  event ra te s  can  be "explained" by  changes in  r isk  factors.
The H aem ostasis and  T hrom bosis labora to ry  in  th e  U niversity 
D epartm en t of M edicine, Glasgow Royal Infirm ary, estab lished  a  
collaboration a t  th e  s ta r t  of the  W.H.O. MONICA stu d y  w ith  its  leader 
Professor H ugh Tunstall-Pedoe, C ard iovascu lar Epidem iology Unit, 
U niversity of D undee. P lasm a fibrinogen and  blood viscosity  were 
m easu red  in  the  first MONICA survey  in  N orth Glasgow in  1984; and  
fibrinogen w as m easu red  in  the  S co ttish  H eart H ealth  S tudy  w hich 
sh a red  its  protocol (Lee et al 1990). For the  Second MONICA survey in
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N orth Glasgow in  1989; a  g ran t w as ob tained  to m easu re  fibrinogen, 
PAI activity, haem atocrit, w hite blood cell co u n t an d  red cell 
aggregation (a m ark er of acu te-p h ase  pro tein  reactions) in  order to 
s tu d y  th e ir  d is tribu tions and  associations in  th is  popu lation  survey. A 
su b se q u e n t g ran t w as obtained  to m easu re  tPA, vWF an d  D -dim er 
an tigens in  the  residual stored  p lasm a  sam ples, again  to s tu d y  th e ir 
d is trib u tio n s an d  associations in  th is  popu lation  sam ple.
AIMS OF STUDY
1) W hat are  the  d is tribu tions of p lasm a  PAI activity an d  tPA, 
VWF and  D -dim er an tigens in a  random  sam ple  of a d u lt 
m en an d  wom en?
2) W hat are the ir associations w ith  s ta n d a rd  dem ographic
and  card iovascu lar r isk  factors, an d  w ith  p revalen t 
card iovascu lar d isease or d iabetes m ellitus?
3) W hat are the  independen t assoc iations of su c h  factors
w ith each  of PAI, tPA, VWF an d  D -dim er in  m ultip le
regression  m odels? W hat percen tage of varia tion  in  PAI, 
tPA, VWF and  D -dim er can  be "explained" by  su c h  factors 
in  th ese  m odels?
4) In fu rth e r m ultiple regression  m odels, w h a t percen tage of
varia tion  in p lasm a levels of PAI, tPA, VWF an d  D -dim er 
can  be "explained" n o t only by su c h  factors, b u t  also by 
biological m echan ism s su c h  a s  haem oconcen tra tion  
(haem atocrit), increases in "reactant" p lasm a  p ro te ins (red
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cell aggregation), and  "reactant" increases in  th e  w hite cell 
count?
5) P lasm a levels of the  cytokine in te rleuk in -6  (IL-6) were also
m easu red  in  a  subsam p le  of sto red  p lasm as, to a sse ss  the  
con tribu tions of th is  m ajor m ed iato r of "acute ph ase  
reactan t"  p lasm a  pro teins to PAI-1 levels.
SUBJECTS AND METHODS
The Second WHO-MONICA survey  of card iovascu lar r isk  factors 
in  a  random  sam ple of the  popu lation  of N orth Glasgow w as 
perform ed betw een J a n u a ry  and  Ju n e , 1989. The MONICA stu d y  
m ethods have been  described in detail (WHO-MONICA Project 1988). 
M en and  w om en aged 25-64 years were random ly selected from the  
reg isters of general p rac titioners in  N orth Glasgow, ba lanced  evenly 
betw een th e  four 10-year age groups, an d  invited to a tten d  a  local 
h e a lth  screen ing  clinic for exam inations in  th e  non-fasting  sta te , 
betw een 08 .00  an d  16.00 hours. If they  did n o t a ttend , a  rem inder 
w ith  a  new  appo in tm en t w as sen t. P artic ipan ts were asked  to 
com plete a  s ta n d a rd  questionnaire  concerning  th e ir m edical history, 
h a b its  and  social background; and  u n d erw en t a  s ta n d a rd  exam ination  
includ ing  height, weight, calcu lation  of body m ass index  (BMI=weight 
in  k g /h e ig h t^  in m) as a  m easu re  of overweight, blood p ressu re , and  
m easu rem en t of se ru m  cholesterol, to ta l an d  high density  lipoprotein 
(HDL) cholesterol, triglyceride, gam m a glutam yl tran sp ep tid a se  (GGT; 
a  m easu re  of alcohol intake) and  th iocyanate  (a m ark er of smoking), 
a s  well as blood glucose (WHO MONICA Project, 1988).
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Prior to com m encing the  study , I held  detailed d iscu ssio n s w ith  
th e  survey team  concern ing  the  collection an d  hand ling  of ex tra  blood 
sam ples for a ssay  of the  haem atological variab les, an d  th e  n u rse s  
w ere tra ined  in blood sam pling and  p rocessing  by  m yself in  the  
H aem ostasis an d  T hrom bosis Laboratory. S ub jects res ted  for a t  lea st 
20  m in u tes  before blood sam pling  from  a  forearm  vein, u sing  
m in im um  venous s ta s is  to m inim ise local release  of tPA an d  PAI-1 
from  forearm  veins and  to m inim ise haem oconcen tration . Sam ple 
tu b e s  for the  "core MONICA protocol" b iochem ical analyses (listed in  
th e  previous paragraph), w hich were perform ed by Dr. R T avendale in  
th e  C ardiovascular Epidemiology Unit, U niversity of D undee, were 
requ ired  to be filled first. T hereafter, fu rth e r venous blood w as 
an ticoagu lated  w ith  0 .109M trisod ium  citra te  (9:1 v:v) in  p lastic  
sam ple  tu b es  freshly p repared  in  the  laboratory . After careful m ixing, 
th ese  sam ples were im m ediately centrifuged a t  2000g for 20  m in u tes  
a t  room  tem pera tu re . The m iddle layer of p lasm a  w as collected (to 
avoid p la te le t or leucocyte contam ination) w ith a  d isposab le  p lastic  
P a s te u r pipette; sn ap  frozen in  aliquots an d  sto red  a t  -70°C  un til 
a ssa y  of fibrinogen, PAI, tPA, VWF, D -dim er and  IL-6. A part from 
fasting, (which could n o t be dem anded  in  th is  random  popu lation  
survey), these  conditions accord w ith th e  Leiden Fibrinolysis Protocol 
for s tan d ard isa tio n  of PAI activity an d  tPA an tigen  a ssay s (Kluft an d  
V erheijen 1990). F u rth e r venous blood w as an ticoagu lated  w ith  
d ipo tassium  edetate  (1.5 m g/m l) for m easu rem en t of red  cell 
aggregation, haem atocrit and  w hite cell count.
Haem atological variab les were m easu red  a s  described  in  
C hap ter 2. Red cell aggregation, haem atocrit and  w hite cell co u n t were 
m easu red  w ith in  24 h o u rs  of sam ple collection. F ibrinogen an d  PAI
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activity were m easu red  w ithin  6 m o n th s of sam ple collection, and  tPA, 
VWF and  D -dim er an tigens and  IL-6 w ere m easu red  w ith in  18 m on th s 
of sam ple collection (after ob tain ing  a  fu rth e r g ran t for th e ir 
m easurem ent).
S ta tistica l analysis w as perform ed by Dr. A J  Lee, 
C ard iovascu lar Epidemiology Unit, U niversity of D undee, w ith  in p u t 
from  m yself and  Professor GDO Lowe, u sin g  th e  S ta tis tica l Package for 
th e  Social Sciences (SPSS) on the  U niversity m ain  fram e com puter. 
B ecause of sex differences in bo th  haem atological variab les and  risk  
factor variables, m en  and  w om en w ere analysed  separately . Due to 
positively skew ed d is tribu tions of PAI, tPA, VWF an d  D-dim er, d a ta  
a re  p resen ted  a s  m edians an d  in ter-quartile  ranges (IQR). Fibrinogen 
an d  red  cell aggregation show ed norm al d istrib u tio n s an d  are  
p resen ted  a s  m ean s and  s ta n d a rd  deviation (SD). D ifferences betw een 
g roups w ere com pared by the  M ann-W hitney U te s t for two groups, 
an d  by  th e  Kruskal-W allis te s t for m ultiple groups. S p earm an  ra n k  
correlations were u sed  to exam ine associations betw een the  
haem atological factors and  risk  factors.
For m ultivariate  analyses, sq u a re  root tran sfo rm atio n s were 
perform ed for PAI, tPA an d  VWF; an d  n a tu ra l log tran sfo rm ations for 
D -dim er, triglycerides, and  GGT were perform ed. Stepw ise m ultiple 
regression  m odels were used  to find th e  percen tage of varia tion  in  
each  of PAI, tPA, VWF and  D -dim er w hich  could be explained by  the  
following variables: age and  tim e of day  (both forced entry); sm oking 
s ta tu s  (current, ex- or never); consum ption  of alcohol (units/w eek); 
w hite fish and  oily fish (eaten rarely; once a  week; twice or th rice  
weekly); social class; p a s t h isto ry  of angina, m yocardial infarction,
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high blood p ressu re , stroke or d iabetes; body m ass  index, systolic 
blood p ressu re , to ta l cholesterol, HDL cholesterol, triglyceride, GGT, 
th iocyanate, glucose; and  (in women) oral contraceptive u se  an d  
m enopausa l s ta tu s .
In a  second m ultivariate  analysis for each  of PAI, tPA, VWF an d  
D-dim er; haem atocrit, w hite cell coun t an d  red  cell aggregation were 
also included, to reflect the  con tribu tions of haem oconcen tra tion , 
inflam m ation  and  acu te -p h ase  pro tein  reactions respectively. A 
fu rth e r  m odel w as also p roduced for D-dim er, includ ing  fibrinogen, 
PAI, tPA and  VWF as well as the  above variab les, to exam ine the  
com bined effect of all these  variab les on fibrin turnover.
In a  random  subsam ple  of 139 sub jec ts, p la sm a  in te rleuk in -6  
(IL-6) w as m easu red  by Ms A Crilly in  the  D epartm en t of M edicine, 
u s in g  a  sensitive b ioassay  (Aarden et al 1987) an d  correlated  w ith  
p la sm a  levels of haem atological variables.
RESULTS
Of 2000  m en  and  w om en invited to a tten d  th e  Second WHO- 
MONICA Survey in N orth Glasgow, a  to ta l of 653 m en  an d  744  w om en 
a tten d ed  for exam ination! to ta l 1397; response  ra te  70%). A c itrated  
p la sm a  sam ple w as obtained  for m easu rem en t of fibrinogen and  PAI 
in  409 m en an d  386 w om en (total 795), due  to e ither refusal of 
venepunctu re , failed venepunctu re , or in adequate  blood to fill th e  
c itra te  tu b e  following filling of "core protocol" sam ple  tu b es  for 
b iochem istry. Following storage of c itrated  p lasm a  sam ples pending  
obtain ing  of funding  for a ssays of VWF, D -dim er an d  tPA antigen,
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th ese  assay s w ere perform ed in th a t  order on 300  m en  a n d  303 
w om en (total 603), 284 m en and  284 w om en (total 568), an d  283  m en  
an d  275 w om en (total 558) respectively. The decreasing  n u m b ers  of 
available sam ples for these  assays reflect decreasing  availability of 
p la sm a  aliquots. Inspection of dem ographic variab les in  su b jec ts  in  
w hom  all a ssay s were, and  were not, perform ed did n o t su g g est any  
significant bias; and  a t least 47 sub jec ts  w ere available in  each  10 
y ear age group for b o th  m en and  w om en (Table 3.1).
Age and  Sex (Table 3.1): M enopause (Table 3.2) and  Oral
C ontraceptive Use (Table 3.3)
Overall th e re  w as no sex difference in p lasm a  levels of PAI 
activ ity ; however there  w as a  m arked  sex difference in  th e  re la tionsh ip  
of PAI to age. There w as no significant change in PAI betw een age 25- 
64  years in  m en (p=0.93); however there  w as a  significant increase  of 
PAI over th is  age range in w om en (from 80 to 95%; p=0.02). 
P rem enopausal w om en h ad  lower levels of PAI th a n  p o st-m enopausa l 
w om en (Table 3.3; p=0.006). However, low PAI levels in  young  w om en 
appeared  to rela te  to cu rre n t u se  of oral contraceptives (Table 3.3; 
p=0.07).
P lasm a tPA an tigen  levels were significantly h igher overall in  
m en  th a n  in w om en (6.5 vs. 4 .9  ng /m l; p< 0.001), an d  th is  sex  
difference w as a p p a ren t a t all ages (Table 3.1). P lasm a tPA increased  
m arkedly  w ith  age in  bo th  m en an d  wom en, the  increase  being 
approxim ately  two-fold over the  range 25-64  years (Table 3.1). 
P rem enopausal w om en h ad  lower tPA levels th a n  p o stm enopausa l 
w om en (Table 3.2).
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Plasm a  VWF antigen  levels also show ed an  overall tren d  to be 
h igher in  m en th a n  w om en (93 vs 89 iu /d l;  p=0.08); an d  show ed a  
g rea te r tren d  to increase  w ith  age. P lasm a VWF levels did n o t increase  
a fter the  m enopause  (Table 3.2); and  oral contraceptive u se  h ad  no 
effect (Table 3.3).
P lasm a D -dim er an tigen  levels, in  con trast, w ere h igher in  
w om en (60 vs. 53 ng /m l; p=0.03); th is  sex  difference d isappeared  after 
th e  m enopause  (Table 3.1). D -dim er levels increased  w ith  age in  bo th  
m en  and  wom en; and  increased  after th e  m enopause  (Table 3.2; 
p=0.001). Oral contraceptive u se rs  h ad  lower levels (Table 3.3).
Tim e of sam ple (Table 3.4)
Significant decreases in p lasm a  PAI activity an d  tPA an tigen  
betw een 08 .00  and  16.00 h o u rs  were observed in  b o th  sexes; an d  in  
VWF and  D-dim er, in  m en only.
C igarette sm oking (Tables 3 .5  and  3.6).
No effect of cigarette sm oking on PAI activity in  m en w as 
observed (p=0.42), a lthough  a  tren d  to h igher levels w as observed in  
fem ale cu rre n t and  ex-sm okers (p=0.07).
C u rren t cigarette sm okers h ad  h igher tPA an tigen  levels th a n  
never-sm okers in  bo th  sexes. E x-sm okers h ad  in te rm ed iate  levels in  
wom en; however ex-sm okers h ad  h igher levels th a n  c u rre n t sm okers 
in  m en.
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Plasm a VWF and  D -dim er levels show ed reversible in creases  in  
sm okers am ong m en, b u t  n o t am ong w om en. The effect of sm oking in  
m en  on  D -dim er levels w as n o t s ta tis tica lly  s ig n ifican t p=0.06). No 
significant re la tionsh ips of PAI, tPA, VWF or D -dim er to repo rted  daily 
cigarette consum ption  am ong sm okers w ere observed.
Alcohol consum ption
On un ivaria te  analysis, reported  alcohol consum ption  show ed 
only a  w eak association  w ith tPA (r=0.11, p=<0.05) in  m en, and  a  
negative association  w ith bo th  VWF (r=-0.16; p<0.01) an d  D -dim er (r=- 
0 .11, p<0.05) in w om en (data no t shown).
F ish  consum ption
R eported w hite fish consum ption  show ed w eak  positive 
correlations w ith  b o th  VWF and  D -dim er in  m en (r=0.10 an d  0.12, 
p<0.05) and  w ith  D -dim er in w om en(r=0.10, p<0.05). Oily fish 
consum ption  show ed no significant correlation  w ith  haem atological 
variab les (data n o t shown).
Social class
B oth PAI activity and  tPA an tigen  show ed in creases  w ith 
decreasing  social c lass in women; a  sim ilar tren d  w as observed for tPA 
an tigen  and  VWF an tigen  in  m en (data  n o t shown).
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D iabetes M ellitus (Table 3.7).
A lthough as  expected the  prevalence of d iabetes w as low in  th is  
age group (1.5%), diabetic sub jec ts  h ad  significantly h igher levels of 
PAI activity th a n  non-d iabetics (p=<0.01), and  also tended  to have 
h igher levels of tPA and  VWF antigens. F ibrinogen and  red cell 
aggregation were also h igher in diabetic sub jec ts.
H ypertension (Table 3.8)
S ubjects w ith  a  h isto ry  of hypertension  h ad  h igher levels of tPA 
an tigen  th a n  persons w ith  no su c h  h isto ry  (men pcO.OOl; w om en 
p<0.05) as well as  h igher levels of fibrinogen and  (in women) red cell 
aggregation.
A ngina or m yocardial infarction (Tables 3 .9  and  3.10)
Men w ith  a  h isto ry  of ang ina  or m yocardial infarction  h a d  
h igher levels of fibrinogen, tPA, VWF an d  D -dim er an tigens, b u t  n o t 
PAI activity, th a n  m en w ith no su ch  h istory . W om en w ith  su c h  a  
h isto ry  also h ad  h igher tPA levels.
O ther card iovascu lar risk  factors (Table 3.11).
P lasm a  PAI activity correlated w ith  body m ass  index, blood 
p ressu re , HDL cholesterol (inversely), triglyceride (Figure 3.1), and  
GGT ; and  w ith  to ta l cholesterol and  glucose in  wom en.
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P lasm a tPA an tigen  correlated w ith body m ass  index, blood 
p ressu re , to ta l cholesterol, triglyceride and  GGT in  b o th  sexes; an d  
w ith  glucose, th iocyanate  and  HDL cholesterol (negative) in  w om en 
(Figures 3.1-3.3).
P lasm a VWF an tigen  correlated w ith  blood p re ssu re  an d  GGT 
(positive) and  triglyceride (negative) in  m en; and  w ith  to ta l cholesterol, 
g lucose and  GGT (positive) and  BMI, triglyceride and  HDL cholesterol 
(negative) in  wom en.
P lasm a D -dim er an tigen  correlated w ith  blood p ressu re , glucose and  
th iocyanate  (positive) and  triglyceride, body m ass  index (negative) in 
m en; and  w ith blood p ressu re  and  cholesterol in  wom en.
In ter-re la tionsh ips of haem atological variables (Table 3.12)
The s trongest correlation observed w as betw een PAI activity and  
tPA an tigen  (r=0.31 for m en, r=0.38 for women). PAI activity also 
correlated  w ith  fibrinogen (r=0.18) and  red cell aggregation (r=0.14) in  
w om en. tPA an tigen  also correlated w ith  haem atocrit, red  cell 
aggregation, fibrinogen, VWF and  D-dim er. VWF an tigen  also 
correlated  w ith  red  cell aggregation, fibrinogen and  D-dim er.
M ultivariate analysis: PAI activity
The significant independen t associations of PAI activity in  m en 
w ere tim e of day, se ru m  triglyceride, se ru m  GGT, an d  h isto ry  of 
d iabetes (total variance explained=9.6% ). The addition  of haem atocrit, 
w hite cell co u n t and  red cell aggregation h ad  little effect on th e  model.
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The significant independen t assoc ia tions of PAI activity in 
w om en were tim e of day and  se ru m  triglyceride (Fig 3.1) (total 
variance  explained =16.5%). The add ition  of haem atocrit, w hite cell 
c o u n t and  red cell aggregation h ad  little effect on th e  model.
M ultivariate analysis: tPA antigen
The significant independen t assoc ia tions of tPA an tigen  in  m en  
w ere age (Table 3.1), se rum  GGT (Fig 3.3), and  triglyceride (Fig 3.3); 
(total variance explained = 37.9%). The addition  of haem atocrit, w hite 
cell co u n t and  red cell aggregation resu lted  in  rep lacem en t of 
triglyceride by haem atocrit, red cell aggregation an d  sm oking (total 
variance  explained =44.5%).
The significant independen t associations of tPA an tigen  in  w om en 
w ere age (Table 3.1), triglyceride (Fig 3.1), se ru m  GGT (Fig 3.2), tim e of 
day, reported  alcohol consum ption  and  social c lass (total variance 
explained =40.6%). The addition of haem atocrit, w hite cell coun t an d  
red cell aggregation resu lted  in  rep lacem ent of social c lass by  BMI (Fig 
3.3) (total variance explained =41.4%).
M ultivariate analysis: VWF antigen
The significant independen t assoc ia tions of VWF an tigen  in  m en  
w ere age, triglyceride (negative), se ru m  GGT, th iocyanate  and  HDL 
cholesterol (negative) (total variance explained = 30.2%). The addition  
of haem atocrit, w hite cell coun t and  red  cell aggregation resu lted  in  
th e  rep lacem ent of HDL cholesterol by  red  cell aggregation (total 
variance  explained =28.7%).
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The significant independen t associations of VWF an tigen  in  w om en 
were age, BMI and  alcohol (negative) (total variance  explained = 8.5%). 
The addition  of haem atocrit, w hite cell coun t an d  red  cell aggregation 
to th e  m odel resu lted  in  en try  of BMI an d  alcohol (total variance 
explained = 8.8%).
M ultivariate analysis: D -dim er an tigen
The significant independen t associations of D -dim er an tigen  in  
m en  were age, ang ina  and  triglyceride (total varia tion  explained = 
15.9%). Addition of haem atocrit, w hite cell co u n t an d  red cell 
aggregation to the  m odel resu lted  in  loss of ang ina  and  triglyceride 
(total varia tion  explained = 12.8%). F u rth e r addition  of fibrinogen, PAI, 
VWF and  tPA into the  m odel resu lted  in the  addition  of VWF (total 
variance explained = 16.9%).
The significant independen t associations of D -dim er an tigen  in  
w om en were age and  h isto ry  of stroke (total variance  explained = 
8.5%). The addition  of haem atocrit, w hite cell co u n t an d  red cell 
aggregation to the  m odel resu lted  in  th e  addition  of red  cell 
aggregation (total variance explained = 13.1%). F u rth e r  addition  of 
fibrinogen, PAI, VWF and  tPA in the  m odel resu lted  in  th e  rep lacem ent 
of age by  fibrinogen (total variance explained = 20.3%).
R elationship  of IL-6 to haem atological variab les
P lasm a IL-6 w as assayed  in a  random  sam ple of 139 sam ples. 
IL-6 show ed significant correlations w ith red  cell aggregation (r= 0.37),
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Table 3 .1
Distributions o f PA I, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed
Cell A ggregation  b y  a g e  a n d  s e x
Age(yrs) Median
Male
I.Q.R. n Median
Female
I.Q.R. n
PAI (%) p=NS p=0.02
Total 93 74,118 409 90 67,113 386
25-34 91 73,108 72 80 61,99 75
35-44 93.5 72,125 98 87 69,106 91
45-54 94 73,126 113 92.5 65,113 112
55-64 92 76,108 126 95 73,128 108
tPA (ng/ml) p<0.001 p<0.001
Total 6.5 5,9 282 4.9 3,7 275
25-34 4.4 3,6 52 3.0 2,5 47
35-44 5.7 4.5,8 66 3.5 2,6 63
45-54 7.0 5,10 74 4.9 4,7 88
55-64 8.5 5,12 90 7.0 5,10 77
VWF (iu/dl) p<0.001 p=0.01
Total 93 72,124 300 89 70,114 303
25-34 73 62, 98 53 80.5 68,107 58
35-44 89 66,107 71 84.5 66,112 74
45-54 93 72,124 82 89 72,110 92
55-64 113 85,154 94 100 75,132 79
Table 3.1 (c o n tin u e d )
Distributions o f  PA I, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed
Cell A g g reg a tio n  b y  a g e  a n d  s e x
Aje(yrs) Median
Male
I.Q.R. n Median
Female
I.Q.R. n
D-dimer (ng/ml) p<0.001 p<0.001
Total 53 35,78 284 60 40, 82 284
25-34 42 24, 61 53 51 30, 78 52
35-44 45 30, 65 68 49 35, 68 68
45-54 50 34, 68 75 62 43,83 93
55-64 77 52,107 88 75 57, 94 71
Mean SD n Mean SD n
Fibrinogen (g/l) p<0.001 p<0.001
Total 2.33 0.61 487 2.42 0.56 462
25-34 1.92 0.34 85 2.31 0.59 90
35-44 2.14 0.58 114 2.21 0.41 107
45-54 2.41 0.59 130 2.46 0.56 134
55-64 2.61 0.60 158 '2.63 0.57 131
Red Cell Aggregation p<0.001 p<0.001
(units)
Total 3.54 1.19 432 3.71 1.22 422
25-34 3.06 1.04 75 3.41 1.19 83
35-44 3.47 1.06 109 3.39 1.17 92
45-54 3.62 1.27 118 3.86 1.18 128
55-64 3.82 1.21 130 4.02 1.22 119
Table 3 .2
Levels o f PA I, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
A ggregation  b y  M e n o p a u s e
Median
Pre
I.Q.R. n Median
Post
I.Q.R. n
PAI (%) 83.5 64,106 210 94 73,121 173
p=0.006
tPA (ng/ml) 3.5 2.5, 5.5 142 6.25 4.5, 8.6 130
p<0.001
VWF (iu/dl) 89 69,110 167 89 71,121 133
p=NS
D-dimer (ng/ml) 52 35, 78 156 71 48,93 125
p<0.001
Mean SD n Mean • SD n
Fibrinogen (g/l) 2.29 0.50 244 2.57 0.59 214
p<0.001
Red Cell
Aggregation
(units)
3.47 1.21 220 3.97 1.18 201
p<0.001
Table 3 .3
Levels of PAI, tPA, VWF, D-dimer, Fibrinogen and Red Cell 
Aggregation by use of oral contraception in 25 to 64 year old 
women
Median
Yes
I.Q.R. n Median
No
I.Q.R. n
PAI (%) 86 65,109 213 92 72,118 170
p=0.07
IPA (ng/ml) 4 2.5, 6.5 142 5.5 4,8 131
p<0.001
VWF (iu/dl) \  ; 82.5 66.5,110 162 95.5 72,122.5 138
p=0.003
D-dimer (ng/ml) 53 36, 78 153 70 47.5, 92.5 c 129
p=0.001
Mean SD n Mean SD n
Fibrinogen (g/l) 2.35 0.55 256 2.52 0.57 203
p<0.001
Red Cell
Aggregation (units)
3.54 1.18 234 3.93 1.24 184
p<0.002
lie 3.4
/els of PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R e d  C ell
gregation by  t im e  o f  s a m p le
Men Women
*
Sampling time Median I.Q.R. n Median I.Q.R. n
m p=0.007 p<0.001
08.00-10.00 98.5 80,137 118 95 75,129 121
I 11.00-12.00 95 76,121 109 96 73,124 102
13.00-14.00 87 70,104 108 79.5 63,103 82
15.00-16.00 84 65,110 73 78 64,95 81
Png/ml) p<0.001 p<0.001
08.00-10.00 1 4.5,11 79 6.3 4,9 93
11.00-12.00 8 6,11 67 5.5 4,8 74
13.00-14.00 5.8 5,9 75 4.1 3,7 55
15.00-16.00 5.4 4,8 61 3 2,4.3 53
Rta/dQ p=0.002 p=NS
08.00-10.00 107 76,142 86 89 69,119 99
11.00-12.00 98 73,128 72 89.5 71,115 84
13.00-14.00 87 69,107 77 89 71,107 65
15.00-16.00 81 70,113 65 90 69,114 55
Mimer(ng/ml) p=0.001 p=NS _ ^
8.00-10.00 63 40, 82 79 59 36,81 90
11.00-12.00 61 41,93 68 65 40,82 79
13.00-14.00 44.5 28,61 74 59 42, 82 61
15.00-16.00 48 31,71 63 60 40, 89 54
able 3.4 (c o n tin u ed )
unpling Time Mean
Men
SD n Mean
Women
SD n
prinogen(g/l) p<0.001 p=0.02
8.00-10.00 2.39 0.60 132 2.51 0.60 148
11.00-12.00 2.43 0.59 124 2.47 0.59 121
13.00-14.00 2.32 0.67 128 2.37 0.49 91
15.00-16.00 2.13 0.54 101 2.29 0.49 102
ledCell p=NS p=0.07
Aggregation (units)
8.00-10.00 3.66 1.05 116 3.77 1.20 137
11.00-12.00 3.53 1.18 116 3.85 1.23 110
13.00-14.00 3.53 1.28 108 3.78 1.18 80
15.00-16.00 3.43 1.26 91 3.42 1.24 95
ible 3.5
Lelsof PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
Aggregation b y  s m o k in g  h a b it
Men Women
Median I.Q.R. n Median I.Q.R. n
«(%)
Current 94 75,120 163 92 73,121 177
Ex 94 74,133 128 92 64,108 75
Never 90 70,108 116
p=NS
83 62,110 132
p=0.07
PA (ng/ml) 
Current 7.0 4.5,10 112 5.5 3.5,8 122
Ex 7.5 4.5,11 94 5.0 3,6.6 60
Never 5.5 4,7 75
p=0.002
4.5 2.9, 6.9 92
p=0.05
WF (lu/dl) 
Current 100 75,144 122 89 70,118 143
Ex 93 74,118 98 90 * 75,111 60
Never 86 69,104 79
p=0.009
89 67,111 98
p=NS
Mimer (ng/ml) 
Current 61 41,78 117 57 36,78 . 131
Ex 53.5 34, 78 92 71 39,91 60
Never 44.5 27, 78 74
p=0.06
65 44,81 92
p=NS
liable 3.5 (c o n tin u e d )
(levels of PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
(Aggregation b y  s m o k in g  h a b it
Mean
Men
SD n Mean
Women
SD n
Fibrinogen (g/l) p<0.001 p=0.01
Current 2.46 0.53 196 2.51 0.62 209
Ex 2.40 0.74 155 2.36 0.51 91
Never 2.05 0.46 134 2.34 0.50 160
Red Cell p=0.001 p<0.001
Aggregation (units)
Current 3.18 0.99 163 3.44 1.18 197
Ex 3.85 1.36 140 4.02 1.25 80
Never 3.66 1.12 127 3.90 1.19 144
Table 3 .6
Distribution o f PA I, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
Aggregation b y  d a ily  c ig a r e t t e  c o n s u m p t io n  a m o n g  s m o k e r s
Male Female
Median I.Q.R. n Median I.Q.R. n
PAI (%)
1-9 86.5 66,105 24 96 64,120 17
10-19 92 74,114 43 92 71,127 68
20-29 97.5 76,124 60 94 73,121 71
30-39 105 86,134 21 89 76,124 13
40+ 82 70,128 15
p=NS
90 60,107 8
p=NS
IPA (ng/ml) 
1-9 5.3 4.5, 7.2 14 4.5 3.5, 9.5 11
10-19 7.5 4.9,10.7 34 5.4 4, 7.6 46
„ 20-29 7 5,10.1 43 5.5 3, 7.5 51
30-39 5.4 3.5,11.5 14 5.8 4.1,8.6 10
40+ 6.7 6,11 7
p=NS
6,4 3, 8.8
X
4
p=NS
VWF (iu/dl) 
1-9 108 66,145 17 92 73,127 13
10-19 98 75,155 38 91 71,116 53
20-29 100 79,151 43 82 66,111 60
30-39 94 70,125 16 115 48,150 13
40+ 104 77,157 8
p=NS
123 75,154 4
p=NS
Table 3.6 (c o n tin u e d )
Distribution o f  PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
Aggregation b y  d a ily  c ig a r e t t e  c o n s u m p t io n  a m o n g  s m o k e r s
Male Female
♦
Median I.Q.R. n Median I.Q.R. n
D-dimer (ng/ml)
1-9 56 30, 71 15 42 29,61 11
10-19 65 45, 84 37 60 41,80 46
20-29 56 42,78 43 57 34,74 57
30-39 59 32, 74 15 76 43,134 13
40+
i
70 46,108 7
p=NS
47 42, 86 4
p=NS
Mean SD n Mean SD ni--------------------------------------
Fibrinogen (g/l)
1-9 2.34 0.56 26 2.29 ’ 0.51 21
10-19 2.45 0.60 54 2.53 0.52 81
20-29 2.51 0.44 74 2.52 0.70 84
30-39 2.44 0.51 25 2.68 0.73 15
40+ 2.45 0.61 17
p=NS
2.56 0.60 8
p=NS
Red Cell
—  —
Aggregation (units)
1 9 3.25 1.07 24 3.68 1.24 21
10-19 3.28 1.09 44 3.53 1.20 74
20-29 3.03 0.90 62 3.32 1.18 79
30-39 3.25 1.06 20 3.31 1.07 . 14
40+ 3.38 0.87 13
p=NS
3.43 1.09 9
p=NS
IwelsofPAI.tPA, VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
legation  by D ia b e te s
Median
Men
I.Q.R. n Median
Women
I.Q.R.
♦
n
COCD
>- 121 97,174 11 118 96,141 12
No
|
92 74,114 379
p=0.009
90 67,111 360
p=0.01
Yes 8.5 4.7,10.8 8 6 3.6,10.6 8
No 6.5 4.5, 9.2 262
p=NS
4.7 3,7 259
p=NS
jlFpu/dl)
Yes 105 84,172 1 117.5 84,161 8
No 93 72,124 279 89 70,113 288
p=NS p=0.03
Wimer (ng/ml)
Yes 71 46,110 8 46 31,67 1
No
I
53 35, 78 264
p=NS
60 40,81 270
p=NS
l^e 3.7 (c o n tin u e d )
rels of PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
gregation by  D ia b e te s
Mean SD n Mean SD * n
rinogen (g/l) 
Yes 
No
2.55 0.42 16 
2.32 0.62 449
p=0.02
2.87 0.63 11 
2.40 0.55 433
p=0.01
ed Cell
Legation (units)
Yes
No
4.31 1.24 11 
3.53 1.19 402
p=0.05
4.16 0.78 8 
3.68 1.22 397
p=NS
0
1 ^
tie 3.8
evels of PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R e d  C ell
leg a tio n  by  H igh  B lo o d  P r e s s u r e
Men Women
Median I.Q.R. n Median I.Q.R. n
IN
Yes 90 74,118 77 91 71,122 87
No 93 73,117 322 90 65,111 295
p=NS p=NS
N (ng/ml)
1
Yes 8 6,11 52 6 3.5,8 63
No 6 ’ 4,9 225 4.5 3,7 209
1 p<0.001 - p=0.02
jlFpu/dl)
Yes 98 81,132 61 91 . 72,116 69
No 91 72,122 233 87 70,113 231
I
p=NS p=NS
(Mimer (ng/ml)
Yes 56 41,94 55 63 42, 90 63
No 53 32,78 223 59 39, 81 218
1
i p=NS p=NSr
/els of PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
gregation b y  H igh  B lo o d  P r e s s u r e
Mean SD Mean SD
brinogen (g/l) 
Yes 
No
2.46
2.30
0.57
0.62
90
385
p=0.003
2.55
2.38
0.53
0.57
104
353
p=0.003
led Cell
legation (units)
Yes 
No
3.67
3.51
1.38
1.14 334
p=NS
4.02
3.61
1.24
1.20
98
321
p=0.003
liable3.9 L evels o f  PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed
bll Aggregation b y  A n g in a
Men Women
Median I.Q.R. n Median I.Q.R. n
I n n
Yes 97 70,121 28 93 71,115 17
No 92 74,117 368
p=NS
90 67,114 356
p=NS
PA (ng/ml)
Yes 10 7.5,12 19 7 5.7,8 12
No 6 4.5,9 254
p<0.001
4.5 3,7 254
p=0.04
VWF (iu/dl)
Yes 112.5 91,148 22 98 76,110 13
No 91 71,121 268
p=0.006
89 70,114 283
p=NS
D-dimer (ng/ml)
Yes 69 55,106 22 77 39,124 12
No 52 33,78 254
p=0.002
59 39, 81 264
p=NS
I
i
v
fable 3.9 (c o n tin u ed )
Levels of PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
Aggregation by  A n g in a
Mean SD n Mean SD ’ n
fibrinogen (g/l)
Yes 2.64 0.60 32 2.58 0.49 20
No 2.30 0.61 441 2.40 0.56 427
p<0.001 p=NS
Red Cell
Aggregation (units)
Yes 3.53 1.23 30 3.99 1.50 19
No 3.55 1.19 390 3.68 1.20 390
p=NS p=NS
liable3.10 L ev e ls  o f  PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R e d
| Cell Aggregation b y  M y o c a rd ia l In fa rc tio n
Men Women
Median I.Q.R. n Median I.Q.R.
*•
n
PAI(%)
Yes 90.5 81,130 18 93 85,139 11
No 92 73,117 374
p=NS
90 67,114 358
p=NS
MPA (ng/ml)
Yes 8.5 5.7,12 16 7 5.7, 9.5 8
No 6.2 5,9 257
p=0.07
4.5 3,7 256
p=0.09
I
i VWF (iu/dl)
Yes 115 84,160 17 99 76,109 8
No 92 72,122 273
p=0.05
89 "-70,114 286
p=NS
D-dimer (ng/ml) 
Yes 78.5 58,141 16 78 ,X 42,89 1
No 52 35,78 259
p=0.004
59 39,81 267
p=NS
liable 3.10 (c o n tin u e d )
evels of PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R e d  C ell
gregation by  M y o c a rd ia l In fa rc tio n
Mean SD n Mean SD n
jFMnogen (g/l) 
Yes 
No
2.69 0.61 24 
2.31 0.61 444
p<0.001
2.66 0.44 12 
2.40 0.56 431
p=0.05
Led Cell
Aggregation (units)
Yes
No
3.57 0.97 21 
3.54 1.20 395
p=NS
4.28 1.25 12 
3.68 1.20 390
p=0.07
Table 3.11
S p e a r m a n  r a n k  c o r r e l a t i o n  m a t r i x  o f  P A I ,  t P A ,  D - d i m e r  a n d  V W F  
w ith  c a r d i o v a s c u l a r  r i s k  f a c t o r s  w h i c h  a r e  c o n t i n u o u s  v a r i a b l e s .  
B M I =  b o d y  m a s s  i n d e x ;  G G T  =  g a m m a  g l u t a m y l  t r a n s p e p t i d a s e .
PAI tPA D-dimer vWF
Men
BMI 0.12* 0.26 *** -0.13* -0.07
S y s t o l i c  BP 0.14* 0.24 *** 0.15** 0.14**
D i a s t o l i c  BP 0.10* 0.30 *** 0.17** 0.12*
T o ta l
c h o l e s t e r o l
0.05 0.28 *** 0.01 0.06
H D L  c h o l e s t e r o l -0.11 * -0.06 0.09 0.06
T r i g l y c e r i d e 0.11 * 0.30 *** -0.014*** -0.11 *
G l u c o s e 0.05 0.08 -0.13* 0.01
T h i o c y a n a t e 0.01 0.02 0.12* 0.09
G G T 0.19*** 0.48 *** 0.01 0.19***
Women
BMI 0.20 *** 0.38 *** 0.08 -0.14**
S y s t o l i c  BP 0.17** 0.34 *** 0.12* 0.10*
D ia s t o l i c  BP 0.12* 0.23 *** 0.09 0.03
T o ta l
c h o l e s t e r o l
0.10* 0.36 *** 0.20 *** 0.36 ***
H D L  c h o l e s t e r o l -0.15** -0.15** 0.01 -0.12*
T r i g l y c e r i d e 0.31 *** 0.46 *** 0.08 -0.10*
G l u c o s e 0.18** 0.13** 0.18** 0.09
T h i o c y a n a t e 0.08 0.11 * -0.08 0.00
G G T 0.24 *** O M  * * * - 0 . o 3 0 .IS T  * *
1 3 . 1 2
Eds of PAI, tPA, VWF, D-dimer, Fibrinogen and Red Cell iregation by High Blood Pressure
Men Women
*
Median I.Q.R. n Median I.Q.R. n
m
Yes 90 74,118 77 91 71,122 87
No 93 73,117 322
p=NS
90 65,111 295
p=NS
W (ng/ml)
Yes 8 6,11 52 6 3.5,8 63
No 6 4,9 225
p<0.001
4.5 3,7 209
p=0.02
f  (iu/dl)
Yes 98 81,132 61 91 > 72,116 69
No 91 72,122 233 87 70,113 231
p=NS P=NS
tinier (ng/ml) 
Yes 56 41,94 55 63 42, 90 63
No 53 32, 78 223
p=NS
59 39, 81 218
p=NS
/■
’able 3.12 (c o n tin u e d )
welsof PAI, tP A , VW F, D -d im er, F ib r in o g e n  a n d  R ed  C ell
L egation by  H igh  B lo o d  P r e s s u r e
Mean SD n Mean SD n
brinogen (g/l) 
Yes 
No
2.46 0.57 90 
2.30 0.62 385
p=0.003
2.55 0.53 104 
2.38 0.57 353
p=0.003
m\
legation (units)
Yes
No
3.67 1.38 88 
3.51 1.14 334
p=NS
4.02 1.24 98 
3.61 1.20 321
p=0.003
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Figure 3.1 Associations of PAI activity and tPA antigen with serum triglyceride in women. 
Data shown are median and IQR by fifths of serum triglyceride.
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Figure 3.2 Associations of tPA antigen with serum gamma glutamyl transpeptidase (GT) and body 
mass index (BMI) in women. Data shown are median and IQR by fifths of serum gamma GT or BMI.
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Figure 3.3 Association of tPA antigen with serum gamma glutamyl transpeptidase (GT) and 
triglyceride in men. Data shown are median and IQR by fifths of serum gamma GT or 
ttriglyceride.
fibrinogen (r=0.23), and  PAI (r=0.24) (all p<0.005), b u t  n o t w ith  age, 
sex, sm oking, w hite cell count, or o ther variables.
DISCUSSION
The d istribu tions and  associations of PAI activity, tPA antigen , 
VWF an tigen  and  D -dim er antigen  in th is  s tu d y  will be d iscu ssed  in 
tu rn , com paring the  findings to those  in th e  lite ra tu re  reported  prior 
to th e  study, a s  well as th a t  reported since th is  s tu d y  w as perform ed. 
The m ost directly com parable s tu d y  of PAI activity an d  tPA an tigen  is 
th e  Second MONICA Survey in  N orthern  Sweden, recen tly  reported  by  
E liasson  and  colleagues (Eliasson e t al 1993; 1994 a, b; E liasson  
1995). This survey u sed  sim ilar m ethodology to th e  p re sen t study , b u t  
w as perform ed on fasting sub jects, sam pled earlier in  th e  day  (07.GO- 
15.00), who were advised no t to sm oke and  who w ere n o t rested . This 
s tu d y  ob tained  a  h igher response ra te  (79%) and  a  h igher percentage 
of sam ples ob tained  for haem atological s tud ies . T hese included  PAI 
activity and  tPA an tigen  assays, perform ed by  different m ethods 
(Biopool AG, Um ea, Sweden) from the c u rre n t study . L aboratory 
m easu rem en t variability  appeared  h igher th a n  in  th e  p re sen t study , 
an d  surprising ly  PAI activity w as zero in  13% of sam ples (E liasson 
1995), w hich  w as never observed in the  p resen t study .
PAI activity
A wide d istribu tion  of p lasm a PAI activity w as observed in  th e  
p re sen t study , in  bo th  m en (range 10-300%  pool) an d  w om en (range 
10-302%  pool). This is in  agreem ent w ith  m any  previous s tu d ies  
(Kruithof e t al 1988; E liasson  1995) and  as no ted  above E liasson
68
(1995) found 13% of the  people in  the  Second MONICA survey  in  
N orthern  Sw eden to have undetectab le  levels of PAI activity. D espite 
th is  wide variation, the  large n u m b er of sub jec ts  in  th e  p re sen t s tu d y  
show ed significant associations of PAI activity w ith  several 
card iovascu lar r isk  factors in the  general population , includ ing  
d iabetes m ellitus. On m ultivariate  analysis, th e  independen t 
d e te rm in an ts  of PAI activity were tim e of day, se ru m  triglyceride, and  
(in m en) se ru m  gam m a-glutam yl tran sp ep tid ase  (a m ark e r of alcohol 
intake) an d  a  h isto ry  of d iabetes m ellitus.
W hile overall there  w as no sex difference in  PAI levels, there  w as 
a  sex -dependen t change w ith  age (Table 3.1). M edian PAI level did n o t 
vary  significantly w th  age in  m en; however levels in  p rem enopausa l 
w om en w ere significantly lower th a n  in  m en or in  p o stm enopausa l 
w om en (Tables 3.1 and  3.2). These re su lts  are very sim ilar to those  of 
E liasson  (Eliasson e t al 1993; E liasson  1995) in the  Sw edish MONICA 
S tudy. The lower PAI activity in  p rem enopausal w om en appeared  
p artly  due  to u se  of oral contraceptives (Table 3.3) w hich  are  know n to 
increase  fibrinolytic activity and  to decrease  PAI (Juhan-V ague et al 
1988); th is  finding w as also observed in  the  Sw edish MONICA S tudy  
(E liasson 1995). These re su lts  suggest th a t  reference ranges for PAI 
activity shou ld  be age, sex  and  horm one-specific.
PAI activity show ed a  significant d iu rn a l varia tion  in  b o th  m en 
an d  w om en, levels falling betw een 08 .00  an d  16.00 h  (Table 3.4). 
S im ilar d iu rn a l varia tion  w as observed in the  Sw edish MONICA S tudy  
(E liasson e t al 1993; E liasson 1995). These re su lts  from  cross- 
sectional population  sam ples confirm  the  re su lts  of sm all longitudinal 
s tu d ies  w hich  frequently  sam pled healthy  vo lun teers over a  24 h
69
period (Andreotti e t al 1988; Angleton e t al 1989). O n m ultivariate  
analysis, tim e of day rem ained a  significant d e te rm in an t of PAI activity 
in  th e  p re se n t study . Hence reference ranges for PAI activity shou ld  be 
tim e-specific (e.g. m orning  or afternoon ranges); an d  th e  d iu rn a l 
varia tion  in  PAI shou ld  be considered in  th e  design of s tu d ies  of PAI 
activity. A ndreotti e t al (1988) have suggested  th a t  h igh  PAI activity in  
the  early  m orning  m ay be relevant to th e  h igh  incidence of m yocardial 
infarction, coronary  d ea th  and  stroke a t  th is  tim e of day; by  reducing  
endogenous lysis of arteria l th rom bi form ed a t th is  tim e.
C igarette sm oking w as n o t significantly associated  w ith  PAI 
activity in  the  p resen t study , a lthough  PAI activity tended  to be lower 
in  fem ale non-sm okers (p=0.07; Tables 3.5 and  3.6). S im ilar findings 
were reported  in  the  Sw edish MONICA S tudy  (E liasson 1995). Global 
fibrinolytic activity m ay be reduced in  chronic sm okers (Meade e t al 
1979; Allen e t al 1984, 1985; Ju h an -V ag u e  et al 1988), b u t  m ay 
reflect decreased  release of tPA from  endothelial cells (e.g. a fter 
desm opressin  infusion) ra th e r  th a n  a n  increase  in  PAI (Allen e t al 
1984, 1985). This decreased  release of tPA is accom panied  by  
decreased  release of VWF in  chronic sm okers (Allen e t al 1985); an d  
m ay reflect exhaustion  of tPA or VWF sto res by the  repeated  release of 
tPA an d  VWF during  acu te  sm oking (Allen e t al 1984), p e rh ap s  due  to 
release of ad renaline  and  vasopressin  (Juhan-V ague et al 1988).
D iabetic sub jec ts  had  significant elevations of PAI activity 
com pared  to non-d iabetic  sub jec ts  (Table 3.7). PAI activity also 
correlated  well w ith  o ther variab les associated  w ith  th e  "insulin  
res is tan ce  syndrom e" (Reaven 1988): body m ass  index, blood 
p ressu re , triglyceride (Figure 3.1), glucose (in women), and  low HDL
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cholesterol (Table 3.11). These findings are co n sis ten t w ith  the  
Sw edish MONICA S tudy  (Eliasson et al 1994a,b; E liasson  1995); an d  
w ith  th e  growing lite ra tu re  w hich suggests  th a t  h igh  PAI activity is 
consisten tly  correlated  w ith  d iabetes and  in su lin  res is tan ce  (Ju h an - 
V ague et al 1988; Gough and  G ran t 1991; Ju h an -V ag u e  an d  Alessi 
1993). On m ultivariate  analysis, h isto ry  of d iabetes m ellitus rem ained  
a  significant d e te rm in an t of PAI in  m en  in  th e  p re sen t s tudy . In su lin  
levels were n o t m easu red  in  the  p re sen t study; how ever in  the  
Sw edish MONICA S tudy  (Eliasson et al 1994a, b; E liasson  1995) and  
in  o th er large s tu d ies  (Juhan-V ague an d  Alessi 1993) fasting  in su lin  
levels appeared  to be the  strongest p red ic to r of PAI activity in  bo th  
m en  and  w om en (r=0.5 for each  sex in  the  Sw edish MONICA Study; 
(E liasson 1995). In wom en, these  correlations w ere stronger in  the  
postm enopausal, th e  obese, and  those  w ith  h igh  triglyceride levels 
(E liasson 1995). However, the  strong  in te r-re la tionsh ip s betw een the  
com ponents of the  in su lin  res istance  syndrom e m ake it difficult to 
sep ara te  the ir associations in  s ta tis tica l analysis. W hether or n o t 
in su lin  stim u la tes PAI-1 release from  endothelial cells or from 
hepatocytes is controversial (Juhan-V ague an d  Alessi 1993).
N either h isto ry  of hypertension  (Table 3.8) or ischaem ic h e a r t 
d isease  (angina or m yocardial infarction; T ables 3 .9  an d  3.10) were 
significantly associated  w ith  PAI activity. However the  n u m b ers  of 
sub jec ts  w ith  ischaem ic h e a rt d isease  w ere sm all; th e  assoc iation  of 
PAI activity w ith  m yocardial infarction  w as su b seq u en tly  s tu d ied  in  a  
larger, case-control s tu d y  (C hapter 4).
O ther card iovascu lar risk  factors (Table 3.11) associated  w ith  
PAI activity on un ivariate  analysis were (as noted above) com ponents
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of th e  in su lin  resistance  syndrom e: body m ass index, blood p ressu re , 
triglyceride (Figure 3.1), glucose (in women), an d  low HDL cholesterol. 
PAI activity also correlated w ith  se ru m  gam m a-glutam yl 
tran sp ep tid ase  (GGT: a  m arker of alcohol intake), an d  to ta l cholesterol 
(in women). On m ultivariate  analysis, se ru m  triglyceride rem ained  a  
significant independen t de te rm inan t of PAI activity in  b o th  m en  and  
wom en; while se ru m  GGT rem ained  a  significant independen t 
d e te rm in an t of PAI in  m en.
These findings on un ivariate  analysis are  sim ilar to those  of the  
Sw edish MONICA S tudy  (Eliasson et al 1994a,b; E liasson  1995) w hich 
found  th a t  in  bo th  m en and  w om en the  stro n g est assoc ia tions of PAI 
activity on un ivaria te  analysis were triglyceride (r=0.44), body m ass 
index  (r=0.40), w aist-h ip  ratio  (r=0.36), HDL cholesterol (r= -0.24), 
to ta l cholesterol in w om en (r=0.24) and  blood p re ssu re s  (r=0.09-0.22). 
In th e  Sw edish study , sub jects were fasted, in su lin  and  w aist-h ip  ratio  
w as m easu red , and  alcohol consum ption  w as n o t m easured ; while in 
th e  p resen t study , sub jects were n o t fasted , in su lin  an d  w aist-h ip  
ra tio  were n o t m easu red , and  alcohol consum ption  w as m easu red . 
T hese differences betw een the  Glasgow and  Sw edish MONICA stu d ies  
m ay explain different findings on m ultivariate  analysis. The Sw edish 
s tu d y  found th a t  independen t pred ictors of PAI activity did n o t include 
triglyceride , b u t  did include age, w aist-h ip  ratio , low he igh t an d  low 
HDL cholesterol in  m en; and  body m ass  index, cholesterol, systolic 
blood p ressu re , sm oking and  age in  w om en (Eliasson e t al 1994a,b; 
E liasson  1995).
R ecent s tu d ies  suggest th a t  the  findings in th e  p re se n t study , 
th a t  se ru m  triglyceride and  alcohol consum ption  (serum  GGT) were
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independen t d e te rm inan ts of p lasm a  PAI activity are  p robably  d irect 
effects. Triglyceride-containing very low density  lipoproteins (VLDL) 
increase  endothelial cell p roduction  of PAI-1 (Stiko-Rahm  e t al 1990; 
M ussoni et al 1990), a s  does oxidised low density  lipoprotein (LDL) 
(Latron et al 1991; C h au tan  et al 1993). H endriks e t (1994) observed 
in  a  controlled s tu d y  th a t  consum ption  of w ine cau sed  a n  acu te  
increase  in  p lasm a  PAI activity.
P lasm a PAI activity levels are  m ajor de te rm in an ts  of tPA activity , 
w hich  w as n o t m easu red  in  the  p resen t study . In the  Sw edish survey, 
PAI activity w as a  strong, inverse d e te rm in an t of tPA activity (r=-0.73 
in  m en  and  -0.59 in  women), w hich therefore show ed re la tionsh ips 
inverse to those  of PAI w ith card iovascu lar risk  factors (Eliasson 
1995).
tPA antigen
P lasm a levels of tPA antigen  in the  p resen t s tu d y  were very 
sim ilar to those  reported  in  the  lite ra tu re  (Kluft 1988); an d  to those  
recen tly  reported  in  the  Sw edish MONICA Survey (E liasson e t al 1993; 
E liasson  1995). As w ith PAI activity, tPA an tigen  show ed significant 
assoc iations w ith  several card iovascu lar risk  factors in  th e  general 
population . On m ultivariate  analysis, the  independen t d e te rm in an ts  of 
tPA an tigen  were age, se rum  triglyceride, and  se ru m  GGT; an d  (in 
women) tim e of day, reported  alcohol consum ption , an d  social class. 
T hese factors "explained" ab o u t 40% of the  to ta l variance  in  p lasm a  
levels.
73
The p resen t s tu d y  confirm ed a  strong  association  betw een tPA 
an tigen  and  PAI activity levels (r=0.31 for m en, r=0.38  for wom en; 
Table 3.12). T his association  m ay be p a rtly  due  to c ircu la ting  tPA-PAI- 
1 com plexes; the  norm al excess of PAI-1 over tPA resu lting  in 
increased  com plex form ation w ith  increasing  PAI-1 levels (Figure 1.3). 
Sim ilar correlations were observed in  the  Sw edish MONICA Survey 
(r=0.40 for m en, r=0.37 for women) (E liasson 1995). The association  of 
tPA an tigen  w ith  se ru m  triglyceride an d  se ru m  GGT m ay therefore 
partly  reflect the  associations of PAI activity w ith  th ese  variables. 
However, the  re la tionsh ips of tPA an tigen  to o ther card iovascu lar r isk  
factors were different from PAI activity. This suggests influences on 
p lasm a  tPA an tigen  levels o ther th a n  m erely p lasm a  PAI levels.
There w as a  significant sex difference in  tPA an tigen  levels, m en  
having h igher levels th a n  w om en a t all ages. In addition  tPA levels 
rose significantly w ith  age in  bo th  m en and  wom en, doubling betw een 
ages 25 and  64 years (Table 3.1), and  doubling after the  m enopause  
(Table 3.2). These resu lts  are  a lm ost identical to those  from the  
Sw edish MONICA S tudy  (Eliasson e t al 1993; E liasson  1995), an d  are  
consisten t w ith  previous lite ra tu re  (Juhan-V ague e t al 1988). Age 
rem ained  th e  m ost im portan t d e te rm in an t of tPA levels on 
m ultivariate  analysis, in  bo th  m en an d  wom en.
A significant d iu rnal variation  in  tPA w as observed, a s  in  the  
Sw edish MONICA S tudy  (Eliasson et al 1993; E liasson  1995). These 
re su lts  from  cross-sectional population  sam ples confirm  th e  re su lts  of 
sm all longitudinal s tud ies  (Andreotti e t al 1988; Angleton e t al 1989); 
and  m irror changes in  p lasm a PAI levels. On m ultivariate  analysis, 
tim e of day  rem ained  a  significant d e te rm in an t of tPA an tigen  in  the
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p resen t study . Hence reference ranges for tPA an tigen  shou ld  be tim e 
specific (e.g. m orn ing  or afternoon ranges); an d  the  d iu rn a l varia tion  
in  tPA shou ld  be considered in the  design of s tu d ies  of tPA antigen .
Unlike PAI activity, cigarette-sm oking (both c u rre n t and  ex­
smoking) w as significantly associated  w ith  h igher tPA an tigen  levels 
(Table 3.5). T his effect w as n o t dose-dependen t (Table 3.6), an d  w as 
stronger in  m en, possibly because  they  inhale  m ore th a n  w om en 
(Table 3.5). For unknow n  reasons, tPA an tigen  w as n o t analysed  in  
relation  to sm oking h ab it in the  Sw edish MONICA S tudy  (E liasson 
1995); an d  there  is little previously pub lished  in form ation  on tPA 
antigen  levels in  chronic sm okers (Nilsson e t al 1991). An association  
of tPA an tigen  w ith  cigarette sm oking w as also observed on un ivaria te  
analysis in m ale p a tien ts  w ith ang ina  pectoris in  the  ECAT A ngina 
Pectoris S tudy  (ECAT A ngina Pectoris S tudy  G roup, 1993). A cute 
sm oking increases tPA (and VWF) levels, p robably  due  to acu te  
endothelial d is tu rb an ce  (Allen et al 1984); and  th e  chronic effect of 
sm oking on bo th  tPA and  VWF in  th e  p resen t s tu d y  m ay reflect 
chronic endothelial d istu rbance .
D iabetic sub jec ts  h ad  non-sign ifican t elevations of tPA an tigen  
in  the  p re sen t s tu d y  (Table 3.7); how ever the  n u m b er of d iabetic 
sub jects w as sm all. Like PAI activity, tPA an tigen  correlated  w ith  o ther 
variables of th e  "insulin  resistance  syndrom e" (Reaven 1988): body 
m ass index and  triglyceride (Figures 3.1-3.3), blood p ressu re , and  
glucose an d  low HDL cholesterol in  w om en (Table 3.11). For unknow n  
reasons, tPA an tigen  w as n o t analysed  in  rela tion  to these  variab les in  
the  Sw edish MONICA stu d y  (E liasson 1995). However, th e  re su lts  of 
the  p resen t s tu d y  are consisten t w ith  recen t repo rts  from  two o ther
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large stud ies: the  ECAT A ngina Pectoris S tudy  (ECAT A ngina Pectoris 
S tu d y  G roup, 1993) and  the  ARIC S tudy  (Iso et al 1993).
Unlike PAI activity, bo th  h isto ry  of hypertension  (Table 3.8) and  
ischaem ic h e a r t d isease  (angina or m yocardial infarction) (Tables 3 .9  
an d  3.10), were significantly associated  w ith  increased  tPA an tigen  
levels. The association  w ith m yocardial infarction w as su b seq u en tly  
stu d ied  in  a  larger, case-control s tu d y  (C hapter 4).
O ther card iovascu lar risk  factors (Table 3.11) associated  w ith  
tPA an tigen  on un ivariate  analysis were (as noted above ) com ponents 
of th e  in su lin  res istance  syndrom e; and  se ru m  GGT. O n m ultivariate  
analysis, se rum  triglyceride and  GGT rem ained  significant 
in d ep en d en t de tem inan ts of tPA in  bo th  m en an d  w om en. These 
assoc iations m irror those  of PAI activity. In the  ARIC S tudy, tPA 
an tigen  w as positively associated  w ith  alcohol in take  in  Ja p a n e se  
m en, b u t  n o t in  C aucasians (Iso e t al 1993). Alcohol s tim u la te s  tPA 
release b o th  in  vitro and  in vivo (Hendriks e t al 1994). W hether or n o t 
triglycerides s tim u la te  tPA release is n o t known; a lthough  a s  no ted  
previously VLDL stim u la tes PAI-1 release from endo thelium  (Stiko- 
R ahm  et al 1990).
VWF antigen
Like PAI-1 and  tPA, von W illebrand factor an tigen  is an  
endothelial product; its associations in  the  p re sen t s tu d y  were 
therefore exam ined to see if they  resem bled  the  assoc ia tions of PAI 
an d  tPA. P lasm a levels of VWF an tigen  were sim ilar to th o se  reported  
in  th e  lite ra tu re , including  two o ther recen t large popu lation  sam ples:
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th e  Caerphilly S tudy  (Elwood et al 1993) an d  th e  ARIC S tudy  (Conlan 
et al 1993). As w ith PAI and  tPA, VWF show ed significant associations 
w ith several card iovascu lar risk  factors in the  general population . On 
m ultivariate  analysis, th e  independen t d e te rm in an ts  of VWF an tigen  
were age; triglyceride (negative), GGT, th iocyanate  an d  HDL 
cholesterol (negative) in  m en; and  body m ass  index  an d  alcohol 
consum ption  (both negative) in wom en. The assoc ia tions of PAI, tPA 
and  VWF w ith  alcohol consum ption  (GGT) in  m en, and  body m ass 
index in  wom en, m ay reflect generalised endothelial d istu rbance . 
However the  inverse associations of VWF w ith  triglyceride in  m en, an d  
w ith  alcohol consum ption  in wom en, are  quite different from  the  
associations of these  variables w ith  PAI an d  tPA. Therefore only som e 
associations of PAI and  tPA w ith card iovascu lar r isk  factors reflect 
generalised  endothelial d istu rbance . VWF show ed stronger 
correlations w ith  tPA antigen  th a n  w ith  PAI activity (Table 3.12), 
p e rh ap s  because  PAI-1 is syn thesised  by  hepatocy tes a s  well a s  
endothelial cells.
In the  p resen t study , VWF levels rose significantly w ith  age 
(Table 3.1) in bo th  sexes. These re su lts  are very sim ilar to those  in  the  
two o ther recen t population  sam ples (Conlan et al 1993; Elwood et al 
1993). There w as a  sex difference w ith age: younger w om en tended  to 
have h igher levels th a n  m en, while older m en  h ad  h igher levels th a n  
wom en (Table 3.1).
A d iu rnal variation  in  VWF w as seen  in  m en (Table 3.4), b u t  w as 
no t significant on m ultivariate  analysis.
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As previously  d iscussed , cigarette sm oking increased  VWF levels 
(as well as tPA an tigen  levels) in m en (Table 3.5), p e rh ap s  due to 
endothelia l d is tu rb an ce . The effect of sm oking on VWF levels w as 
significant on m ultivariate  analysis in  bo th  the  p re sen t s tu d y  and  the  
ARIC S tudy  (Conlan e t al 1993).
D iabetic sub jec ts  (although few) h ad  h igher levels of VWF 
an tigen  com pared  to non-diabetic  sub jec ts  (Table 3.7). This is 
co n sis ten t w ith  m any  previous s tud ies  (O sterm an an d  van  de Loo 
1986) and  w ith  th e  ARIC population  s tu d y  (Conlan e t al 1993). These 
elevations did n o t appear p a r t  of th e  "insulin  res is tan ce  syndrom e", 
b ecau se  VWF show ed inverse correlations w ith  body m ass  index, 
triglyceride an d  glucose; and  only a  w eak correlation  w ith  blood 
p re ssu re  (Table 3.11).
Von W illebrand factor w as n o t associated  w ith  h isto ry  of 
hypertension  (Table 3.8), b u t  w as h igher in  m en  w ith  ischaem ic h e a r t 
d isease  (angina or m yocardial infarction) (Table 3 .9  an d  3.10). The 
assoc ia tion  w ith  m yocardial infarction w as su b seq u en tly  s tud ied  in  a  
larger, case-contro l s tu d y  (C hapter 4).
O ther card iovascu lar risk  factors (Table 3.11) show ing associations 
w ith  VWF an tigen  on un ivariate  analysis were GGT in  m en  ; an d  to ta l 
cholesterol in  wom en. However cholesterol w as n o t a  significant 
assoc ia tion  on m ultivariate  analysis.
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F ib rin  D -dim er
P lasm a fibrin D -dim er levels are  a  m ark e r of increased  fibrin 
tu rn o v e r (conversion of fibrinogen to fibrin by  th e  coagulation  system , 
followed by lysis of fibrin by fibinolytic enzym es includ ing  tPA). D- 
d im er an tigen  w as m easu red  in the  p re sen t s tu d y  as  a  m ark e r of in 
vivo fibrinolysis, and  w as com pared to levels of PAI, tPA an d  VWF.
A lthough high levels of PAI activity m ight be expected to inh ib it 
fibrinolysis in  vivo, there  w as only a  weak, non-sta tis tica lly  significant, 
inverse  correlation betw een PAI activity an d  D -dim er an tigen  (r=-0.03 
in  m en and  r=-0 .07  in women; Table 3.12). tPA an tigen  show ed a  
m o d es t positive correlation w ith D -dim er (r=0.14 in  m en  an d  0 .16  in  
w om en; p<0.01; Table 3.12). VWF an tigen  show ed a  stronger 
co rre la tion  w ith  D -dim er (r=0,29 in  m en and  0 .22 in  wom en; p<0.001; 
T able  3.12). Therefore elevated D -dim er levels appeared  to correlate 
b e tte r  w ith  th is  m ark er of endothelial d is tu rb an ce  th a n  PAI or tPA 
levels. This m ight reflect fibrin form ation on dam aged vessel walls, 
followed by appropria te  local endogenous fibrinolysis.
P lasm a D -dim er increased  w ith  age in  each  sex  (Table 3.1) and  
on  m ultivariate  analysis correlated m ost strongly  w ith  age. D -dim er 
a lso  correlated  w ith  fibrinogen, VWF and  tPA; and  w ith  w hite cell 
coiunt in  m en and  red cell aggregation in  w om en (Table 3.12). It is 
therefo re  possible th a t  the  increase  in  D -dim er w ith  age reflects 
in c reased  fibrin tu rnover associated  w ith  age-related increases  in  
fibrinogen levels, endothelial d istu rbance , tPA release, and  
in flam m atory  reactions. These factors m ight in  tu rn  reflect underly ing
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a thero sc le ro sis  (Al-Zahrani et al 1992; S m ith  et al 1993; Lee e t al 
1995; W oodburn et al 1995). W hen m ultivariate  analysis of D -dim er 
w as repeated  including  fibrinogen and  VWF, VWF w as a  m ore 
im p o rta n t d e te rm in an t of D -dim er th a n  age in  m en; while red  cell 
aggregation  replaced age a s  a  d e te rm in an t of D -dim er in  w om en.
A sex difference w as observed in  D -dim er before the  m enopause , 
w ith  h igher levels in  p rem enopausal w om en (Table 3.1). This 
difference d isappeared  after the  m enopause  (Table 3.3), hence one 
possib le  cause  is u terine  (m enstrual) fibrin turnover. This m ight also 
reflect lower PAI activity in  p rem enopausal w om en (Table 3.1).
A d iu rnal varia tion  in D -dim er w as seen  in m en (Table 3.4) b u t  
w a s  n o t significant on m ultivariate  analysis.
D -dim er levels were n o t significantly associated  w ith  d iabetes or 
h y p e rten s io n , b u t  were h igher in m en  w ho sm oked or w ho h a d  a  
h is to ry  of ang ina  or m yocardial infarction  (Tables 3 .5-3.10). The la tte r  
asso c ia tio n  w as stud ied  fu rth er in  a  larger case-contro l s tu d y  
(C hap ter 4).
D -dim er levels also correlated inversely w ith  body m ass  index, 
triglyceride, and  glucose in  m en; and  possitively w ith  blood p ressu re  
a n d  th iocyanate. In wom en, D -dim er correlated  w ith  blood p ressu re , 
to ta l cholesterol, and  glucose (Table 3.11). Only th e  inverse 
asso c ia tio n  w ith  triglyceride in m en w as significant on m ultivariate  
analysis: th is  m ay reflect the  association  of triglyceride w ith PAI 
activity, w hich m ight inh ib it fibrin lysis.
80
Interleukin-6
It h a s  a lready been  noted  th a t  PAI, tPA, VWF and  D -dim er 
correlated w ith  red cell aggregation (a global m easu re  of th e  acu te  
p h a se  pro tein  reaction) and  w ith fibrinogen, an  acu te  p h a se  protein . 
S tud ies of acu te-p h ase  pro tein  reactions (e.g. surgery) have show n 
acu te-p h ase  behav iour of PAI-1 and  tPA an tigen  (Juhan-V ague e t al 
1988). It h a s  recently  been  show n th a t  th e  cytokine, in te rleuk in -6  (IL- 
6) is a  m ajor prom otor of the  acu te  p h ase  reaction. S erum  IL-6 levels 
were therefore m easu red  in a  random  subsam ple  of 139 sam ples in  
the  p resen t study , to see if they  correlated  w ith PAI activity, fibrinogen 
or red  cell aggregation in the  general population . As expected, a  s trong  
correlation w as observed betw een IL-6 levels and  red cell aggregation, 
a  global m easu re  of the  acu te-p h ase  p ro tein  reaction  (r=0.37; 
pcO.OOl). IL-6 also correlated w ith  fibrinogen (r=0.23; p<0.005); the  
syn thesis  of fibrinogen by hepatocy tes is know n to be IL-6 dependen t 
(de Boer e t al 1991). Interestingly, the  correlation  of PAI activity w ith 
IL-6 w as equally  strong  (r=0.24; p<0.005), suggesting  th a t  IL-6 m ay 
also m ediate hepatic  syn thesis  of PAI-1. De Boer e t al (1991) show ed 
th a t  in v itro , hepatom a cell lines increased  PAI-1 sy n th esis  w hen 
exposed to in te rleu k in -1 (IL-1) and  tu m o r necrosis factor (TNF), b u t  
n o t to IL-6. However, K ruithof (1993) reported  th a t  in jection of IL-6 in 
vivo in  baboons led to strong  increases in  PAI-1 and  tPA.
This p relim inary  s tu d y  suggests th a t  cytokines su c h  a s  IL-6 
m ediate som e of the  variance of PAI-1 levels in the  general population . 
F u rth e r s tu d ies  are required  to investigate th is  hypo thesis , an d  to 
determ ine if IL-6 an tagon is ts  m ay reduce high PAI-1 levels an d  th u s  
stim ula te  endogenous fibrinolysis.
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CHAPTER 4
A CASE CONTROL STUDY OF PLASMA PLASMINOGEN
ACTIVATOR INHIBITOR ACTIVITY. TISSUE PLASMINOGEN
ACTIVATOR ANTIGEN. FIBRIN D-DIMER ANTIGEN. VON
WILLEBRAND FACTOR ANTIGEN AND FIBRINOGEN IN
SURVIVORS OF PREMATURE MYOCARDIAL INFARCTION
INTRODUCTION
As d iscussed  in C hap ter 1, a  n u m b er of s tu d ies  have show n 
associations of p lasm a plasm inogen activator inh ib ito r (PAI) or tissu e  
p lasm inogen activator (tPA) w ith ischaem ic h e a r t d isease  (IHD) in  
cross sectional stud ies; as well as th e  predictive value of several 
haem ostatic variab les for bo th  prim ary  an d  secondary  m yocardial 
infarction  (MI). Fibrinogen is bo th  a  p rim a iy  (Meade e t al 1980, 1986) 
and  secondary  (M artin e t al 1991) pred ictor of IHD events, while PAI 
activity (H am sten e t al 1987), tPA an tigen  an d  VWF an tigen  (Jan sso n  
et al 1991 a,b; 1993) have also been  show n to p red ic t rec u rren t MI. 
Several s tu d ies  have com pared indiv iduals w ith  ischaem ic h e a r t 
d isease  (IHD) and  controls for levels of PAI, tPA an d  VWF (Table 1.5); 
b u t  none have u sed  controls from a  random  popu lation  s tu d y  (see 
C hap ter 1). In th is  study , an  a ttem p t w as m ade to define th e  degree of 
chronic d is tu rb an ce  in  PAI, tPA, von W illebrand factor (VWF), fibrin D- 
dim er and  fibrinogen in  survivors of p rem atu re  MI, com paring  th em  to 
age-m atched controls from a  sim u ltaneous random  sam ple  of the  
population  (Second Glasgow MONICA survey), w hich w as described in  
C hap ter 3. Red cell aggregation w as also m easu red  as a  m ark e r of 
rea c ta n t p lasm a  pro teins.
82
SUBJECTS AND METHODS
The cases for the  s tu d y  were consecutive survivors of p rem atu re  
(i.e. before the  age of 60 years) m yocardial in farction  (determ ined by 
W orld H ealth  O rganisation  (WHO) criteria: WHO 1976), w ho were 
adm itted  to the  U niversity M edical Unit, one of four general m edical 
u n its  in  one of th ree  hosp ita ls in  North Glasgow. T hese p a tien ts  were 
stud ied  in 1990, 1 to 6 years after infarction, to avoid "acute phase" 
reactions. P a tien ts were selected from u n it records by  Dr PM B alendra  
and  Professor GDO Lowe. Of 171 p a tien ts  w ho were invited to a tten d  
for study , 100 (59%) a ttended , 74% of w hom  were m ale and  26%  
female. These cases underw en t the  sam e risk  factor a sse ssm e n t u sed  
in  the  co n cu rren t Second Glasgow MONICA Survey (Table 4.1). PAI 
activity, tPA antigen, VWF antigen, D -dim er antigen , fibrinogen an d  
red cell aggregation were also m easu red  a s  decribed in  C h ap te r 2.
358 age m atched  (40-65 years) individuals from  th e  Second 
Glasgow MONICA survey  da tab ase  were u sed  a s  th e  control group. 
These sub jec ts  h ad  no evidence of card iovascu lar d isease  a s  defined 
by  h isto ry  of m yocardial infarction, angina, hypertension , stroke  or 
d iabetes.
S ta tistica l analysis w as perform ed by Dr A J  Lee, 
C ardiovascu lar Epidemiology Unit, U niversity of D undee, w ith  in p u t 
from Professor GDO Lowe and  myself. G roups w ere com pared  by  t- 
tes ts , W ilcoxon ra n k  su m  tests , or te s ts  for differences in  p roportions 
(sm oking categories), a s  appropriate . M ultivariate logistic regression
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'lie 4.1
M io n a l risk factors in cases of myocardial infarction and in 
filiation controls (mean values with SD in brackets, or % 
smokers). *p<0.05, **p<0.01, ***p<0.001
Men
Cases Controls
Women 
Cases Controls
Ige (years) 56.1 (5.6) 51.3 (7.4) 
★**
56.4 (5.9) 52.1 (7.4) 
***
iody mass index
ijtf)
27.2 26.0 28.0 25.3
[
Diastolic blood 
pressure (mmHg)
82 (11) 78(12) 
★ *
81 (13) 77(13)
tolesterol
L )
6.94 (1.22) 6.75 (1.22) 7.44(1.46) 6.93 (1.39)
t  cholesterol
■ol/l)
1.06 (0.26) 1.21 (0.36) 
**★
1.16(0.38) 1.44 (0.46) 
**
Ifiglyceride
m\l\)
2.12(1.20) 1.97 (1.25) 2.47(1.71) 1.54 (0.85) 
*
pol/l)
6.25 (2.65) 5.20 (0.98) 
**
5.84(1.96) 5.25 (2.48)
Smokers
current
ex-
never
50.0%
44.6%
5.4%
47.6%
30.1%
22.3%
64.0%
32.0%
4.0%
48.1%
20.1%
31.8%
analysis w as perform ed for each of PAI, tPA, VWF, fibrinogen and  red 
cell aggregation, to exam ine w hether or not differences in cases versus 
controls were independent or no t of s tan d ard  risk  factors: age, body 
mass index (BMI), diastolic blood p ressure , total and  high density  
lipoprotein (HDL) cholesterol, triglyceride, glucose, and  two dum m y 
variables represen ting  cu rren t and  ex-sm oking hab it respectively. 
Results for m en and  wom en were analysed separately  because of sex 
differences in bo th  risk  factors and haem atological variables.
RESULTS
In both  sexes, haem atological variables are show n as m edians 
for PAI and  D-dimer, and  as m eans for the other variables (Table 4.2). 
PAI, tPA, VWF, D-dimer, fibrinogen and red cell aggregation were all 
significantly h igher in survivors of p rem ature  MI com pared to 
controls, w ith the exception of tPA in men.
Conventional risk  factors, including age, BMI, diastolic blood 
p ressure  (DBP), cholesterol, HDL cholesterol, triglyceride, glucose and 
sm oking were also analysed. As expected, some of these were higher 
in cases th an  in controls (Table 4.1).
A m ultivariate logistic regression analysis w as then  perform ed 
on cases versus controls, ad justing  for age, BMI, DBP, cholesterol, 
HDL cholesterol, triglyceride, glucose, cu rren t sm oking and  ex 
smoking. PAI in men; D-dimer, fibrinogen, and  red cell aggregation; 
and VWF in wom en rem ained significantly higher in cases com pared 
with controls. tPA no longer showed a statistically  significant
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Table 4.2
PAI, tPA, vWF, D-dimer, fibrinogen and red cell aggregation in 
cases of myocardial infarction and in population controls (mean 
with SD in brackets; medians with IQR in brackets for PAI and D- 
dimer)
* p<0.05; ** p<0.01; *** p<0.001
Cases
Men
Controls
Women 
Cases Controls
PAI (% pool) 113 *** 94 127 k k k 92
(114) (49) (86) (50)
tPA (ng/ml) 8.6 8.0 7.8 k 6.4
(3.8) (3.7) (3.6) (3.6)
VWF (iu/dl) 124 ** 112 136 • k ic k 102
(40) (44) (51) (39)
D-dimer (ng/ml) 90 ** 57 105 • k ic k 61
(63) (40) (53) (41)
Fibrinogen (g/1) 2.98 k k k 2.52 3.48 • k ic k 2.55
(0.72) (0.69) (0.68) (0.68)
Red cell 4.5 ■ kick 3.9 5.2 k k k 3.9
aggregation (units) (1.2) (1.2) (1.4) (1.3)
association  w ith MI w hen these  o ther risk  factors were tak e n  into 
acco u n t (Table 4.3).
DISCUSSION
T his population-controlled  s tu d y  show ed survivors of p rem atu re  
MI to have chronic (1-6 years post-infarct) abnorm alities in  PAI 
activity, tPA an tigen  (in women), VWF an tigen  , D -dim er antigen, 
fibrinogen and  red cell aggregation, in  addition  to a  h igher frequency 
of several s tan d a rd  risk  factors, w hen com pared to controls w ithou t 
evident card iovascu lar d isease. M ultivariate analysis suggested  th a t  
the  increases in  cases in  PAI (in men); D-dim er, fibrinogen, red  cell 
aggregation; and  VWF (in women) rem ained  sta tistica lly  significant 
after a d ju s tm en t for age and  s ta n d a rd  card iovascu lar r isk  factors.
The increase  observed in  p lasm a PAI activity in  survivors of 
p rem atu re  m yocardial infarction in  th is  s tu d y  is co n sis ten t w ith 
previous reports prior to 1990 w hen th is  s tu d y  w as perform ed (see 
Table 1.5 in C hap ter 1). It also suggests th a t  s ta n d a rd  risk  factors, 
su ch  a s  body m ass index or triglyceride w hich are associated  w ith  
PAI-1 (C hapter 3), do n o t fully accoun t for th is  increase, a t  lea s t in  
m en. W hen these  risk  factors were included in a  m ulivariate  analysis, 
the  association  of PAI w ith m yocardial in farction  becam e non  
significant in  wom en. These findings m ay have been  influenced by  the  
sm all n u m b er of wom en who were stud ied  com pared to m en  (26 
versus 74). A larger s tu d y  of w om en is therefore indicated  to exclude 
an  independen t association  of PAI activity w ith  MI in wom en.
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Table 4 .3
Statistical s i g n i f i c a n c e  o f  c a s e  c o n  
(egression a n a l y s i s ,  i n c l u d i n g  t h e  
6ble4.1. NS =  n o t  s i g n i f i c a n t  (p>0.
t r o l  d i f f e r e n c e s  o n  l o g i s t i c  
) c o n v e n t i o n a l  r i s k  f a c t o r s  i n  
05).
M e n W o m e n
Ml N S
PA N S N S
iWF N S *★
Wimer * * *
fibrinogen ***
Bed c e ll a g g r e g a t i o n * * * ***
I
In these  survivors of p rem atu re  MI, the  increase  in p lasm a  tPA 
an tigen  w as less m arked  th a n  the  increase  in  PAI activity (Table 4.2). 
It w as n o t sta tistica lly  significant in  m en; of only borderline 
significance in  w om en (p<0.05); and  n o t significant on m ultivariate  
analysis in  e ither sex. These findings are  co n sis ten t w ith  previous 
repo rts  p rio r to 1990, w hen th is  s tu d y  w as perform ed; som e of w hich 
found increased  tPA an tigen  while o thers did n o t (see Table 1.5 in  
C hap ter 1). The strong  rela tionsh ip  of tPA an tigen  w ith several 
s ta n d a rd  card iovascu lar risk  factors (C hapter 3) m ay explain w hy its 
association  w ith  m yocardial in farction  w as n o t significant in  
m ultivariate  analysis.
There are  no previously reported  s tu d ies  of increased  levels of 
p lasm a D -dim er in  survivors of m yocardial infarction, a lthough  
increased  levels have been  observed in acu te  MI or u n s ta b le  ang ina  
(C hapter 1). The p re sen t s tu d y  show s for th e  first tim e th a t  p lasm a  D- 
dim er an tigen  levels are  significantly increased  in  bo th  m ale and  
female survivors of p rem atu re  m yocardial in farction  (Table 4.2). W hen 
m ultivariate  analysis including card iovascu lar r isk  factors w as 
perform ed, th ese  increases rem ained  sta tistica lly  significant. This is 
consisten t w ith  the  lack  of correlation of D -dim er w ith  r isk  factors 
w hich w as found in  the  population  survey reported  in  C hap te r 3.
The increase  in  p lasm a VWF an tigen  levels in  survivors of 
p rem atu re  m yocardial infarction is co n sis ten t w ith the  two previous 
pub lished  reports  (H am sten et al 1985; Schm itz-H uebner e t al 1988). 
O n m ultivariate  analysis, th e  association  of VWF w ith  previous 
m yocardial infarction rem ained sta tistica lly  significant in  w om en b u t  
no t in m en  (Table 4.2). Similarly, H am sten  et al (1985) observed
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h ig h er levels of VWF in female survivors of m yocardial infarction  th a n  
in  controls, b u t  no significant difference in m en.
M any previous s tu d ies  have show n increased  p lasm a  fibrinogen 
levels in  IHD (reviewed by  E rn s t and  R esch 1993, and  Lowe e t al 
1995), and  sim ilar increases found in  th e  p resen t s tu d y  of survivors of 
m yocardial in farction  are consisten t w ith  these  previous observations. 
T his increase  in  fibrinogen m ay also explain in  p a r t  th e  increase  in  red 
cell aggregation in  these  individuals. As d iscussed  in  C hap te r 3, it is 
possib le  th a t  th e  associations of PAI, tPA, VWF, D-dim er, fibrinogen 
a n d  red  cell aggregation w ith m yocardial infarction  m ay be partly  due 
to  chronic inflam m ation (?in arteries) and  release  of cytokines su c h  as 
in terleuk in -6 . F u rth e r  stud ies are required  to ad d ress  th is  possibility.
The associations of p lasm a PAI, tPA, VWF, D -dim er and  
fibrinogen w ith  m yocardial infarction m ay also be due  to underly ing  
coronary  arte ry  a therosc le rosis , and  th is  is in keeping w ith  the  
recen tly  pub lished  re su lts  of the  ECAT A ngina Pectoris S tu d y  (1993). 
In th is  s tu d y  3 ,000  p a tien ts  undergoing  co ronaiy  angiography were 
exam ined, and  it w as found th a t  those w ith  co ronaiy  a therosclerosis 
h a d  h igher levels of PAI activity, tPA an tigen  an d  fibrinogen th a n  those  
w ith  no coronary  a therosclerosis. In th a t  s tu d y  however, n e ith e r PAI 
activity no r tPA an tigen  were related  to the  ex ten t or grade of 
a therosclero tic  stenosis; a lthough  fibrinogen w as.
A therosclerosis is a  generalised  d isease  and  a lthough  it occurs 
in  the  coronaiy  arteries, the  m ajority of a therosclero tic  lesions are  
found in the  peripheral a rteries supplying th e  lower lim bs. S tud ies in  
o u r laboratory  have show n th a t  PAI, tPA, VWF, D -dim er and
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fibrinogen are also associated  w ith  peripheral a rte ria l d isease  (Reid 
1991; S m ith  et al 1993; Lee et al 1995), and  th a t  D -dim er an d  
fibrinogen are also associated  w ith  the  ex ten t of d isease  (Lee et al 
1995; W oodburn e t al 1995).
The association  of PAI, tPA, VWF, D -dim er an d  fibrinogen w ith  
previous m yocardial infarction observed in  the  p re sen t s tu d y  suggests 
the  possibility  th a t  increased  levels of these  variab les m ight be 
consequences of arteria l disease. To investigate th e  possib ility  th a t  
th ese  increased  levels m ight precede the  onse t of detectable 
card iovascu lar d isease requ ires prospective stud ies . C h ap te r 5 repo rts  
the  predictive value of these  variables in a  cohort of m en  m ostly  free 
from  detectable card iovascu lar d isease (the Caerphilly H eart Study); 
and  C hap ter 6 reports the  predictive value of these  variab les in  a  
cohort of m en and  w om en w ith  peripheral a rte ria l d isease  (the 
E d inburgh  C laudication Study).
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CHAPTER 5
PROSPECTIVE STUDY OF THE PREDICTIVE VALUE OF PLASMA
PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY. TISSUE
PLASMINOGEN ACTIVATOR ANTIGEN. D-DIMER ANTIGEN AND
VON WILLEBRAND FACTOR ANTIGEN FOR ISCHAEMIC HEART
DISEASE EVENTS: THE CAERPHILLY HEART STUDY
INTRODUCTION
In terest in  the  role of m easu rem en ts  of the  fibrinolytic system  in  
th e  pred iction  of ischaemic h e a r t d isease (IHD) h a s  grown in  recen t 
years. This is partly  due  to the  resu lts  from the  Northwick P ark  H eart 
S tudy  w hich have show n an  association  betw een low fibrinolytic 
po ten tial of blood, as m easu red  by th e  d ilu te  whole blood clot lysis 
tim e, an d  the  incidence of IHD (Meade et al 1986). In s tu d ies  u sing  
m ore specific m easu rem en ts  of th e  fibrinolytic system , high  
p lasm inogen activator inh ib ito r (PAI) w as a  r isk  factor for rec u rren t 
infarction  in  young  m ale survivors of m yocardial infarction  (H am sten 
e t al 1987); a s  were tissu e  plasm inogen activator (tPA) an d  von 
W illebrand factor (VWF) (Jansson  et al 1991 a, b;1993).
In 1992, there  were no pub lished  s tu d ies  of th e  predictive value 
of PAI, tPA, fibrin D -dim er or VWF in  h ea lth y  persons. D iscussions 
w ith  D r JW G Yam ell in  1992 indicated  th a t  stored , u n th aw ed  c itrated  
p lasm a sam ples were available from the  C aerphilly  H eart S tudy  
exam ination  in  1984-1986, on over 2000  m en, of w hom  over 100 h ad  
since experienced ischaemic h e a rt d isease events on follow-up. 
F und ing  w as therefore obtained to perform  a ssay s of PAI, tPA, D-
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d im er and  VWF in  these  sam ples, and  to exam ine th e ir predictive 
v a lu e  for ischaemic h e a r t d isease events. The predictive value of 
fibrinogen, p lasm a viscosity and  w hite cell coun t for ischaemic h e a r t 
d isease  events in  th is  cohort h a s  a lready been  reported  (Yamell e t al 
1991).
SU BJECTS AND METHODS 
S tu d y  Population
The Caerphilly H eart S tudy  is a  s tu d y  of risk  factors (including 
haem atological r isk  factors) for IHD in  m iddle-aged m en  in  Caerphilly, 
S o u th  W ales (Yamell e t al 1991). The original cohort of 2512  m en 
aged 45 to 59 years w as recm ited  betw een 1979 an d  1983, an d  since 
th e n  they  have been  re-exam ined a t five-yearly in tervals. The m en 
w hose stored  sam ples were stud ied  were those  seen  a t th e  first re ­
exam ination  betw een 1984 and  1988, w hen they  w ere aged 49 to 65 
years. M en of the  sam e age who h ad  m oved in to  th e  defined 
geographical a re a  since the  original rec ru itm en t w ere also eligible to 
be  exam ined. A to ta l of 2398 m en a ttended  the  s tu d y  clinic an d  a  
fasting  blood sam ple w as obtained  from 2223 (93%) of them .
The m en  were invited to a tten d  afternoon or evening clinics, 
w here a  detailed m edical and  lifestyle h isto ry  w as obtained , th e  
London School of Hygiene and  Tropical M edicine (LSHTM) ch est p a in  
questionnaire  w as adm inistered , a  full 12 lead electrocardiogram  
(ECG) w as recorded, an d  w eight and  blood p ressu re  m easu red . The 
m en  w ere th e n  invited to re tu rn , fasting, to a n  early  m orn ing  clinic 
w here a  blood sam ple w as taken .
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Blood Collection. Storage and  Analysis
Blood w as tak en  betw een 07 .00h  an d  lO.OOh for 91%  of the  
m en. It w as tak en  before 07 .00h  for 7% and  betw een lO.OOh an d  
ll.O O h for the  rem ain ing  2%. The blood w as collected in to  evacuated  
con ta iners and  syringes using  a  19-gauge bu tte rfly  needle an d  
S a rs te d t m onovette adap to rs. V enous s ta s is  w as rem oved as  soon as 
blood flow com m enced. C entrifugation w as carried  o u t w ith in  the  
h ou r, and  c itrated  p lasm a  stored  a t -70°C. One b a tc h  of sam ples w as 
unavailab le  for th e  c u rre n t analysis so th a t  VWF, tPA, and  D -dim er 
an tigens were m easu red  on 1998 fasting sam ples. A nother b a tc h  h ad  
been  thaw ed on one occasion an d  w as therefore u n su itab le  for a ssay  
of PAI activity, w hich w as m easu red  on 1569 sam ples. I perform ed 
these  m easu rem en ts  du ring  1994, w hen th e  p lasm a  h a d  been  sto red  
for betw een 6 an d  10 years, u sing  the  m ethods described  in  C hap ter 
2 .
Inciden t IHD
Follow-up w as perform ed by Mr P Sw eetnam , D r P Elwood, D r 
JW G Y am ell an d  colleagues in  the  MRC Epidem iology U nit (South 
Wales), Cardiff a t  an  average in terval of 61 m on ths. All m en  were 
flagged w ith  th e  N ational H ealth  Service C entra l Registry (NHSCR), 
and  d ea th  certificates coded to In terna tional C lassification of D isease 
(ICD) 410-414  inclusive were u sed  as the  definition of fata l IHD. Some 
questions ab o u t adm ission  to hosp ita l w ith  ch est p a in  w ere added to 
the  LSHTM questionnaire . These, together w ith  lis ts  from  H ospital 
Activity A nalysis (HAA) of all m en  adm itted  to local hosp ita ls  w ith a
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diagnosis of ICD 410-414, were u sed  as  the  b asis  for a  sea rch  of 
hosp ita l no tes for events m eeting s ta n d a rd  WHO criteria  (WHO 1976) 
for acu te  m yocardial infarction (MI). Finally, the  appearance  on the  
follow-up ECG of m ajor or m oderate  Q-waves (M innesota codes 1-1 or 
1-2) w hen  th ere  w ere no Q-waves on th e  rec ru itm en t ECG w as tak en  
a s  evidence th a t  a  non-fata l MI h ad  occurred  du ring  th e  follow-up 
period.
U sing these  definitions there  were 129 m ajor inc iden t IHD 
events am ong the  1998 m en who h ad  m easu rem en ts  of tPA, D -dim er 
and  VWF antigens, and  103 events am ong the  1569 m en  w ho h a d  PAI 
activity m easu red . The average a n n u a l incidence of IHD events w as 
1.3%.
S ta tistica l M ethods
S ta tistica l analysis w as perform ed by  Mr P Sw eetnam  in  Cardiff 
after d iscussions w ith  m yself and  Professor G D O Lowe. A djusted  
m ean  differences (Table 5.1) were obtained by analysis of covariance, 
in  w hich fibrin  D -dim er w as transfo rm ed  to logarithm s b ecau se  of its 
positively skew ed d istribu tion . The rem ainder of th e  analysis w as 
perform ed u sin g  m ultiple logistic regression  analysis w ith  th e  
occurrence, or not, of a  m ajor inciden t IHD event a s  th e  dependen t 
variable. The haem ostatic factors were trea ted  in  two ways. F irst, th e ir  
d istribu tions were divided into equal 'fifths' u sing  th e  four quintiles, 
an d  the  re su lts  p resen ted  as  the  odds of m ajor inc iden t IHD in  each  
'fifth ' relative to a  baseline  'fifth ' w hich w as alw ays tak e n  a s  the  20%  
of m en w ith  the  low est levels. Second, the  haem ostatic factors were 
en tered  in to  the  sam e m odels as con tinuous variab les to provide a  te s t
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for th e  tren d  in  the  relative odds of IHD. W hen u sed  a s  a  con tinuous 
variable, D -dim er w as again transfo rm ed  to logarithm s. O ther r isk  
factors included  in  m ultivariate  analysis were age, sm oking hab it, 
d iastolic blood p ressu re , body m ass index, to ta l an d  HDL cholesterol, 
p e rsonal h isto ry  of d iabetes, family h isto ry  of m yocardial infarction  
before age 55 years, and  tim e of blood sam pling.
Men w ith  evidence of ischaem ia a t rec ru itm en t were n o t 
excluded from th e  analysis. R easons for th is  are  given in  detail 
elsew here (Yamell e t al 1991). Briefly, 31%  of th ese  m en  h a d  som e 
evidence of ischaem ia a t  baseline, a s  judged  from  th e  LSHTM ch est 
p a in  questionnaire  or the  ECG. E xclusion of su c h  a  large group, 
am ong w hom  ju s t  over h a lf of the  m ajor inciden t events occurred , did 
n o t seem  satisfactory . Instead , we included  s tan d ard ised  m easu re s  of 
angina, h isto ry  of severe ch est pa in  an d  ECG ischaem ia a t  baseline  as 
th ree  covariates in  the  logistic regression  analysis. T his is likely to  be 
a  conservative p rocedure  in  th a t  it m ay u n d erestim a te  the  association  
betw een the  haem ostatic factors an d  incidence of IHD.
RESULTS
M ean p lasm a  levels of PAI activity and  tPA an tigen  w ere h igher 
in  th e  p resen t s tu d y  th a n  in  the  Glasgow MONICA stu d y  (Table 5.1), 
probably  b ecau se  m ost m en  were sam pled  in  th e  early  m orning  
(C hapter 3). P lasm a levels of PAI, tPA, VWF an tigen  an d  D -dim er 
an tigen  w ere all h igher am ong the  m en  who developed m ajor IHD, as 
show n in  Table 5.1. The age ad ju sted  m ean  difference for PAI activity 
of 9.8%  pool u n its  (95% Cl from  -1.5 to +21.1%  pool un its), w hich  w as 
no t sta tistica lly  significant (p>0.05). The age ad ju sted  m ean  difference
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in  tPA w as 0 .9  n g /m l w ith  a  95% Cl of 0 .2  to 1.7 n g /m l (p=0.02). 
M uch the  s tro n g est association  of IHD w as w ith  D-dim er. Geom etric 
m ean  D -dim er w as 89 .6  n g /m l am ong the  m en  w ho developed m ajor 
IHD com pared w ith  70.7  n g /m l am ongst those  w ho did n o t 
(p<0.0001). The age ad ju sted  m ean  difference in  log (D-dimer) of +0.21 
im plies th a t  th e  age ad ju sted  geom etric m ean  level w as 23%  higher, 
w ith  a  95% Cl from  12% to 35%. The age ad ju sted  m ean  difference for 
VWF w as 7 .4  iu /d l  (95% +0.1 to +14.8) (p=0.05).
Table 5 .2  an d  figure 5.1 show  incidence an d  relative odds of 
IHD by 'fifths' of PAI activity. There w as som e suggestion  of a  tren d  of 
increasing  incidence of IHD w ith  increasing  PAI activity in  bo th  the  
u n ad ju s ted  re su lts  and  on ad ju s tm en t for age and  sm oking hab it. 
However the  tren d  is no t sta tistica lly  significant, and  w as m u ch  
reduced  on ad ju stin g  for r isk  factors and  evidence of ischaem ia a t 
baseline. F u rth e r  controlling for tPA, w ith  w hich  PAI w as strongly 
correlated (r=+0.45) rem oved any  suggestion  of a  trend .
For tPA an tigen  (Table 5.3, figure 5.1) th e  incidence of IHD 
increased  from 4.5%  in  the  20% of m en w ith  the  low est levels to 7.8%  
in  th e  20%  w ith  th e  h ighest levels. U nad justed , th e  tren d  for incidence 
of IHD to increase  w ith  increasing  tPA w as sta tistica lly  significant 
(p=0.009) and  rem ained  so on ad ju sting  for age an d  sm oking h a b it 
(p=0.03). However, th e  tren d  becam e non-sign ifican t after ad ju sting  
for o ther r isk  factors and  evidence of ischaem ia a t  baseline.
Table 5 .4  an d  figure 5.1 show  a  very s trong  tren d  (p<0.0001) for 
incidence of IHD to increase from 3.0%  in  the  20%  of m en  w ith  the  
lowest levels of D -dim er an tigen  to 11.7 % am ong th e  20%  w ith  the
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h ig h e s t levels. U nadjusted , the  relative odds increased  fairly steadily  
to  4 .22  (95% Cl 2 .23 to 7.98). Controlling for all r isk  factors and  
evidence of ischaem ia a t baseline  reduced  th e  trend , b u t  it rem ained  
h igh ly  sta tistica lly  significant (p=0.0003) a n d  the  relative odds in  the  
to p  20%  w ere still 3 .53  (95% Cl, 1.82 to 6.85). The fu rth e r  addition  of 
p la sm a  fibrinogen (Yamell e t al 1991) to th e  m odel m ade no m ateria l 
difference to th e  association  betw een D -dim er and  inc iden t IHD.
Table 5 .5  and  figure 5.1 show  incidence an d  relative odds of 
IHD by  'fifths' of VWF an tigen . T here is a  clear tren d  of increasing  
incidence  of IHD w ith  increasing  VWF in  bo th  the  u n a d ju s te d  resu lts , 
a n d  on  a d ju s tm en t for risk  factors.
DISCUSSION
In  th is  study , we have found strong  evidence for an  independen t 
a sso c ia tio n  betw een p lasm a  fibrin D -dim er an d  inc iden t IHD. D -dim er 
is a  b reakdow n p roduct form ed w hen  p lasm in  a c ts  on cross-linked 
fib rin  an d  can  therefore be considered to be an  ind irect m easu re  of 
fib rin  tu rnover. The p resen t s tu d y  therefore suggests th a t  increased  
fib rin  tu rnover is a  r isk  p redictor for ischaemic h e a r t d isease.
Since we perform ed th e  p resen t study , R idker e t al (1994a) have 
a lso  associated  elevated levels of D -dim er w ith  increased  risk  of IHD, 
a lth o u g h  in  th e ir study , D -dim er did n o t ap p ea r to be an  independen t 
p red ic to r w hen  o ther risk  factors were included in  m ultivariate  
ana ly sis . However, the  s tu d y  of R idker e t al (1994a) w as a  n ested  
case-con tro l s tu d y  in  a  selected group of United S ta te s  physic ians, 
w h e reas  the  p resen t s tu d y  w as a  cohort s tu d y  in  an  unse lec ted
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population . We found th a t  D -dim er w as still a  very strong  p red ic to r of 
IHD after controlling for a  large se t of r isk  factors an d  for baseline  
evidence of ischaemia. Fully ad ju sted  relative odds of IHD increased  
fairly stead ily  to 3 .53 an d  the  te s t for trend  w as highly sta tistica lly  
significant (p=0.0003). T his association  betw een D -dim er an d  inciden t 
IHD w as found bo th  in the  69% of m en  w ith  no evidence of ischaem ia 
a t  rec ru itm en t an d  am ong the  31% w ho did have su c h  evidence. The 
group  of r isk  factors ad ju sted  for included fibrinogen, so th a t  the  
association  betw een D -dim er and  IHD does n o t arise  sim ply because  
b o th  are  associated  w ith  fibrinogen (Yarnell e t al 1991).
O ur finding of an  independen t predictive value of p lasm a  VWF 
an tigen  for IHD is consisten t w ith the  recen t repo rts  of M eade e t al 
(1994a) in  h ea lthy  m en, of T hom pson et al (1995) in  p a tien ts  w ith  
an g in a  pectoris, and  of J a n s s e n  et al (1991a) in  m yocardial infarction. 
T hese findings all su p p o rt a  role for th is  m ark er of endothelial 
d is tu rb an ce  in  prediction  of ischaemic h e a r t  d isease.
The p resen t s tu d y  found only a  w eak, non-sign ifican t 
re la tionsh ip  betw een PAI activity and  inciden t ischaemic h e a r t  d isease. 
H am sten  and  colleagues (1987) found th a t  PAI activity w as a  risk  
factor for rec u rren t MI in  m en w ith  a  first m yocardial in farction  before 
age forty-five years. M eade and  colleagues (1986, 1993a) found th a t  
low fibrinolytic activity, a s  m easu red  by  the  d ilu te  whole blood clot 
lysis tim e, w as a  p red ictor of IHD in  m en initially aged 40  to  54 years. 
They found no association  in  m en aged 55 to 64  years a t  recru itm en t. 
None of the  m en  in  the  p resen t s tu d y  were younger th a n  45 a t 
baseline, b u t  one th ird  were aged 45 to 56 years. T here w as no 
suggestion  in  o u r d a ta  of a  stronger association  betw een PAI activity
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an d  inciden t IHD am ong these  younger m en. O ur re su lts  are  
co n sis ten t w ith  those  of R idker et al (1992) w ho found  no association  
betw een PAI an tigen  an d  inciden t IHD am ong the  apparen tly  healthy  
U nited S ta te s  doctors in  the  Physician 's H ealth  S tudy. Furtherm ore , 
b o th  J a n s s o n  et al (1991b; 1993) and  T hom pson et al (1995) found no 
association  betw een PAI activity and  su b seq u e n t card iovascu lar 
events am ong sub jec ts  w ith  ang ina  pectoris. It therefore ap p ea rs  th a t  
PAI activity m ay only pred ict ischaemic h e a r t d isease  in  young  m en.
We found a  significant (p=0.009) tren d  for inciden t IHD to 
increase  w ith  increasing  levels of p lasm a tPA an tig en , su c h  th a t  
relative odds of IHD in  the  20% of m en w ith  th e  h ig h est levels of tPA 
an tigen  were 1.75 (95% Cl 0 .99 to 3.10). However, th a t  tren d  w as 
largely abolished on ad justing  for o ther card iovascu lar risk  factors, in  
p a rticu la r se ru m  lipids, w ith w hich tPA an tigen  is correlated (C hapter 
3). This finding is rem arkably  sim ilar to th a t  of R idker et al (1993a,b). 
J a n s s o n  e t al (1991a; 1993) and  T hom pson et al (1995) also found a  
positive association  of tPA w ith ischaemic h e a r t  d isease  events, b u t  in  
th e ir  large groups of pa tien ts  w ith  severe an g in a  pectoris, th e  
association  rem ained  after ad justing  for o th er r isk  factors. T hese 
contrad ictory  findings m ay be related  to th e  fact th a t  th e  m ean  
difference in  tPA betw een the  group who developed IHD events and  the  
group who did n o t w as 1.6 n g /m l in  the  s tu d y  of J a n s s o n  e t al (1993) 
an d  1.9 n g /m l in  the  s tu d y  of ang ina  p a tien ts  by  T hom pson  e t al 
(1995), b u t  only 1.2 n g /m l in the  s tu d y  of R idker e t al (1993a) and  0 .9  
n g /m l in  th e  c u rre n t study. F urtherm ore, an  ind ep en d en t association  
of tPA w ith  p revalen t ischaemic h e a r t d isease  w as n o t found in  o u r 
case-contro l s tu d y  (chapter 4).
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It is necessary  to consider th e  lim itations and  possible b iases in  
th e  c u rre n t study . The m ost serious po ten tial lim itation  is th a t  the  
p la sm a  sam ples were sto red  for betw een six  an d  ten  years before 
analysis. T here are a t  least th ree  rea so n s  for a ssu m in g  th a t  long-term  
storage h a s  n o t affected o u r resu lts . Firstly, the  levels ob tained  are  
sim ilar to those  reported  from  o ther stud ies , and  are  sim ilar (allowing 
for d iu rn a l variation) to those  found w hen  m easu rin g  sam ples after 
sh o rt-te rm  storage in  healthy  persons in  o u r labora to ry  (chap ter 3). 
Secondly, the  associations th a t  we found betw een PAI, tPA, D-dim er, 
VWF an d  o ther card iovascu lar risk  factors in  the  p re sen t s tu d y  were 
very sim ilar to those  reported by o u r own labora to ry  in  th e  Glasgow 
MONICA s tu d y  in  C hap ter 3 (unpub lished  data). Thirdly, e rrors 
in troduced  by storage would be likely to obscure  assoc ia tions ra th e r  
th a n  to generate  them , and  we have found assoc iations betw een these  
variab les an d  inciden t IHD w hich are sim ilar to those  reported  from 
o ther stud ies . A nother potential problem  w as th a t  one b a tc h  of 
sam ples h ad  been  thaw ed on one occasion. B ecause thaw ing  can  
affect PAI activities, th is  w as n o t m easu red  on th is  sam ple set. 
D ifferences in  m ean  tPA, D -dim er an d  VWF levels betw een thaw ed an d  
u n th aw ed  sam ples were trivial (data n o t shown).
B ecause of the  w eak associations betw een D -dim er or VWF 
an tigen  levels and  s ta n d a rd  card iovascu lar risk  factors (chap ter 3), 
they  m ay  add significantly to predicting  th e  risk  of ischaemic h e a r t 
d isease  in  th e  general population . T heir independence a s  r isk  
p red ic to rs is consis ten t w ith  th e ir independen t assoc ia tions w ith  
p revalen t m yocardial infarction in the  case  control s tu d y  reported  in  
ch ap te r 4. T aken together, the  re su lts  of the  s tu d ies  reported  in
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chap ter 4 an d  th e  p resen t ch ap ter su p p o rt ro les for increased  
endothelial d is tu rb an ce  and  fibrin tu rnover in  ischaemic h e a r t d isease.
The predictive value of D -dim er and  VWF an tigens for ischaemic 
h e a rt d isease  in  p a tien ts  w ith  estab lished  arte ria l d isease 
(claudication) a re  considered in  C hap ter 6.
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CHAPTER 6
PROSPECTIVE STUDY OF THE PREDICTIVE VALUE OF PLASMA 
FIBRIN D-DIMER ANTIGEN. VON WILLEBRAND FACTOR ANTIGEN. 
AND FIBRINOGEN FOR THE PROGRESSION OF PERIPHERAL 
ARTERIAL DISEASE AND THE RISK OF ISCHAEMIC HEART 
DISEASE IN CLAUDICANTS: THE EDINBURGH CLAUDICATION 
STUDY.
INTRODUCTION
In p a tien ts  w ith  clinically evident ischaem ic h e a r t  d isease  (IHD), 
longitudinal s tud ies  have show n th a t  a n  increased  risk  of m ajor 
card iovascu lar events is related  to several abnorm alities in  fibrinolysis 
and  coagulation w hen  m easu red  a t baseline. These include fibrinogen 
(Cooper an d  D ouglas 1991; M artin  et al 1991), tis su e  p lasm inogen 
activator an tigen  (tPA) (Jansson  et al 1991b), von W illebrand factor 
(VWF) (Jan sso n  et al 1991a) and  p lasm inogen activator inh ib ito r (PAI) 
(H am sten e t al 1987).
In a  previous case control s tu d y  from  th is  d ep artm en t and  from  
the  W olfson U nit for Prevention of Peripheral V ascu la r D iseases, 
U niversity of E dinburgh , we have show n th a t  periphera l a rte ria l 
d isease  in  a  population  w as associated  w ith increased  fibrinogen, 
increased  fibrin tu rnover as m easu red  by  fibrin  D -dim er an d  
increased  endothelial d istu rbance  a s  show n by h igher levels of VWF. 
Raised levels of PAI-1 were also observed (Sm ith e t al 1993). F und ing  
w as therefore obtained  for a  prospective s tu d y  of p a tien ts  w ith  
in te rm itten t c laudication  w hich aim ed to relate  D-dim er, VWF an d
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fibrinogen to the  progression of peripheral a rte ria l d isease  (as 
m easu red  by the  ank le-b rach ia l p ressu re  index  (ABPI), and  th e  risk  of 
ischaem ic h e a r t d isease (IHD).
SUBJECTS & METHODS
The E d inburgh  C laudication S tudy  w as perform ed in  
collaboration w ith D rs FGR Fowkes and  E H ousley of the  W olfson U nit 
for Prevention of Peripheral V ascu lar D iseases, U niversity of 
E d inburgh . 742 consecutive pa tien ts  w ith  in te rm itten t c laud ication  
d iagnosed in  the  Peripheral V ascu lar Clinic in  the  Royal Infirm aiy  of 
E d inbu rgh  w ere followed u p  for 1 year. This is the  only su c h  clinic in 
E d inburgh . P a tien ts were excluded from the  s tu d y  if they  h ad  re s t 
pain , gangrene, u lceration  or im pending angioplasty  or a rteria l 
surgery. 617  p a tien ts  w ithou t su ch  exclusions were th en  en tered  into 
th e  study , w hich w as in  keeping w ith  the  pow er calcu lation  th a t  600  
p a tien ts  w ould be needed to detect a  9% difference in  m ean  fibrinogen 
level betw een those  who w ould an d  those  who w ould n o t have a  
co ronaiy  event du ring  the  1 year follow-up.
The London School of Hygiene and  Tropical M edicine (LSHTM) 
questionnaire  on in te rm itten t c laudication  an d  an g in a  w as com pleted 
by  each  p a tien t a t the  o u tse t of the  study . This questionnaire  also 
included  details of sm oking and  diabetic s ta tu s . P ressu re  
m easu rem en ts  were m ade in one leg and arm , from  w hich  th e  Ankle 
B rachial P ressu re  Index (ABPI) w as derived. T his index  h a s  been  
show n to be as good an  ind icator of peripheral a rte ria l d isease  a s  
other, m ore invasive m easu rem en ts  (Fowkes e t al 1988). The 
labo ra to ry  resea rch  a ss is ta n ts  were tra ined  in th e  D epartm en t of
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M edicine in  th e  s ta n d a rd  m ethods of blood sam pling  prio r to the  
study . V enous blood w as w ithdraw n for m easu rem en t of VWF, D- 
dim er, h aem ato crit and  fibrinogen, w hich  were assayed  as  described  
in ch ap te r 2. The sam e physical investigations were carried  o u t on th e  
p a tien ts  1 year later, b u t  no blood w as taken . D eaths were identified 
from th e  G eneral P ractitioners, relatives an d  from th e  S co ttish  NHS 
C entral Registry. C ard iovascular events identified a t  th e  clinic an d  
card iovascu lar d ea th s were confirm ed by  reviewing m edical records 
an d  w ere classified by WHO criteria  (WHO 1976).
S ta tis tica l analysis w as perform ed by  Dr R E lton, Dept, of Public 
H ealth  Sciences, University of E d inburgh , w ith in p u t from  D r FGR 
Fowkes, Professor GDO Lowe and  myself. The W ilcoxon ra n k  su m  te s t 
w as u se d  to determ ine associations betw een each  baseline  factor and  
IHD events. To calculate  the  odds ratios, the  range of values of 
labora to ry  te s ts  w as divided a t the  m edian, or into quintiles. 
Confidence in tervals were calculated  by  th e  exact m ethod. The odds 
ra tios approxim ated  to relative risk  b ecau se  of th e  low n u m b er of 
events. M ultiple logistic regression  analysis w as u sed  to te s t th e  
significance of se ts  of factors ad ju sted  for one ano ther, and  confidence 
in tervals for odds ra tios were calcu lated  w ith  th e  norm al 
approxim ation. The association  betw een change in  the  ABPI an d  
baseline factors w as tested  by  Wilcoxon ra n k  su m  te s t  or S pearm an  
ra n k  correlation. M ultiple linear reg ression  w as u sed  to  te s t for 
association  betw een final ABPI and  se ts  of factors ad ju sted  for one 
an o th e r and  for baseline ABPI.
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RESULTS
D uring  the  year of follow-up, 32 p a tien ts  died an d  558 re tu rn ed  
for th e  1 year exam ination. Ischaemic h e a r t d isease events occurred  in  
36  p a tien ts , 15 of w hich were fatal. Of the  non-fata l events, 4 were 
inc iden t ang ina  and  17 were m yocardial infarction. The re la tionsh ips 
betw een  the  baseline  factors and  ischaemic h e a r t d isease  events over 
th e  following year are  show n in Table 6.1. This show s th a t  fatal 
ischaem ic h e a r t d isease events were significantly re la ted  to p lasm a 
fibrinogen and  to p lasm a D-dim er. D -dim er w as th e  only variable to 
show  a  re la tionsh ip  to to ta l ischaemic h e a r t d isease events (p=0.0006).
W hen stepw ise m ultiple logistic regression  analysis w as carried  
o u t (Table 6.2), age and  fibrinogen were seen  to be independen t 
p red ic to rs of ischaemic h e a rt d isease death , while th ese  ad ju s tm en ts  
resu lted  in  D -dim er and  o ther factors losing sta tis tica l significance. 
However, all ischaemic h e a rt d isease  events w ere independen tly  
p red icted  by  m ale sex and  D -dim er level. Figure 6.1 show s th e  relative 
r isk s  for com bined ischaemic h e a rt d isease  events for fifths of D -dim er 
expressed  relative to the  lowest quin  tile. The fou rth  and  fifth quintile  
g roups show ed an  increased  relative r isk  of 3 .3  (95% Cl 0.9-14.4) and  
4 .4  (95% Cl 1.3-19.0), respectively.
P lasm a VWF show ed a  non-significant tren d  to prediction  of 
ischaemic h e a r t d isease events (Table 6.1).
The m ean  reduction  in ABPI w as 0 .010 (SE 0.007). Progression 
of a rte ria l d isease , as m easured  by a  fall in the  ABPI, w as g rea ter in
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Figure 6 .1  Relative risk s (95%CI) for fata l an d  non-fata l IHD w ith in  
one year for u p p e r four quin tiles of D -dim er relative to low est quintile
sm okers th a n  non-sm okers after 1 year, b u t  show ed no significant 
correlation  w ith  any  of the  haem atological factors m easu red  on 
un ivaria te  analysis. However a  stepw ise m ultip le  reg ression  show ed 
th a t  only c u rre n t cigarette sm oking (p=0.0004), age (p=0.0051) and  D- 
d im er levels (p=0.0077) were each  independen tly  associated  w ith  
change in  final ABPI (Table 6.3).
DISCUSSION
P atien ts  w ith  in te rm itten t c laudication  have a n  increased  risk  of 
critical limb ischaem ia, am pu ta tion  and  card iovascu lar events, 
especially ischaem ic h e a rt d isease (IHD) events. Previous s tu d ies  have 
described  h igher p lasm a levels of fibrinogen, D -dim er an d  VWF in  
p a tien ts  w ith peripheral a rteria l d isease  w hen com pared to controls 
(Sm ith e t al 1993). These variables m ay play a  p a r t  in  a therogenesis 
and  throm bogenesis.
In th is  study , p lasm a fibrinogen levels and  age were show n to be 
the  m ost im p o rtan t independen t pred ictors of ischaem ic h e a r t  d isease  
d ea th s  in  c laud ican ts . This w as also observed in  th e  Northwick P ark  
prospective s tu d y  of p a tien ts  w ith  stab le  in te rm itten t claud ication  
(Banerjee e t al 1992) and  provides fu rth e r evidence th a t  p lasm a  
fibrinogen concen tra tion  is bo th  a  p rim ary  (E rnst and  R esch 1993) 
and  a  secondary  (Cooper and  D ouglas 1991; M artin  e t al 1991; 
Banerjee e t al 1992) risk  factor for a rte ria l disease.
The findings of th is  s tu d y  th a t  p lasm a fibrin D -dim er levels were 
predictive of fatal and  non-fata l IHD events in  c laud ican ts , and  th a t  
D-dim er h ad  predictive value for the  progression  of peripheral a rteria l
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disease  (as m easu red  by th e  fall in  ABPI) have n o t previously been  
reported . The predictive value of D -dim er for IHD in  c lau d ican ts  is 
co n sis ten t w ith  its predictive value for IHD in  th e  C aerphilly  H eart 
S tu d y  cohort, described in C hap ter 5; and  w ith  th e  recen t re su lts  of 
th e  PLAT stu d y  (Cortellaro e t al 1993). Increased  D -dim er levels have 
been  found in p a tien ts  w ith peripheral a rte ria l d isease, w hich 
correlated  w ith  clinical severity (Al-Zahrani e t al 1992) an d  w ith  the  
ex ten t of d isease  a s  m easu red  by th e  ABPI (Reid 1991; S m ith  e t al 
1993; W oodburn et al 1994). This suggests th a t  th e  increased  fibrin 
tu rnover in  these  p a tien ts  is rela ted  to the  ex ten t of th e ir  a rte ria l 
d isease. These findings are consisten t w ith ongoing fibrin form ation 
and  lysis con tribu ting  to the  progression  of bo th  coronary  and  
peripheral a therosclerosis (the R okitansky-D uguid hypothesis: D uguid 
1946).
In th is  study , a  non-sign ifican t tren d  w as observed for a  
predictive value of p lasm a VWF an tigen  for IHD events. T his is 
c o n sis ten t w ith  the  re su lts  of the  C aerphilly  H eart S tudy  (C hapter 5) 
and  w ith  the  re su lts  of s tu d ies  of survivors of m yocardial in farction  or 
ang ina  p a tien ts  (Jan sso n  e t al 1991b; T hom son et al 1995).
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CHAPTER 7
PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY. TISSUE 
PLASMINOGEN AACTIVATOR ANTIGEN AND VON WILLEBRAND 
FACTOR ANTIGEN IN NON-INSULIN DEPENDENT DIABETIC 
PATIENTS WITH AND WITHOUT MICROALBUMINURIA.
INTRODUCTION
People w ith  n on -in su lin  dependen t d iabetes m ellitus (NIDDM) 
have been  show n to have increased  p lasm a  PAI activity, tPA an tigen  
an d  VWF an tigen  levels com pared to non-d iabetic  su b jec ts  (C hapters 
1 an d  3). It h a s  been  estab lished  th a t  m ic roalbum inuria  is a  m ark er 
for early rena l dam age and  m ortality  in  in su lin -d ep en d en t d iabetes 
(Viberti e t al 1978, 1982). In non -in su lin  dependen t diabetics, 
a lb u m in u ria  is associated  w ith  increased  m ortality, an d  subclin ical 
increases in  a lbum in  excretion (m icroalbum inuria) have been  show n 
to be predictive of dea th  from card iovascu lar d isease  (M ogenson e t al 
1984; J a r r e t t  e t al 1984; Schm itz an d  V aeth  1988). S tan d a rd  
card iovascu lar risk  factors do n o t com pletely explain the  high  
prevalence of card iovascu lar d isease in  NIDDM w ith  m icroalbum inuria  
(Allawi and  J a r r e t t  1990). Several s tu d ies  have suggested  th a t  
haem osta tic  and  fibrinolytic changes m ay con tribu te  to the  
pathogenesis of diabetic com plications (O sterm an an d  v an  de Loo 
1986; Sm all e t al 1987, 1989; Gough an d  G ran t 1991).
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AIMS OF STUDY
In th is  s tu d y  the  p rim aiy  aim  w as to determ ine if any  
differences could be found in  p lasm a  levels of PAI, tPA, VWF or 
fibrinogen betw een NIDDM p a tien ts  w ith, an d  those  w ithout, 
m icroalbum inuria ; and  to com pare these  two g roups of p a tien ts  w ith  
m atch ed  non-d iabetic  controls. A second aim  w as to see if these  
variab les were correlated  w ith two m easu res  of free rad ical activity, 
w hich  h a s  been  show n to be abnorm al in  NIDDM su b jec ts  (Kaji e t al 
1985), and  w hich m ay  be im plicated in v ascu la r endothelial dam age 
(Blake e t al 1985, S tringer e t al 1989).
SUBJECTS AND METHODS
24 NIDDM p a tien ts  were studied; 12 who h ad  m icroalbum inuria  
an d  12 who h a d  not. 12 m atched  non-d iabetic  control su b jec ts  w ere 
also stud ied . P atien ts and  controls were selected by  Dr. A Collier. 
M icroalbum inuria  w as determ ined w ith an  im m uno tu rb im etric  a ssay  
(Spooner e t al 1987), and  w as defined as a n  a lbum in-crea tin ine  ratio  
of > 3 .5  w ith  u rin a ry  pro tein  concen tra tion  <200m g/L . The m ean  
u rin a ry  a lbum in  excretion ra te s  from th ree  tim ed overnight u rin e  
collections ranged  from 42 to 140 g /m in . None of th e  p a tien ts  h ad  
any  clinical or electrocardiographic evidence of ischaem ic h e a r t 
d isease, an d  all h ad  easily palpable peripheral pu lses. Two of the  
d iabetics were tak ing  a  cardioselective J3-blocker; otherw ise none of 
the  p a tien ts  were tak ing  m edication o ther th a n  su lphony lu reas. In all 
p a tien ts  the  blood p ressu re  w as less th a n  140/90m m H g. No p a tien t 
h ad  proliferative retinopathy , b u t  ten  p a tien ts  w ithou t
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m icro lbum inuria  and  all p a tien ts  w ith  m icroalbum inuria  h ad  
backg round  re tinopathy . Total cholesterol concen tra tions were 
<6.5mM , and  triglyceride concen tra tions were <2.0mM . All p a tien ts  
an d  controls were venesected in  the  fasting  s ta te  betw een 09 .0 0 h  and  
lO.OOh. Blood glucose w as m easu red  u sing  a  glucose oxidase m ethod 
on  a  Perspective analy ser (American M onitor UK, B urgess Hill, UK), 
a n d  HbA i by  gel e lectrophoresis (Coming, H alstead, UK).
PAI activity, tPA antigen, Von W illebrand factor an tigen  and  
fibrinogen were m easu red  as described in C hap ter 2.
Linoleic acid (PL-9, 12-LA) and  its diene conjugate (PL-9, 11-LA) 
w ere m easu red  by  h igh-perform ance liquid chrom atography  (HPLC) 
(Cawood et al 1983; Iverson et al 1985). The ratio  w as u sed  as  a  
m easu re  of free rad ical activity. Lipid peroxides w ere also m easu red  
u sin g  HPLC and  were expressed as m alondialdehyde (MDA) (Collier e t 
al 1990). T hese a ssay s were perform ed by  Mr A G Rum ley in  th e  
D epartm en t of B iochem istry. G artnavel G eneral H ospital, Glasgow.
S ta tis tica l analysis w as perform ed by  Dr A Collier. R esu lts  a re  
p resen ted  a s  m ed ians and  ranges. The th ree  groups w ere com pared 
u sin g  th e  Kruskall-W allis analysis of variance, and  th e  possible 
in fluences of glycaemic control (as m easu red  by HbA^ an d  p lasm a  
glucose) and  a lbum in  excretion on the  variab les m easu red  were 
a ssessed  by m ultip le regression  analysis.
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RESULTS
All th ree  g roups of sub jects were closely age m atched , and  the  
d iabetic  groups were m atched  for d isease  d u ra tio n  and  glycaem ic 
control (Table 7.1). Increases in  p lasm a PAI activity, tPA antigen , VWF 
an tigen  an d  fibrinogen were found in  diabetic sub jec ts  w hen  
com pared w ith  controls (p<0.05). In p a tien ts  w ith m icroalbum inuria , 
fu rth e r increases were seen  in  tPA (p=<0.03) and  in  VWF (p<=0.03) 
w hen com pared to norm oalbum inuric  diabetic p a tien ts  (Table 7.2). 
There w as no difference in  the  concen tra tion  of linoleic acid (PL-9, 12- 
LA) betw een the  control sub jects and  th e  two d iabetic  groups. The 
concen tra tion  of th e  non-peroxide isom er of linoleic acid (PL-9, 11-LA) 
w as h igher in  the  m icroalbum inuric  diabetic group th a n  in  control 
sub jec ts  (p<0.05). The m olar ratio  (9, 11-LA: 9, 12-LA) w as elevated in  
bo th  the  norm oalbum inuric  (p<0.05) and  the  m icroalbum inuric  
(p<0.05) diabetic g roups com pared w ith  controls; there  w as no 
difference betw een the  two diabetic groups (Table 7.2). The 
concen tra tion  of MDA w as grea ter in  the  m icroalbum inuric  diabetic 
group com pared w ith  the  norm oalbum inuric  diabetic group (p<0.05) 
an d  the  control sub jec ts  (p<0.001). The concen tra tion  of MDA w as 
also elevated in the  norm oalbum inuric  p a tien ts  com pared  w ith  the  
control sub jec ts  (p<0.01).
No significant correlation w as observed betw een any  of the  
haem osta tic  or fibrinolytic p a ram eters  an d  e ither m easu re s  of free 
radical activity, ra te  of a lbum in  excretion, or glycaemic control.
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DISCUSSION
T his s tu d y  confirm s the  increases in  PAI activity, tPA antigen, 
VWF an tigen  and  fibrinogen in NIDDM p a tien ts  show n in  previous 
s tu d ie s  (O sterm an and  van  de Loo 1986; Sm all e t al 1989; K ruithof e t 
a l 1988; Gough and  G ran t 1991) and  it also show s th a t  these  
d is tu rb an c es  are m ore m arked in p a tien ts  w ith  m icroalbum inuria . 
T here is little pub lished  inform ation on the  re la tionsh ip  betw een these  
variab les and  a lbum inuria . Schm itz and  Ingerslev (1990) an d  
S tehouw er e t al (1992) observed th a t  elevation in VWF w as m ore 
m arked  in  NIDDM sub jects  w ith  m icroalbum inuria  th a n  in  those  
w ithou t. Gough and  G ran t (1991) reported  a  correlation  betw een 
u r in a iy  a lbum in  level and  p lasm a  PAI-1 activity an d  antigen . The 
p re se n t s tu d y  confirm s and  extends these  findings. The elevations in  
PAI, tPA and  VWF m ay be due to endothelial d is tu rb an ce  in  diabetic 
sub jects: there  is evidence for bo th  m orphological an d  functional 
abnorm alities of endothelium  in diabetics. M icraoalbum inuria  reflects 
ren a l g lom erular dam age, pe rh ap s as p a rt of generalised  endothelial 
d is tu rbance . It is therefore possible th a t  th e  g rea ter elevation in  the  
endothelial p roducts, tPA and  VWF, in  NIDDM su b jec ts  w ith  
m icroalbum inuria  reflects m ore w idespread endothelial d istu rbance .
The elevation of PAI activity and  fibrinogen m ay be partly  due  to 
release  of IL6 and  o ther cytokines w hen m onocytes adhere  to dam aged 
endothelium  (as d iscussed  in C hap ter 3).
E levations in PAI, tPA, VWF and  fibrinogen are  po ten tial 
card iovascu lar risk  factors in non-diabetic  sub jec ts  (C hapters 5 an d  
6). In diabetics, fibrinogen and  VWF have been  show n to pred ict
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card iovascu lar events (Breddin et al 1986; K annel e t al 1990; 
S tehouw er e t al 1992). E levations in  these  variables m ay  therefore be 
one possible cau sa l link  betw een m icroalbum inuria  an d  
card iovascu lar risk  in  NIDDM, by  increasing  th e  tendency  to 
th rom bosis.
Free rad ical form ation, including th a t  p roduced  by  activated 
n eu tro p h ils  and  endothelial cells, is one po ten tial m echan ism  by 
w hich  endothelial d is tu rb an ce  m ay occur in  d iabetes and  its  v ascu la r 
com plications (Dorm andy 1983; S tringer e t al 1989). The re su lts  of 
th e  p resen t s tu d y  confirm  previous w ork suggesting  increased  free 
rad ica l form ation in  NIDDM (Jennings et al 1987; Collier e t al 1990). 
A lthough m easu res  of free radical form ation were m ore elevated in  
p a tien ts  w ith  m icroalbum inuria , there  were no significant correlations 
betw een  th ese  m easu res and  haem ostatic  factors. A sim ilar lack  of 
corre lation  w as observed betw een lipid peroxides or diene conjugates 
an d  increased  levels of PAI, tPA, VWF and  fibrinogen in  o u r s tu d y  of 
cases of peripheral v ascu la r d isease and  controls (Sm ith e t al 1993). 
T hese d a ta  therefore do n o t su p p o rt the  hypothesis th a t  increased  free 
rad ical form ation is related  to haem ostatic  changes. However fu rth er 
w ork is required  to confirm  or reject th is  hypothesis.
Recently, S h earm an  et al (1992) reported  th a t  exercise in 
c lau d ican ts  induced  free rad ical form ation and  also induced  
m icroalbum inuria . They therefore suggested  th a t  leg ischaem ia  m ight 
cau se  free radical- induced  renal g lom erular dam age. Exercise can  
also induce  m icroalbum inuria  in  diabetics (Viberti e t al 1978).
E ndothelial release of PAI-1, tPA and  VWF can  also be 
s tim u la ted  by  insu lin -induced  hypoglycaem ia in in su lin -d ep en d en t
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diabetic pa tien ts , and  in  non-diabetics; an d  by acu te  exercise in  
d iabetics (more likely in the  younger, m ore active, less obese IDDM 
p a tien ts  th a n  in  NIDDM patients) an d  in  norm al su b jec ts  (Prowse and  
M acGregor 1988). The la s t two ch ap te rs  of th e  p re sen t th es is  therefore 
com pared th e  effects of in su lin -induced  hypoglycaem ia an d  acu te  
exercise in  IDDM p a tien ts  and  in m atched  non-d iabetic  controls.
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CHAPTER 8
EFFECTS OF INSULIN-INDUCED HYPOGLYCAEMIA ON 
PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY. TISSUE 
PLASMINOGEN ACTIVATOR ANTIGEN. FIBRIN D-DIMER ANTIGEN. 
VON WILLEBRAND FACTOR ANTIGEN AND FIBRINOGEN IN 
INSULIN-DEPENDENT DIABETIC PATIENTS AND NON-DIABETIC 
CONTROLS.
INTRODUCTION
In h u m an s , catecholam ines (adrenaline and  noradrenaline) are 
released  in  response  to acu te  hypoglycaemia (Gader et al 1974). This 
catecholam ine release h a s  a  n u m b er of effects on th e  blood, including  
decreased  p lasm a  volum e and  increases in  haem atocrit (Hilsted e t al 
1985), w hite cell and  erythrocyte coun ts  (Frier e t al 1983, 1988) and  
p la te le t aggregation (H utton e t al 1979). Few stu d ies  have looked a t 
th e  effects of acu te  hypoglycaemia, w hich  s tim u la tes  catecholam ine 
release, on fibrinolysis or haem ostasis. A drenaline h a s  been  show n to 
increase  fibrinolytic activity (M acfarlane and  Biggs 1948), an d  factor 
VIII activity (Ingram  1961) and  to m ediate  VWF and  tPA release  from 
endothelium  via J3 adrenergic m echan ism s (Cryer 1980; G ran t e t al 
1987; Prowse and  M acGregor 1988). Arginine vasop ressin  release m ay  
also p lay a  role (Fisher e t al 1987); while grow th horm one probably  
does n o t (Lowe e t al 1982). H yperinsulinaem ia w ithou t hypoglycaem ia 
does n o t re su lt in  changes in VWF or global fibrinolytic activity, 
excluding a  d irect effect of in su lin  on th ese  variab les (G rant e t al
1987). DDAVP, a  syn thetic  analogue of arginine vasopressin , h a s  been  
show n to increase  factor VIII, VWF and  fibrinolytic activity (M annucci
1 1 3
e t al 1977), and  can  be used  in the  trea tm en t of acquired  and  
congenital b leeding disorders.
As d iscussed  in  C hap ters 1 and  3, n o n -in su lin  dependen t 
d iabetic  (NIDDM) p a tien ts  have increased  levels of PAI, tPA, VWF and  
fibrinogen. In in su lin  dependen t d iabetes m ellitus (IDDM) increasing  
levels of VWF are seen, b u t  there  are  conflicting repo rts  on changes in  
fibrinolytic activity, PAI an d  tPA (Fuller e t al 1979; G ough an d  G ran t 
1991). In IDDM, it h a s  been  suggested  th a t  in su lin -induced  
hypoglycaem ia m ay be one m echan ism  causing  increased  release  of 
VWF from endothelium  and  therefore increased  p lasm a  VWF levels 
(Lowe et al 1982). The effects of in su lin  on PAI and  tPA in  d iabetic  and  
non-d iabetic  sub jec ts  are conflicting (Prowse and  M acGregor 1988; 
G ran t e t al 1987; Gough and  G ran t 1991). Insu lin  h a s  been  show n to 
cau se  the  release of PAI-1 from cu ltu red  h ep atom a cells (Alessi e t al
1988). PAI-1 levels in  obese non-d iabetics and  in NIDDM have also 
been  show n to correlate w ith  endogenous in su lin  levels (Juhan-V ague 
et al 1988). However a  s tu d y  looking a t sh o rt-te rm  hyperin su linaem ia  
w ithou t hypoglycaem ia in  d iabetics show ed no effect on the  euglobulin  
clot lysis tim e, a  global te s t of fibrinolytic activity (G rant e t al 1987).
AIM OF STUDY
The aim  of th is  s tu d y  w as to exam ine the  effects of acu te  
hypoglycaem ia on levels of PAI activity, tPA antigen, an d  VWF an tigen  
(as m arkers  of endothelial d istu rbance), as well a s  D -dim er and  
fibrinogen. Normal sub jec ts  were com pared w ith  in su lin - dependen t 
d iabetics in  o rder to determ ine if there  were any  differences in  the  
b asa l levels a n d /o r  p a tte rn  of change betw een the  two groups.
1 1 4
SUBJECTS AND METHODS
Six norm al hea lth y  m ale vo lun ters w ere u sed  as  controls. They 
w ere aged betw een 21-30  years, h ad  a  norm al body m ass  index  and  
none w ere tak ing  m edication. The diabetic p a tien ts  aged 20-39  years 
(m ean age 27 years) were recru ited  by Dr. M F isher from th e  diabetic 
clinic a t  Glasgow Royal Infim aiy. To confirm  the  absence  of 
endogenous insu lin , p lasm a concen tra tions of C -peptide were 
m easu red  and  found to be <0.3 nmol/1, b o th  fasting  an d  in  response  
to 1.0 m g in travenous glucagon. The diabetic p a tien ts  h ad  poor 
glycaem ic control, w ith  glycated haem oglobin values of >10% (norm al 
<8.5%). Four of the  p a tien ts  h ad  d iabetes of less th a n  5 years 
du ra tion , one h ad  du ra tio n  of d iabetes of 17 years, an d  one of 25 
years  (m ean du ra tio n  8 years.) D irect optical ophthalm oscopy  detected  
m ild d iabetic re tino pathy  in  the  two p a tien ts  w ith  th e  longer d u ra tio n  
of d isease. No clinical evidence of peripheral n eu ro p a th y  w as found 
an d  none of th e  p a tien ts  show ed laboratory  evidence of 
m icroalbum inuria  based  on a  latex  agglu tination  te s t (Spooner e t al 
1987).
S ub jects were m ain tained  sup ine  after an  overnight fas t an d  an  
indwelling can n u la  w as in serted  into an  an ticu b ita l vein, a n d  kep t 
p a te n t w ith  150mM saline. At 06 .00h  an  in travenous b o lu s of sh o rt 
acting  in su lin  (H um an Actrapid; Novo, B asingstoke, H ants.) 0 .15  u /k g  
body w eight w as given and  the  tim e to the  o n se t of th e  acu te  
autonom ic response  (R) w as recorded. This reaction  is m an ifest a s  a n  
a b ru p t rise  in  h e a r t ra te  and  the  onse t of au tonom ic sym ptom s (such 
as sweating) and  neuroglycopenic sym ptom s includ ing  confusion  and
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drow siness. In all sub jects, R coincided w ith the  n a d ir  of blood 
glucose. Blood glucose levels were m onitored u sin g  a  Reflolux II 
g lucom eter (BCL, Lewes, E as t Sussex). It w as n ecessa ry  to know  the  
n a d ir  for each  individual, a s  there  is a  biological varia tion  w hich  m u s t 
be ta k e n  in to  accoun t w hen  deciding the  tim es of su b seq u e n t 
sam pling  du ring  the  recovery p h a se  from hypoglycaem ia. The 
expected varia tion  w as found in the  tim e to reach  the  blood glucose 
n a d ir  w ith  a  range of 25-45 m inu tes. To allow for th is  individual 
response  and  m ake com parisons m eaningful, blood sam pling  du ring  
the  recovery p h ase  w as tim ed from R. All sub jec ts  gave w ritten  
inform ed consen t to the  study, w hich  w as approved by th e  hosp ita l's  
E th ica l Com m ittee.
Blood glucose w as m easu red  w ith a  B eckm an au to -an a ly se r 
(Beckm an In s tru m en ts  Inc., Fullerton, California) u sin g  the  glucose 
oxidase m ethod. P lasm a levels of PAI activity, tPA antigen , VWF 
antigen , D -dim er antigen, fibrinogen an d  fibrin p la te  lysis a re a  w ere 
m easu red  as described in  C hap ter 2. P lasm a levels of ad renaline  and  
no rad renaline  were m easu red  in th e  MRC Blood P ressu re  U nit a t  the  
W estern  Infirm ary, Glasgow by radioenzym ic assays (Ball e t al 1986).
S ta tis tica l analysis w as perform ed by  Dr. M F isher u sin g  the  
Starview  512 package (Brainpower Inc., C alabasas, CA, USA) on a n  
Apple M acintosh SE C om putor (Apple C om puter UK Ltd., Hemel 
H em pstead, H erts., UK). C hanges w ith in  a  group were com pared  u sin g  
S tu d e n t's  t- te s t for paired data . C om parisons of b a sa l va lues betw een 
the  two groups were m ade using  S tu d e n t's  t- te s t for u n p a ired  da ta , 
and  com parisons betw een the  g roups in  response  to hypoglycaem ia 
were m ade by  u sing  analysis of variance for repeated  m easu res. The
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re su lts  are p resen ted  as m eans and  SEM. P values of less th a n  0 .05  
w ere considered significant.
RESULTS
Evidence of hypoglycaem ia w as seen  in  all sub jec ts  w ith  
increased  h e a r t ra te , sw eating an d  m oderate  neuroglycopenia. The 
m ean  tim e to the  acu te  au tonom ic response  (R) show ed no differences 
in  the  two groups: norm al sub jec ts  26±2 m in u tes  and  diabetic 
p a tien ts  30±4 m inutes.T here  were no diferences in  h e a r t  ra te  or blood 
p resu re  responses betw een the  two groups.
Blood G lucose
Sim ilar baseline  concen tra tions of blood glucose w ere found in 
p a tien ts  an d  controls w ith a  m ean  of 4.8±0.2 m m ol/1 in  controls and  
4 .6± 0 .4m m ol/l in pa tien ts . The n ad ir of blood glucose achieved by the  
two groups w as also sim ilar (Figure 8.1).
C atecholam ines
In th e  control group the  p lasm a adrenaline  concen tra tions rose  
from  0.110.1 to 2 .410.2  nm ol/1 a t R '+15 m in  (S tuden t's  t-te s t, 
p<0.001). The rise in  the  diabetic group w as less, reach ing  a  
m axim um  of 1.810.4 nm ol/1 (analysis of variance, p<0.05). The 
p lasm a  concentration  of noradrenaline  increased  in response  to 
hypoglycaem ia in bo th  groups and  no significant difference w as 
observed betw een the  two groups. (Figure 8.2).
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F ib rin  Plate Lvsis Area
Global fibrinolytic activity as m easu red  by  th e  fibrin p la te  lysis 
a re a  (FPLA) w as h igher in the  control group th a n  th e  d iabetics (143± 
15m m ^ vs 124± 15m m ^ p=0.357). The FPLA rose significantly  in  the  
contro l group to 193± 26m m 2 a t R  +15m in (p<0.01); an d  sim ilarly  in  
th e  diabetic  group to 155± l lm m ^  (analysis of variance p=0.67).
PAI activity.
B aseline PAI w as n o t significantly different in  th e  control and  
diabetic groups. PAI activity show ed a  significant fall in  controls, 
d ropping from  117±9% to 95±16% a t R' (p<0.05) The response  of the  
diabetic p a tien ts  w as no t significantly different w ith  a  fall from  1 17±20 
% to 82±11 %  (analysis of variance p=0.26) (Figure 8.3).
TPA an tigen
B asal concen trations of tPA an tigen  were significantly  reduced  
in  the  diabetic  pa tien ts  com pared to controls, a t 3 .4±0.7 vs 8 .5±1.3 
n g /m l ( p<0.01). The increase  in response  to hypoglycaem ia w as lower 
th a n  in  th e  control group, b u t  th is  w as n o t s ta tistica lly  significantly 
different. tPA antigen levels rose to 11.1 ± 2.5 n g /m l a t  R+15m in in  
controls, an d  to 5.3±2.2 n g /m l in d iabetics ( analysis of variance, p= 
0.26) (Figure 8.3).
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VWF antigen
The b asa l levels of VWF antigen  in p a tien ts  and  controls were 
no t significantly different, a lthough  h igher in  the  d iabetics (75±9iu/d l 
for controls an d  104± 25iu /d l for patien ts). There w as a n  increase  in  
VWF levels in  bo th  groups in  response  to hypoglycaem ia, an d  th e  
increase  in  th e  diabetic group w as significantly g rea ter th a n  th e  
controls (analysis of variance, p<0.02). A m axim um  of 130± 30 iu /d l 
w as seen  in p a tien ts  a t R + 60m ins as com pared to 109± 8 iu /d l in  the  
controls (Figure 8.4).
D -dim er an tigen
No significant changes were observed in D -dim er levels in  
response  to hypoglycaem ia in e ither group, w ith  concen tra tions in  th e  
control sub jec ts  of 36±6 n g /m l basally , 35 ± 5 n g /m l a t  R, 35 ± 7 
n g /m l a t R+15m in, and  33 ± 8 n g /m l a t R+60m in; an d  concen tra tions 
in  the  diabetic p a tien ts  of 38 ± 4 n g /m l basally , 36  ± 5 n g /m l a t  R, 
and  35 ± 5 n g /m l a t R+15m in, and  35 ± 5 n g /m l a t R+60m in.
Fibrinogen
B aseline fibrinogen levels were n o t significantly different in  the  
control and  diabetic  groups; a lthough  they  tended  to be h igher in 
diabetics. F ibrinogen levels did n o t change in  response  to 
hypoglycaem ia (Figure 8.4).
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DISCUSSION
In th is  study , p a tien ts  w ith  in su lin -d ep en d en t d iabetes m ellitus 
(IDDM) show ed a  tendency  to h igher levels of VWF an tigen  and  
fibrinogen th a n  in non-d iabetic  controls, in  accordance w ith  previous, 
la rg e r s tu d ies  (O sterm an an d  van  de Loo 1986). S tud ies of PAI activity 
a n d  tPA an tigen  have show n conflicting re su lts  in  IDDM (G rant an d  
M edcalf 1990). In the  p resen t study , IDDM p a tien ts  h ad  significantly 
low er tPA an tigen  levels, sim ilar levels of PAI activity, an d  a  tendency  
to lower global fibrinolytic activity, as m easu red  by the  fibrin p late  
ly sis  area.
In th is  study , the  expected changes in  fibrinolysis were observed 
d u rin g  acu te  hypoglycaem ia. Total p lasm inogen activator as m easu red  
b y  th e  fibrin  p late lysis a rea  w as increased  in  b o th  controls and  
d iabetic  sub jects. tPA an tigen  w as seen  to increase  an d  PAI activity to 
fail in  b o th  groups. These findings are co n sis ten t w ith  the  endothelial 
re lease  of tPA and  the  form ation of PAI-tPA com plexes and  clearance 
from  th e  circu lation . Only one previous s tu d y  (D alsgaard-N ielsen e t al 
1982) com pared  changes in  fibrinolysis in  in su lin -d ep en d en t d iabetics 
a n d  non-d iabetic  controls, u sing  th e  euglobulin  clot lysis tim e a s  a  
global te s t  of fibrinolytic activity. They found a  g rea ter increase  in  
fibrinolytic activity ("potential") in  controls th a n  in  d iabetics. The 
global fibrinolytic response  to hypoglycaem ia in  th e  p re sen t s tu d y  (as 
m ea su re d  by  the  fibrinolytic activity of the  euglobulin  fraction on 
fib rin  plates) likewise appeared  lower in  d iabetics a lthough  the  
difference w as no t sta tistica lly  significant (Figure 8.3). Likewise, there  
w a s  a  tren d  for lower tPA an tigen  increm ents in  diabetics, a lthough  
th is  difference also w as n o t sta tistica lly  significant (Figure 8.3). T his
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m ay be a  m an ifesta tion  of endothelial d istu rbance . On the  o ther h an d , 
VWF release  w as grea ter in  d iabetics (Figure 8.4).
T hese changes appeared  m axim al a t the  tim e of peak  p lasm a 
catecholam ine activity (Figure 8.1 and  8.2), co n sis ten t w ith  the  
p o stu la ted  3  adrenergic m echan ism  of tPA release from  endothelium  
(Prowse a n d  M acGregor 1988).
D espite the  hypoglycaem ia induced  increases in  VWF an d  tPA 
an tigen  observed in  th is  study, there  w as no detectab le  increase  in  
fibrin form ation or lysis, as m easu red  by  D -dim er levels. T his 
observation  is co n sis ten t w ith previous repo rts  (M arsh an d  Gaffney 
1982).
In conclusion, th is  s tu d y  (and th a t  of D alsgaard-N ielsen e t al 
1982) suggests  th a t  IDDM p a tien ts  m ay have im paired endothelial 
function, a s  m easu red  by a  lesser release of tPA in response  to 
insu lin . The power of these  stud ies w as lim ited by th e ir sm all sam ple 
size, w hich  is u n d e rs tan d ab le  because  few p ersons are  p repared  to 
vo lun teer for insu lin -induced  hypoglycaem ic s tre ss . The ability of 
th ese  s tu d ies  to dem onstra te  differences betw en su b jec t g roups is also 
lim ited by  the  im precision of tim ing of m axim al au tonom ic response  
(R). N evertheless, the  significant acu te  increase  in VWF an tigen  in  
IDDM p a tien ts  suggests th a t  in su lin  independen t hypoglycaem ia m ay 
be one m echan ism  for the  chronic elevation in  p lasm a  VWF in  IDDM 
(Lowe e t al 1982). The lower baseline  level of tPA an tigen  in  IDDM in  
th e  p re se n t s tu d y  is unexplained; a lthough  as  noted  above decreased  
endothelia l release of tPA m ay be an o th e r m an ifesta tion  of endothelial 
d is tu rb an c e  in  th is  condition.
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CHAPTER 9
THE EFFECTS OF SUBMAXIMAL EXERCISE ON PLASMINOGEN 
ACTIVATOR INHIBITOR ACTIVITY. TISSUE PLASMINOGEN 
ACTIVATOR ANTIGEN. VON WILLEBRAND FACTOR ANTIGEN AND 
FIBRINOGEN IN INSULIN-DEPENDENT DIABETIC PATIENTS AND 
NON-DIABETIC SUBJECTS.
INTRODUCTION
P atien ts w ith in su lin -dependen t d iabetes m ellitus (IDDM) m ay 
have im paired endothelial response  (release of tP A ) to in su lin -induced  
hypoglycaemia (C hapter 8). Acute subm axim al exercise also releases 
tPA (and VWF) from  endothelium , again v ia  J3 adrenergic m echan ism s 
(Prowse an d  M acGregor 1988). C ash  and  McGill (1969) show ed th a t  
IDDM p a tien ts  h a d  an  im paired increase  in global fibrinolytic activity 
(as m easu red  by the  euglobulin clot lysis time) after acu te  exercise 
com pared to non-d iabetic  m atched  controls. There are  no reported  
s tu d ies  of the  effects of exercise on specific fibrinolytic variab les (PAI 
o r tPA) or VWF in  IDDM com pared to non-d iabetic  controls.
AIM OF STUDY
T he aim  of th is  s tu d y  w as to investigate changes in  PAI activity, 
tPA antigen , VWF an tigen  and  fibrinogen in  response  to subm axim al 
exercise in  IDDM p a tien ts  and  in  m atched  non-d iabetic  control 
sub jects.
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SUBJECTS AND METHODS
E ight control sub jec ts  and  eight age m atched  in su lin -d ep en d en t 
d iabe tics  (20-35yrs) were enrolled in  the  s tu d y  by  Dr. A Collier. All 
w ere m ale. The diabetic p a tien ts  were poorly controlled (m ean HbA j 
10.4  SEM 0 .4  %; norm al range 5-8%  ), and  d u ra tio n  of d iabetes 
ran g ed  from 4-13 years.
After an  overnight fast, an  indwelling c an n u la  w as in se rted  into 
a n  an tecu b ita l vein a t 08 .00h. In order to p revent hypoglycaemia, 
p a tie n ts  were given a  reduced  dose of sho rt-ac ting  in su lin  20  m in 
p rio r to a  s ta n d a rd  (40G carbohydrate) b reakfast.
R esting an d  treadm ill electrocardiography were perform ed u sin g  
th e  B ruce protocol. Control sub jec ts  and  diabetic p a tien ts  were 
exercised  u n til tiredness or u n til th e  developm ent of lim iting 
sym ptom s. S tan d ard  12 lead electrocardiogram s were perform ed 
before an d  im m ediately after exercise, while du ring  th e  te s t  th e  h e a r t 
ra te  an d  electrocardiogram  were m onitored con tinuously  in  th ree  
electrocard iographic leads. All those involved in  the  s tu d y  h a d  norm al 
re s tin g  electrocardiogram s w ith no abnorm al changes du ring  or after 
exercise. All sub jec ts  gave w ritten  inform ed consen t to the  study , 
w h ich  w as approved by the  hosp ita l's  E th ical Com m ittee.
Blood sam ples were tak en  before an d  a t 0, 15, 30, 60  an d  120 
m in u te s  after exercise. PAI activity, tPA antigen, VWF antigen, 
fibrinogen and  haem atocrit were m easu red  a s  described  in  C h ap te r 2. 
D -dim er levels were n o t m easu red  b ecau se  of th e  lack  of change
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following hypoglycaemia (C hapter 8) or after exercise a s  show n in  a  
p rev ious s tu d y  (M arsh an d  Gaffney 1982). G lucose, glycated 
haem oglobin, catacholam ines and  cortisol were also m easu red  a s  
described  in  C hap ter 8.
S ta tis tica l analysis w as perform ed jo in tly  by  Dr. A Collier and  
m yself. C hanges w ith in  a  group were com pared u sin g  S tu d e n t's  t- te s t 
for paired  da ta , and  b asa l values betw een groups u sin g  S tu d e n ts 's  t- 
te s t  for u n p a ired  data . C om parisons betw een the  g roups in  response  
to  hypoglycaemia were m ade u sing  analysis of variance  for repeated  
m easu res . The re su lts  are  p resen ted  as  m ean  ± SEM.
RESULTS
T here w as no significant difference in  the  d u ra tio n  of exercise 
betw een th e  control and  s tu d y  groups (15-18m ins). T here were also no 
differences in  the  h e a rt ra te  and  blood p ressu re  m easu rem en t 
betw een th e  control sub jects and  th e  diabetic p a tien ts  (data  n o t 
shown).
Blood G lucose
As expected, there  were significant differences betw een d iabetics 
and  control sub jec ts  a t all tim e poin ts in  the  s tu d y  (Figure 9.1).
C atecholam ines and  cortisol
T here were no significant differences in  no rad renaline , 
ad renaline  (Figure 9.1) or cortisol (Figure 9.3) in  reponse  to exercise 
betw een th e  two groups.
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Figure 9 .2  C hanges in  PAI activity, tPA antigen  an d  VWF in  response  
to acu te  exercise, in  d iabetic p a tien ts  (solid circles) an d  non-d iabe tics 
(open circles). D ata  given a s  m ean  an d  SEM.
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Figure 9 .3  C hanges in  fibrinogen, haem atocrit a n d  cortisol in  
response  to ‘acu te  exercise in  d iabetic p a tien ts  (solid circles) a n d  non- 
d iabetics (open circles). D ata  given a s  m ean  and  SEM.
PAI activity
B aseline PAI activity w as sim ilar in  the  contro ls and  diabetic 
g roup  (75 ± 9.9%  in  controls; 70 ± 7.4%  in  d iabetics ), b u t  th e  fall in  
PAI activity a t the  end of the  exercise period w as m ore m arked  in  the  
controls; 75 ± 10% to 7 ± 2% (p< 0.002) in controls com pared to 75 ± 
10% to 29 ± 8%( p<0.02) in  d iabetics (Figure 9.2).
tPA an tigen
B asal concen tra tions of tPA were sim ilar in  th e  control an d  
IDDM groups (3.0 ± 0.8 vs 2 .4  ± 0.2 ng/m l). However a t  the  end of the  
period of exercise, tPA an tigen  levels rose in the  control sub jec ts  to 
26 .0  ± 2 .6  n g /m l com pared to only 10.2 ± 1 . 9  n g /m l in  th e  diabetic 
group (analysis of variance p=0.0019) (Figure 9.2).
VWF antigen
T here w as no significant difference betw een baseline  VWF levels 
in  th e  two groups. There w as no sta tistically  significant difference 
betw een th e  two groups in  the  response  of VWF to exercise (Figure 
9.2), a lthough  a  slightly g reater increase  w as observed in  th e  control 
group, from  a  b asa l level of 84 ± 12 iu /d l  to a  m axim um  of 186 ± 18 
iu /d l  15 m ins after exercise (p<0.0001). In the  diabetic  group, the  
VWF levels rose from a  b asa l level of 81 ± 13 iu /d l  to a  m axim um  of 
161 ± 2 1  iu /d l, 60 m ins after exercise (p<0.001).
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Fibrinogen
There w as no significant change in  the  p lasm a  fibrinogen levels 
in  response  to exercise in  e ither of the  two groups, n o r any  significant 
difference in  th e  baseline  levels (Figure 9.3).
Haem atocrit
The haem atocrit rose significantly from baseline  after exercise 
(p<0.05), w ith  a  sim ilar increase  in  bo th  IDDM and  control groups. No 
difference w as observed in baseline levels (Figure 9.3).
DISCUSSION
In th is  study , acu te  subm axim al exercise p roduced  the  expected 
increase  in tPA antigen, in  bo th  controls and  IDDM groups (Prowse 
an d  M acGregor 1988). PAI activity levels fell in  b o th  groups, 
c o n sis ten t w ith com plex form ation betw een tPA an d  PAI and  th e ir 
c learance from  the  circu lation  (Prowse and  M acGregor 1988). In the  
d iabetic  group, exercise caused  a  lesser increase  in  tPA levels, and  
henceforth  a  lesser decrease in  PAI activity com pared w ith  th e  control 
sub jec ts. T hese re su lts  are consisten t w ith  the  s tu d y  of C ash  an d  
McGill (1969) w hich observed a  lower global fibrinolytic response  to 
exercise in  IDDM patien ts; and  suggest decreased  endothelial 
response  (tPA release) to exercise in IDDM, w hich m ay also explain th e  
non-sign ifican t tren d  to lower VWF release in  response  to exercise. 
Alternatively, the  difference m ay reflect differences in  hepatic  blood
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flow, w hich  clears tPA from the  circu lation  (de Boer e t al 1993). The 
differences in  tPA release canno t be explained by different degrees of 
haem oconcentration (increased haem atocrit, due to decreased  p lasm a  
volume) in  the  two s tu d y  groups (Figure 9.3); n o r by  different 
catecholam ine or cortisol responses (Figures 9.1 and  9.2).
The sm aller increase  in  tPA release in  IDDM p a tien ts  com pared 
to controls dem onstra ted  in th is  s tu d y  are  sim ilar to the  lower tPA 
release provoked by  in su lin -induced  hypoglycaemia (C hapter 8), w hich  
again  m ay reflect an  im paired endothelial response  to catecholam ine 
increase.
In conclusion, we have observed th a t  exercise cau ses  sm aller 
increases in tPA antigen, and  possibly  in VWF antigen , in IDDM 
p a tien ts  com pared to controls. These differences a re  consisten t w ith 
endothelial dysfunction  in  IDDM.
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CHAPTER 10
GENERAL DISCUSSION AND SUGGESTIONS FOR FURTHER WORK
P lasm a p lasm inogen activator inh ib ito r (PAI) activity
A strup  and  Perm in (1947) originally proposed th a t  im paired  
fibrinolysis m ay lead to decreased  rem oval of a rteria l fibrin deposits, 
and  th u s  atherosclerosis and  arteria l th rom bosis. As d iscussed  in  
C hap ter 1, recen t s tud ies have confirm ed th a t  fibrin plays an  
im p o rtan t p a rt in atherosclerosis and  th rom bosis. P lasm a levels of 
p lasm inogen activator inh ib ito r (PAI) activity (which in  n o n -p reg n an t 
persons is m ainly PAI-1 activity) is th e  m ain  d e te rm in an t of p lasm a  
fibrinolytic po ten tial w hich it inh ib its. High levels of PAI activity m ay  
therefore be a  causa l factor in  a therosclerosis and  th rom bosis. T his 
possibility  w as supported  by the  findings of H am sten  e t al (1987) of 
h igh PAI activity in survivors of p rem atu re  m yocardial infarction, 
w hich predicted  fu rth e r infarction.
The s tu d y  of laboratory  and  biological (longitudinal) variability  
in  PAI activity (C hapter 2) found th a t  b o th  were acceptable w hen  
m easu red  over a  4-week period, over a  range of norm al and  ra ised  
levels in  p a tien ts  w ith  a rteria l d isease (in te rm ittan t claudication). The 
s tu d y  of variability  in  a  population  sam ple  (C hapter 3) show ed th a t  
d iu rn a l varia tion  , se rum  triglycerides, alcohol in tak e  (in men) an d
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d iabe tes m ellitus h ad  significant effects on p lasm a  PAI activity. T hese 
findings are  consis ten t w ith  o ther stud ies .
In th e  case control s tu d y  of previous m yocardial infarction, PAI 
activity  w as significantly h igher in  in farc t survivors (C hapter 4). In 
m en, th is  w as n o t explained by  s ta n d a rd  risk  factors su c h  a s  
triglyceride levels. These findings confirm  an d  extend previous 
findings of high PAI activity in  m en w ith ischaem ic h e a r t d isease  
(IHD). However PAI activity w as n o t a  p red ictor of IHD events w hen 
m easu red  in  stored  p lasm a sam ples from  the  prospective Caerphilly 
H eart s tu d y  (C hapter 5). This negative finding m ight be explained by  
prolonged sam ple storage a lthough  th is  is unlikely  (see d iscussion  in  
C h ap te r 5). While it is possible th a t  PAI-1 activity does p lay  a  role in 
IHD, it appeares from th is  study, and  th a t  of R idker e t al (1992), th a t  
it is n o t a  r isk  pred ictor for IHD events.
In th e  population  s tu d y  (C hapter 3), PAI activity correlated  w ith  
in terleuk in -6 , a  cytokine involved in  th e  acu te -p h ase  pro te in  reaction . 
F u rth e r  s tu d ies  are suggested to determ ine w he ther or n o t th is  is a  
d irec t effect in  m an, as suggested by  the  experim ental s tu d ies  of 
K ru ithof (1993) in  baboons. A ntagonists of IL-6 m ay be a  po ten tial 
ap p ro ach  to lowering elevated PAI activity levels, an d  thereby  
s tim u la tin g  endogenous fibrinolysis in  m an.
P lasm a PAI activity m ay be determ ined n o t only by 
environm ental factors and  cytokines, b u t  also by genetic varia tion  a t 
the  PAI-1 locus. D awson and  H enney (1991) identified a  guanosine  
in sertion  /  deletion polym orphism , -675 base  pa irs  u p s tre am  from th e  
s ta r t  of tran scrip tio n  of the  PAI-1 gene, w here one allele h ad  a
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sequence  of four guanosines (4G) and  the  o ther h ad  five guanosines 
(5G). 4G hom ozygotes h ad  h igher p lasm a  PAI activity th a n  4G /5 G  
heterozygotes or 5G /5G  hom ozygotes, w hether or n o t they  h ad  
ischaem ic  h e a r t d isease (Dawson and  H enney 1992; Ye et al 1995). In 
n o n -in su lin -d ep en d en t d iabetes m ellitus, recen t s tu d ies  suggest th a t  
th e  4G genotype is m ore frequent in  those  w ith  ischaem ic h e a r t 
d isease  and  is also associated  w ith  increasing  PAI levels w ith  p lasm a  
glucose or triglyceride (Mansfield et al 1995). F u rth e r  s tu d ies  m ight 
therefore investigate the  com bination of PAI levels, genotypes, glucose 
in to lerance, lipid levels and  m arkers of the  acu te  p h ase  reaction  in  
card iovascu lar d isease and  diabetes. High PAI-1 levels were observed 
in  NIDDM p a tien ts  w ith  m icroalbum inuria  (C hapter 7), co n sis ten t 
w ith  endothelial dam age in su c h  pa tien ts . At p resen t, th ere  is 
evidence th a t  high p lasm a  PAI-1 levels can  be reduced  by w eight 
reduction , exercise, or m etform in trea tm en t of NIDDM (Gris e t al 
1990; Ju h an -V ag u e  and  Alessi 1993). R eduction in PAI-1 levels is one 
possible  m echan ism  for the  card iovascu lar benefits of these  
trea tm en ts .
P lasm a tis su e  plasm inogen activator (tPA) antigen
As d iscussed  in C hap ter 1, elevated tPA an tigen  levels are  
associated  w ith  elevated PAI-1 levels, probably  due to circu lating  tPA- 
PAI-1 com plexes. They m ay also reflect endothelial d is tu rbance , an d  
m ay be predictive of IHD.
The s tu d y  of laboratory  and  biological (longitudinal) variability  
in  tPA an tigen  (C hapter 2) found th a t  bo th  were acceptable w hen  
m easu red  over a  4-week period, and  th a t  bo th  were of a  sim ilar 
m agn itude  to PAI activity. The s tu d y  of variability  in  a  population
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sam p le  (C hapter 3) confirm ed th a t  tPA an tigen  correlated  w ith  PAI 
activ ity  (r = 0.3-0.4) and  w ith several card iovascu lar r isk  factors 
Includ ing  age, m ale sex, tim e of day, c igarette-sm oking, triglyceride, 
alcohol consum ption  and  (in men) haem atocrit and  red  cell 
aggregation. C om parison w ith  PAI activity, VWF levels an d  red cell 
aggregation suggested  th a t  som e of th ese  associations m ay reflect 
c ircu la ting  PAI-tPA com pexes, and  o thers m ay reflect endothelial 
d is tu rb an ce  or acu te -p h ase  reactions.
In the  case-control s tu d y  of previous m yocardial infarction, tPA 
an tigen  w as significantly h igher in  in farc t survivors (C hapter 4). 
However th is  w as n o t sta tistically  significant on m ultivariate  analysis, 
suggesting  th a t  o ther risk  factors accoun ted  for th is  difference. 
Likewise, the  significant predictive value of tPA an tigen  for IHD events 
in  the  Caerphilly H eart S tudy  (C hapter 5) w as accoun ted  for by o ther 
risk  factors on m ultivariate  analysis, a s  in the  s tu d y  of R idker e t al 
(1993a,b). On the  o ther hand , th ree  recen t s tu d ies  have found th a t  
tPA an tigen  w as an  independen t p red ic to r of IHD events in  p a tien ts  
w ith  an g in a , who have h igher tPA levels (Jan sso n  e t al 1993; R idker e t 
al 1994b; T hom pson e t al 1995). T hese findings suggest th a t  there  
m ay be a  th resho ld  a t w hich high p lasm a  tPA levels p red ict 
th rom botic  events, and  th a t  endothelial d is tu rb an ce  (which re leases 
tPA) m ay  play a  role. F u rth e r s tud ies  are  suggested  to estab lish  th e  
clinical predictive value of tPA an tigen  in  p a tien ts  w ith  a rteria l 
d isease.
The s tu d ies  of diabetic p a tien ts  show ed h igher tPA an tigen  
levels in  NIDDM p a tien ts  w ith m icroalbum inuria , w hich  again  
suggests endothelial d istu rbance  in su c h  p a tien ts  (C hapter 7).
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Y ounger p a tien ts  w ith  IDDM and  m inim al com plications h a d  im paired 
endothelial release of tPA antigen  in response  to in su lin -induced  
hypoglycaem ia (C hapter 8) or exercise (C hapter 9) com pared  to 
m atch ed  non-d iabetic  controls. This w as accom panied  by  a  lesse r fall 
in  p la sm a  PAI activity levels (the fall probably  reflecting form ation of 
tPA-PAI-1 complexes). Im paired tPA release m ay be a  m ore sensitive 
in d ica to r of endothelial d is tu rb an ce  th a n  elevated tPA levels. F u rth e r  
s tu d ie s  of release of endothelial tPA in  response  to exercise are  
suggested  in  o ther g roups of pa tien ts  a t increased  risk  of IHD, for 
exam ple p a tien ts  w ith hyperlip idaem ia or hypertension .
P lasm a von W illebrand factor (VWF) antigen
As d iscussed  in  C hap ter 1, p lasm a levels of VWF an tigen  m ay 
be an o th e r m ark er of endothelial d is tu rb an ce  in  a therosclerosis and  
d iabetes m ellitus. The s tu d y  of laboratory  an d  biological (longitudinal) 
variability  of VWF (C hapter 2) found th a t  while labora to ry  variability  
w as sim ilar to PAI activity and  tPA antigen, longitudinal variability  
w as m u ch  lower. This m ay reflect its  longer circu lation  half-life, an d  is 
advan tageous in  defining an  individual p e rson 's  m ean  level accu ra te ly  
from  a  single sam ple.
The s tu d y  of variability  in  a  popu lation  sam ple  (C hapter 3) 
show ed re la tionsh ips of VWF to age, cigarette-sm oking and  d iabetes 
m ellitus. Unlike PAI activity and  tPA antigen, VWF an tigen  w as n o t 
re la ted  to variables of the  "insulin res istance  syndrom e". T his suggests 
th a t  elevated levels of PAI-1 and  tPA an tigen  in th is  syndrom e m ay 
reflect increased  hepatic  syn thesis of PAI-1 (?in response  to
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trig lyceride-rich  VLDL), ra th e r  th a n  increased  release  of PAI-1 /tP A  
from  endothelium .
The case-contro l s tu d y  of previous m yocardial infarction  show ed 
th a t  VWF an tigen  w as h igher in cases. On m ultivariate  analysis, VWF 
an tigen  w as significantly h igher in  fem ale cases b u t  n o t m ale cases. 
O n th e  o th er h an d , VWF w as a  significant in d ep en d en t p red ic to r of 
IHD events in  the  Caerphilly H eart S tudy  (C hapter 5), an d  show ed a  
tren d  to prediction  of fatal IHD events in  the  E d inburgh  C laudication  
S tudy  (C hapter 6). Recently, M eade et al (1994a) found th a t  VWF w as 
also a  significant independen t pred ictor of IHD events in  the  
N orthw ick P ark  H eart S tudy. W oodbum  (1995) also found th a t  VWF 
w as a n  independen t p redictor of peripheral a rteria l graft occlusion. 
T aken  together, these  observations suggest th a t  fu rth e r s tu d ies  of 
VWF an tigen  in prediction of IHD would be w orthw hile. R aised VWF 
levels m ay reflect underly ing  endothelial d is tu rbance , for exam ple due 
to a therosclerosis. They m ay also prom ote th rom bosis by  increasing  
p late le t adhesion  an d  aggregation.
NIDDM p a tien ts  w ith m icroalbum inuria  also h ad  h igher VWF 
levels th a n  those w ithou t m icroalbum inuria  (C hapter 7), again  
suggesting  endothelial d istu rbance . As w ith  tPA antigen , IDDM 
p a tien ts  show ed a  lesser release of VWF an tigen  th a n  non-d iabetic  
contro ls to in su lin -induced  hypoglycaem ia (C hapter 8) an d  to exercise 
(C hapter 9). This again  suggests endothelial d is tu rb an ce  in  su c h  
p a tien ts . F u tu re  s tu d ies  of bo th  tPA and  VWF release  in  response  to 
exercise are  suggested  in  o ther g roups a t  increased  risk  of IHD, for 
exam ple p a tien ts  w ith hyperlip idaem ia or hypertension .
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P lasm a fibrin D -dim er antigen
P lasm a levels of PAI and  tPA ind icate  the  fibrinolytic po ten tia l of 
p lasm a, b u t do n o t m easu re  ongoing lysis of fibrin in  vivo. In the  
s tu d ie s  reported  in  th is  thesis , p lasm a  D -dim er an tigen  w as m easu red  
a s  a  m ark e r of fibrin form ation and  cross-linking  (through activation  
of th e  coagulation system ) followed by  fibrin lysis by  p lasm in  to  yield 
cross-linked  degradation  p roducts possessing  D -dim er antigen .
The s tu d y  of laboratory  and  biological (longitudinal) variability  
in p lasm a  D -dim er an tigen  (C hapter 2) found th a t  labora to ry  
variability  w as h igher th a n  for PAI, tPA or VWF (16%); how ever 
biological variability  w as low over 4 w eeks (1%). T hese stab le  levels of 
D -dim er m ay reflect its  longer circu lating  half-life, and  a s  w ith  VWF 
m ay be advan tageous in  th a t an  individual p e rson 's  level m ay  be 
determ ined  accura te ly  from a  single p lasm a  sam ple.
The s tu d y  of variability  in a  popu lation  sam ple (C hapter 3) 
show ed increasing  D -dim er an tigen  w ith  age and  w ith  previous h isto ry  
of a n g in a  in  m en. A ddition of o ther haem atological variab les to m odels 
show ed th a t  VWF, red cell aggregation and  fibrinogen w ere also 
assoc iated  w ith  D-dim er. Fibrin  tu rnover m ay therefore increase  w ith 
age b ecau se  of underly ing  arteria l d isease, endothelial d is tu rbance , 
a cu te -p h ase  reactions, or increasing  p lasm a  levels of fibrinogen from 
w hich  fibrin is formed.
The case-contro l s tu d y  of previous m yocardial infarction  show ed 
th a t  D -dim er w as h igher in  cases, and  th a t  th is  w as n o t explained by
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o th er r isk  factors (C hapter 4). D-dim er w as also the  strongest 
in d ep en d en t p red ictor of IHD events in  the  C aerphilly H eart S tudy  
(C hapter 5). Cortellaro e t al (1993) and  R idker et al (1994a) recently  
ob tained  sim ilar resu lts . These resu lts  m ay reflect th e  association  of 
D -dim er w ith  underly ing  atherosclerosis (Reid 1991; A l-Zahrani e t al 
1993; Sm ith  e t al 1993; Lee et a ll9 9 5 ; W oodburn e t al 1995). D -dim er 
levels p redicted  progression  of a therosclerosis in  the  E d inburgh  
C laudication  S tudy  (C hapter 6). These findings are  co n sis ten t w ith  th e  
R okitansky-D uguid hypothesis; th a t  fibrin form ation con tribu tes to 
coronary  an d  peripheral a therosclerosis (Duguid 1946).
We have recently  found th a t D -dim er levels are  ra ised  in  a tria l 
fibrillation, in  w hich there  is an  increased  risk  of throm boem bolism  
from  the  h e a r t (Lip et al 1995). W arfarin, w hich decreases th e  r isk  of 
th rom bosis , norm alised  D -dim er levels in these  pa tien ts . Persons w ith 
ra ised  D -dim er levels m ay therefore benefit from  w arfarin  in 
preven tion  of throm bosis. F u rth e r stud ies are suggested  to explore 
th is  possib ility .
It is possible th a t  increased  D -dim er levels reflect th e  body's 
response  to increased  form ation of in trav ascu la r fibrin, ra th e r  th a n  
th e  activation of the  fibrinolytic system . The effect of w arfarin  in  
lowering D -dim er levels (Lip et al 1995) is co n sis ten t w ith  th is  
hypothesis. On the  o ther hand , acu te  increase  in  tPA levels in  
response  to in su lin -induced  hypoglycaem ia did n o t re su lt in  increased  
D -dim er levels (C hapter 8). Likewise, M arsh and  Gaffney (1982) found 
no increase  in  D -dim er levels following release of tPA by acu te  
exercise. In these  stud ies, lack of in trav ascu la r fibrin m ay be th e
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exp lanation  of w hy increase  in tPA levels is no t followed by increased  
D -dim er levels.
C onclusion
R ecent advances in  laboratory  technology (chrom ogenic activity 
an d  ELISA assays) have allowed m easu rem en t of specific com ponents 
of fibrinolysis and  of endothelial p roducts. The s tu d ies  reported  in  th is  
th es is  suggest th a t  the  a ssays of PAI activity, tPA antigen , VWF 
an tigen  and  D -dim er an tigen  are potentially  usefu l in  study ing  th e ir 
roles in  card iovascu lar d isease and  d iabetes m ellitus. The re su lts  of 
these  s tu d ies  suggest several lines of fu tu re  research , and  also 
suggest several considerations for in te rp re ta tion  of th e ir p lasm a  levels.
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